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ABSTRACT 
 
 
 
 Uropathogenic Escherichia coli (UPEC) cause the overwhelming majority 
of community-acquired urinary tract infections (UTI) worldwide. A particularly 
problematic aspect of UPEC-associated UTI is the rate of recurrent infections—
one in four UTIs will recur within six months of the initial infection. In the majority 
of cases, the strain responsible for the primary infection is identical to the strain 
causing the recurrent infection. Usually, the urinary tract is maintained as a 
sterile environment by an array of host defenses. Some of the genetic 
mechanisms by which UPEC cope with or subvert host defenses in order to 
colonize and persist within the urinary tract is the primary focus of this thesis. I 
start by exploring the effects of global metabolic and stress response 
transcriptional regulation on the virulence potential of UPEC within the murine 
urinary tract. Therein, I better define the metabolic and stress response 
limitations affecting UPEC colonization of this niche. I then address the 
advantages of chromosomally encoded toxin-antitoxin systems in allowing for 
niche-specific colonization of the urinary tract and explore how these small 
genetic elements can specifically affect the stress resistance and antibiotic 
persistence of UPEC. This work, specifically, identifies a novel target for 
chemotherapeutic agents that would theoretically home in on and hinder only 
uropathogenic subsets of E. coli, combating UTI while leaving commensal E. coli 
  iv 
unphazed. Lastly, I attempt to better understand the generation of UPEC stress 
resistance by studying the evolutionarily conserved genomic rearrangement of 
chromosomally encoded toxin-antitoxin hicAB within these pathogens. I found 
that constructing this evolutionarily conserved hicAB truncation within the 
ancestral E. coli MG1655 promotes serum resistance and survival of this 
characteristically nonpathogenic strain of E. coli within the blood of a murine 
host.  Furthermore, ancestral strains carrying this truncated allele are, in general, 
more resistant to stress than their unevolved counterparts. In total, this body of 
work better defines the stress resistance and persistence capacities of UPEC. 
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CHAPTER 1 
 
 
 
INTRODUCTION 
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Molecular mechanisms of urinary tract infections 
Escherichia coli is a Gram-negative bacterium most commonly associated 
with the gastrointestinal tract of warm-blooded vertebrates. Nonpathogenic 
strains of E. coli maintain a commensal relationship with their host, providing 
necessary vitamins (i.e., vitamin K and B-complex vitamins) and promoting 
gastrointestinal homeostasis. The E. coli species, however, is extremely 
heterogeneic 1. Aside from the nonpathogenic commensals, there are a variety of 
pathogenic strain groups that cause a wide range of diseases. 
Enterohemorrhagic E. coli—best known for the O157:H7 serotypes found on 
contaminated food—along with enteropathogenic E. coli infections typically 
cause serious diarrhea and are the most widely publicized E. coli subgroups to 
cause pathology within the gastrointestinal tract. Fortunately, the disease caused 
by these pathogens is generally self-limiting and isolated solely within the 
gastrointestinal tract. These E. coli pathogens can be juxtaposed with a separate 
subset of pathogenic E. coli—extraintestinal pathogenic E. coli (ExPEC)—that 
lead a seemingly innocuous existence within the gastrointestinal tract but cause 
disease when given access to alternative niches such as the bloodstream, 
nervous system, or urinary tract. 
ExPEC are the leading cause of Gram-negative sepsis and are, most 
notably, the most common etiologic agent of urinary tract infections (UTI). A 
UTI—defined as a microbial infection of the urethra (urethritis), bladder (cystitis), 
or kidney (pyelonephritis)—is one of the most common bacterial infections 
worldwide. In the United States alone, UTIs account for 8 million infections each 
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year with an estimated annual cost exceeding $2.14 billion 2,3. This disease 
occurs most commonly among otherwise healthy women, and it is estimated that 
one in three women will suffer from a UTI by the age of twenty-four with 50% of 
women experiencing a UTI during their lifetime 4,5. The gender bias observed in 
UTI epidemiology can mostly be attributed to differences in genitourinary 
anatomy. Women possess a significantly shorter urethra than men, which greatly 
reduces the distance traversed by infectious microbes from urethral opening to 
bladder lumen. Furthermore, colonization of the vaginal introitus by UTI-
competent bacteria—likely as a result of fecal contamination—can increase the 
likelihood of UTI by increasing the proximity and abundance of infectious 
microbes 6,7.  
As alluded to earlier, ExPEC strains are the most common bacterial cause 
of UTI. To be more precise, a subset of ExPEC called uropathogenic E. coli 
(UPEC) is the causative agent of disease in more than 80% of uncomplicated 
community-acquired UTI 4,5,8,9. A distinct hallmark of UPEC-associated UTI is a 
high rate of recurrent infection. Of any individual experiencing UTI, there is a 
25% chance the infection will recur within six months of the initial infection, and in 
the majority of cases, the strain responsible for the recurrent infection is identical 
to the strain causing the incident infection 10-12. Unfortunately, the molecular 
mechanisms of recurrent UTI have not been definitively characterized. Previous 
research has been focused more generally on the virulence factors involved in 
UPEC pathogenesis within the urinary tract and possible ways by which UPEC 
may persist within the urinary tract. In an effort to design effective therapeutics 
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for combating UTI and preventing recurrent UTI, we must understand how UPEC 
cope with the inherent stresses of host-associated niches and by what molecular 
mechanisms they can persist in these environments. Some of the previously 
identified factors that influence UPEC colonization and virulence within the 
urinary tract include iron acquisition systems, secreted toxins, and adhesins. 
 
Iron acquisition systems 
Pathogenic E. coli must survive and replicate in order to persist within the 
urinary tract. Fitness factors such as iron acquisition systems play a large role in 
allowing survival and replication of E. coli in this niche. Ferric iron (Fe+3) is an 
important element for the proper functioning of many cellular and bacterial 
proteins, but it is a limited and carefully guarded resource in vivo 13. Importantly, 
ferric iron is insoluble, necessitating constant association with an iron transport 
protein. This presents a dilemma to pathogenic bacteria. They must acquire iron 
in order to replicate and survive in vivo, but available iron is already bound to 
host proteins. UPEC circumvent this problem by producing iron scavenging 
proteins known as siderophores, and the most common siderophore produced by 
UPEC is a protein called enterobactin. Enterobactin has a much stronger affinity 
for iron (Kd = 10-49) than the mammalian iron transport protein transferrin (Kd = 
10-20), allowing it to outcompete host proteins for iron binding 14. Enterobactin is a 
common siderophore found in many commensal and pathogenic E. coli, and its 
widespread use is likely what provided the evolutionary pressure for host 
variation of iron acquisition. Instead of increasing the binding affinity for iron to 
5 
 
outcompete bacterial siderophores, the host protein lipocalin 2 binds directly to 
enterobactin and prevents its reuptake into bacterial cells. By importing 
enterobactin-bound lipocalin 2, the host regains its previously pilfered iron 15. 
Some UPEC have developed a countermeasure to host lipocalin 2 sequestration 
of enterobactin. The bacterial gene iroA glucosylates enterobactin—forming the 
siderophore salmochelin—preventing lipocalin 2 binding yet still maintaining a 
high affinity for iron 16. In addition to enterobactin and salmochelin, UPEC often 
encode additional iron acquisition systems 17. This increases their efficiency at 
acquiring iron necessary for growth and survival within the host. 
 
Secreted toxins 
In some cases, virulence factors may not confer an observable fitness 
advantage to the infectious microbe but can, instead, impact disease severity. 
UPEC secreted toxins such as cytotoxic necrotizing factor 1 (CNF1), secreted 
autotransporter toxin (Sat), and α-hemolysin (HlyA) are examples of virulence 
factors that affect UTI severity, but their role in bacterial fitness or colonization of 
the urinary tract is less well defined. In fact, of the three secreted toxins listed, 
CNF1 is the only toxin that is linked with a possible fitness advantage within the 
urinary tract 18. Other aforementioned toxins may offer distinct fitness advantages 
in vivo, but the current model systems used to investigate UTI in the laboratory 
may not have the resolution required to define these traits. Researchers have, 
however, been able to discern some of the molecular mechanisms of toxin 
activity within host cells. CNF1 interacts with a laminin precursor protein on the 
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surface of the urothelial cell, inducing its endocytosis. Upon release in the host 
cytoplasm, CNF1 changes glutamine residues in the catalytic domains of Rho 
family GTPases to glutamate, effectively switching the Rho GTPases to a 
constitutively active state 19. This has many downstream effects on the host cell, 
including filopodia formation, membrane ruffling, and apoptosis 20-23. 
 Sat is a UPEC secreted toxin that promotes host tissue damage during 
infection. Cell culture-based experiments have shown that Sat triggers 
vacuolation in bladder and kidney cells, and histological analysis of in vivo 
infections show Sat-dependent damage primarily to glomeruli and proximal 
tubule epithelial cells within the kidney 24. Sat causes extensive damage to host 
cells—especially during pyelonephritis—and can significantly affect patient 
morbidity during infection. 
HlyA is a prototypic member of the RTX (Repeats in ToXin) protein family. 
RTX toxins are largely recognized for their ability to form pores within eukaryotic 
host cell membranes. Unlike other RTX toxins, HlyA exhibits an affinity for a 
range of target cells that includes leukocytes and epithelial cells 25-28. The 
consequence of HlyA pore-formation is dichotomous. If the response made by 
host cells to repair porous lesions is outpaced by pore-formation (e.g., at high 
toxin concentrations), intoxication culminates in cytolysis 29. On the other hand, at 
sublytic toxin concentrations—which is posited to be more physiology relevant 
during infection—HlyA elicits a range of physiological alterations that include 
modulation of immune signaling and cytoloskeletal rearrangements 30. Although 
the hlyA gene is carried by approximately 50% of UPEC isolates and there has 
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yet to be a fitness advantage directly attributed to expression of this toxin, it is 
agreed that its polyergic properties drastically influence the qualitative nature of 
the host-pathogen interface. 
 Incidence of severe, highly inflammatory UTI in humans is correlated with 
HlyA-producing UPEC isolates 31,32. The histological basis for this relationship 
was recently described in a murine UTI model system. Smith et al., (2008) 
observed that HlyA deficient UPEC do not evoke the same level of hemorrhaging 
and urothelial exfoliation as a wild type, HlyA containing parent strain 33. UPEC 
expressing HlyA within the urinary tract leads to increased leukocyte influx and 
edema, possibly due to widespread tissue damage 27. The precise mechanism by 
which HlyA induces such injury could be explained by its cytolytic function; 
however, it is becoming appreciated that sublytic concentrations of this toxin may 
in fact be contributing equally to disease outcome. For example, it was recently 
found that at low concentrations, HlyA activates serine proteases including 
mesotrypsin within the murine urothelium and cultured human bladder epithelial 
cells 30. This unchecked protease activity leads to selected degradation of 
proteins involved in immune signaling such as the RelA subunit of the 
transcription factor NFkB and regulatory components of the cytoskeleton such as 
paxillin. An attractive model for HlyA induced exfoliation, which requires further 
experimental support, involves the directed manipulation of host urothelial 
signaling and structural components by this toxin that initiate tissue-wide 
pathologies—in contrast to general, rampant cytolysis. The duality of HlyA 
intoxication may afford UPEC a tunable ability to alter the outcome of infection. 
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Taken together, manipulation of the host cell by secreted toxins may contribute to 
the persistent, recurrent nature of UPEC infections within the urinary tract. 
 
Adhesins 
Adherence is an important step in the colonization and pathogenesis of 
UPEC, a process that is mediated by a number of adhesive organelles called pili 
(also known as fimbriae). By adhering to cells within the urinary tract, bacteria 
can withstand the shear flow of urine and avoid being flushed out during 
micturation. Type 1 pili mediate adherence of UPEC within the bladder and have 
been shown to be indispensible for colonization and pathogenesis within the 
murine urinary tract 34-36, but there is conflicting evidence as to the necessity of 
this organelle for full virulence during human UTI 37,38. Superficial bladder 
epithelial cells produce a set of at least four proteins known as uroplakins that 
assemble into hexagonal complexes that are further arrayed into plaques that 
cover most of the luminal surface of the bladder. From electron microscopic 
observations it seems that the adhesive tip of type 1 pili (FimH) directly interacts 
with the central depression formed by the hexagonal uroplakin complex to 
negotiate binding of UPEC with the bladder epithelium 39. In vitro assays have 
determined UP1a—a component of the uroplakin plaques—as one of the many 
receptors for type 1 pili. In general, type 1 pili adhere to N-linked oligomannose 
glycoproteins, which include UP1a, CD48, type I and IV collagen, fibronectin, 
laminin, and α3β1 integrins 40-45. Exogenous, soluble D-mannose or any soluble 
glycoprotein with mannose rich residues can act as a receptor decoy to inhibit 
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adherence of type 1 piliated UPEC within the urinary tract. This is exemplified in 
mammals where Tamm-Horsfall protein—a glycoprotein produced to high 
concentrations within the urinary tract—can act as a receptor decoy for type 1 
piliated uropathogens to combat adhesion of UPEC to uroepithelial cells 46,47.  
 There are other adheins that are important for UPEC pathogenesis. 
Epidemiological data from human studies show that 90% of UPEC causing 
pyelonephritis and 100% of UPEC causing bacteremia encode the P pili 48,49. In 
this case, epidemiological data correlate with experimental evidence that bacteria 
encoding P pili have increased adherence to uroepithelial cells 50. A human study 
characterizing the importance of P pili in adherence and immune system 
activation showed that P pili expressing bacteria adhered better to uroepithelial 
cells and upregulated the recruitment of inflammatory cells to the urinary tract 51. 
Complementing this study, intravital microscopy of UPEC-induced pyelonephritis 
in rats showed that UPEC expressing P pili were better able to adhere to renal 
cells than their counterparts lacking P pili 52.  
Murine models of UTI demonstrated that P pili are not necessary for 
fulminate pyelonephritis, yet similar studies, along with human epidemiological 
data, suggest that the P pilus is an important virulence factor for UPEC 
pathogenesis, specifically adherence 49,50. The binding of UPEC to the host 
kidney urothelium is dependent upon the P fimbrial adhesion protein PapG, and 
a few classes of PapG adhesins have been identified, which seem to provide P 
pili expressing UPEC with a certain amount of tissue tropism. The PapGII allele 
is associated with human pyelonephritis and bacteremia, whereas the PapGIII 
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allele correlates with human cystitis 49,53-55. All variants bind to Galα(1-4)Galβ 
moieties present on glycosphingolipids but differ in specificity based upon the 
total number of N-acetylgalactosamine moieties or sialic acid residues attached 
to the Galα(1-4)Galβ backbone 56.  
Other pili expressed by UPEC include the F1C, S, and Dr/Afa adhesins, 
and each of these adhesins bind distinct epitopes within the urinary tract. Briefly, 
F1C pili bind lactosylceramide-containing receptors; S pili are specific for α-sialyl-
2,3-β galactoside-containing receptors; and Dr/Afa pili adhere to CD55 
(alternatively referred to as complement decay-accelerating factor), α5β1 
integrins, and type-IV collagen 27,57. Notably, Dr/Afa pili are associated with 
pyelonephritis in pregnant women, which may be related to elevated expression 
of CD55 in the urinary tract of gestational women 58,59. Dr/Afa adhesins are also 
necessary for the establishment of chronic pyelonephritis within rat and mouse 
models 60. However, these data have yet to be correlated with human chronic 
pyelonephritis, and the importance of Dr/Afa adhesins in the pathogenesis of 
UPEC leading to acute uncomplicated pyelonephritis is not well characterized. 
Overall, adhesins play a major role in the colonization and pathogenesis of 
UPEC within the urinary tract. 
 
UPEC invasion 
Traditionally, virulent strains of E. coli have been considered extracellular 
pathogens. However, UPEC have been shown to invade and live transiently 
within host epithelial cells. UPEC are competent to invade many urothelial cells, 
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including the epithelial cells of the bladder as well as the proximal tubule 
epithelial cells and collecting duct cells of the kidney 61-63. Cell culture assays 
have verified a bacterial adhesive organelle—the type 1 pilus— as both 
necessary and sufficient for UPEC invasion of urothelial cells 64. UPEC 
adherence to the cell surface via type 1 pili induces a signaling cascade within 
urothelial cells that causes localized rearrangements of the actin cytoskeleton, 
ultimately resulting in the engulfment of the adherent bacteria by the host plasma 
membrane through a zipper-like process. Both focal adhesion kinase and 
phosphoinositide-3 kinase are involved in host actin cytoskeletal rearrangements 
and are absolutely required for UPEC invasion. Furthermore, it seems that lipid 
rafts provide important signaling clusters to promote the endocytosis of adherent 
UPEC. 61,65-68. Type I piliated UPEC can also affect their internalization in a 
clathrin-dependent manner through binding α3β1 integrins on the surface of 
urothelial cells. In total, type 1 pili serve as both an important mediator of 
adherence and promote the invasion of urothelial cells by UPEC. 
The flagellum—a bacterial motility organelle—is necessary for ascending 
UTI and likely doubles as a UPEC invasin. Flagellar expression occurs 
concomitant with and is required for UPEC ascension of the urinary tract, and 
upon entering the kidney, flagellated UPEC can interact with and invade 
collecting duct cells in an actin-dependent manner 69,70. Together, these data 
suggest that UPEC utilize flagella as a motility organelle in order to ascend the 
ureters to the kidney but may also use the flagella as an invasin to mediate entry 
into collecting duct cells.  
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Once internalized, invasive UPEC can replicate, forming a biofilm-like 
cluster known as an intracellular bacterial community. Most of the normally rod-
shaped E. coli growing within an intracellular bacterial community (IBC) have 
been reported to take on a more coccoid morphology within hours after invasion, 
while a subset is filamentous, stretching as long as 50 µm. These long, 
filamentous UPEC can extrude through the epithelial cell and potentially mediate 
invasion of a neighboring bladder epithelial cell while protecting itself from 
neutrophil phagocytosis 71-73. In some instances, the IBC ruptures, spilling its 
contents within the bladder lumen to potentiate further rounds of intracellular 
bacterial community formation. Conversely, invading UPEC may remain 
quiescent within LAMP-1 positive endosomes, enmeshed within an actin cage, 
and this subset of quiescent bacteria is thought to make up a reservoir population 
capable of seeding recurrent infections 27,74.  
UPEC invasion and temporary quiescence within the bladder epithelium 
may contribute to the high rate of recurrent infections. Up to 90% of community-
acquired, uncomplicated recurrent UTI is caused by the same strain of bacteria 
as the index infection 11,12. Below is a hypothetical model for how invasion of 
urothelial cell provides a mechanism for recurrent UTI. Upon entry into the 
bladder lumen, UPEC can secrete toxins like CNF-1 and α-hemolysin to cause 
exfoliation of bladder epithelial cells, exposing undifferentiated bladder cells. 
These underlying cells retain cell surface receptors, such as α3β1 integrins, that 
allow UPEC to bind and be subsequently internalized within endosomal 
compartments enmeshed with actin filaments. The internalized bacterium 
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remains in a quiescent, nonreplicative state until the immature bladder epithelial 
cell undergoes differentiation into a superficial umbrella cell weeks to months 
later. The process of differentiation involves active actin cytoskeletal 
rearrangements, releasing the imprisoned UPEC from its actin cage. The freed 
bacterium can now grow intracellularly, form an intracellular bacterial community, 
rupture, and release a hoard of UPEC into the bladder lumen. These events 
culminate in a recurrent infection by the same strain that was caused the initial 
infection. 
 
Host response to UTI 
The mammalian urinary tract is meant to be a sterile system, and there 
are many host-associated components that promote sterility and combat infection 
within the urinary tract. Antimicrobial peptide production is paramount in 
maintaining a sterile urinary tract, and two antimicrobial peptides classes, namely 
cathelicidins and defensins, play a pivotal role in this process. Cathelicidins can 
be expressed by myeloid cells—especially neutrophils—as well as by epithelial 
cells all over the body, including those of the gastrointestinal tract, skin, lungs, 
epididymis, and urinary tract. They are constitutively made at low levels by 
bladder epithelial cells and proximal tubule epithelial cells, with additional 
activation and release minutes after the detection of microbes within the urinary 
tract 75,76. The human gene Camp encodes the cathelicidin propeptide that is 
processed into two α-helical, amphipathic peptides, LL-37 and cathelin. These 
antimicrobial peptides bind negatively charged groups on the outer leaflet of 
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bacterial membranes and insert into the membrane to form a pore, neutralizing 
the microbe. Incidentally, UPEC strains causing pyelonephritis are significantly 
more resistant to LL-37 than cystitis causing strains, and murine studies show 
that Camp-/- mice are significantly more prone to acute pyelonephritis 76. Two 
major types of defensins, α and β, are synthesized in response to infection. 
Neutrophils produce α-defensin, and epithelial cells in the loop of Henle, distal 
tubules, and collecting duct cells manufacture β-defensin. Both subsets of 
defensins are thought to kill by forming pores in the bacterial membrane—similar 
to cathelicidin-mediated bacterial killing—though the mechanism of defensin-
mediated bacterial killing is an active area of research. Both cathelicidins and 
defensins are made as a component of the innate defense to maintain a sterile 
urinary tract. 
Another protein made in defense of UTI is the Tamm-Horsfall protein 
(THP). This glycoprotein is synthesized in abundance within the loop of Henle 
and distributed to the downstream urinary tract via the urine and is the most 
abundant protein in healthy mammalian urine. THP is heavily glycosylated and 
contains an evolutionarily conserved mannose-rich side chain. At physiologically 
relevant concentrations, THP acts as a soluble receptor for type 1 pili to prevent 
bacterial adherence to mannose-rich host cell receptors via type 1 pili 47. 
Because adherence is such a critical step in the pathogenesis of UPEC within 
the urinary tract, THP is a potent innate factor of host defense to bacterial 
infection.  This is exemplified in murine studies of UTI where Thp-/- mice have 
higher bacterial titers from infection with type-1-pili-positive UPEC 46. 
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In addition to secreting proteins that frustrate bacterial infection, host cells 
of the urinary tract can also respond to the presence of invasive bacteria by 
producing toxic chemicals like nitric oxide, peroxynitrite, and nitrosothiols—
collectively referred to as reactive nitrogen intermediates (RNI). Hours after 
infection, the levels of nitric oxide in the urine can reach up to 50 times more than 
that of an uninfected control 77. RNIs can be deleterious to bacterial growth, 
damaging their nucleic acids, proteins, and lipids. Some resistance mechanisms 
to RNIs within UPEC have been previously characterized, including the 
production of polyamines, but it is theorized that many genes contribute to UPEC 
resistance to RNIs 78. 
 Toll-like receptors (TLRs) are another important mediator of host innate 
immunity. In general, TLRs recognize conserved bacterial motifs and signal the 
associated cell to produce a proinflammatory response through cytokine and 
chemokine production. This response alerts, attracts, and activates host innate 
immune responders like neutrophils to promote the clearance of invasive 
microbes. In mouse models, the most relevant TLRs in the defense against UTI 
are TLR4 and TLR11 45,79,80. TLR4 recognizes the bacterial endotoxin 
lipopolysaccharide, which is an integral part of the outer membrane of Gram-
negative bacteria. Recognition and response to UPEC in symptomatic UTI 
seems dependent upon functional TLR4 expression. Murine and human studies 
show that reduced expression of TLR4 promotes asymptomatic bacteriuria, and 
humans with specific promoter or coding region single nucleotide polymorphisms  
have an increased frequency of asymptomatic bacteriuria 81,82. 
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The ligands for TLR11 include the apicomplexan profiling protein of the 
parasite Toxoplasma gondii and the flagellin subunit of Salmonella Typhi 83,84. 
Although the UPEC specific ligand has yet to be identified, once activated during 
UPEC infection of the urinary tract, TLR11 signals through a MyD88-dependent 
pathway to elicit a potent IL-12 response 80. Murine studies indicate TLR11 
potently reduces the severity and extent of renal colonization as Tlr11-/- mice 
have a significantly higher bacterial load in the kidneys 80. However, the effects of 
TLR11 activation in human acute pyelonephritis are questionable because a 
premature stop codon in the human TLR11 gene likely precludes its expression 
in humans.  
Although TLR11 may not have a direct impact on susceptibility to acute 
pyelonephritis in humans, there are other known genes (e.g., Irf3 and CXCR1) 
that increase patient susceptibility to acute pyelonephritis. Both human and 
murine studies show that transcription factor Irf3 is an important determinant of 
acute pyelonephritis susceptibility. P-piliated UPEC can signal specifically 
through TLR4 via glycosphingolipid-dependent ceramide release to activate 
transcription factor Irf3. Decreased promoter activity of Irf3 is coincident with 
increased susceptibility to acute pyelonephritis, and the specific polymorphisms 
seen in human populations leading to an increased susceptibility to acute 
pyelonephritis were experimentally validated in the murine model of UTI. In the 
absence of Irf3 signaling, neutrophils recruited to infected tissues within the 
urinary tract were incapable of effectively clearing the infiltrating bacteria, 
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demonstrating that cellular Irf3 expression must be regulated appropriately for 
the crucial downstream activation events necessary for limiting UTI 85. 
Human studies have correlated reduced expression of the IL-8 receptor 
CXCR1 with an increased risk of acute pyelonephritis. IL-8 is a major mediator of 
neutrophils chemotaxis during the proinflammatory response to infection, and 
appropriate levels of CXCR1 on neutrophils are crucial for proper chemotaxis to 
the site of infection. Recruited neutrophils eliminate infiltrating microbes through 
phagocytosis and are necessary for microbial clearance within the urinary tract. 
Unsurprisingly, many studies have highlighted the importance of functional 
CXCR1 in neutrophil recruitment and action within the urinary tract 86-89. In 
particular, it has been shown that acute pyelonephritis-prone patient populations 
exhibit intronic and coding region single nucleotide polymorphisms that reduce 
expression of CXCR1, correlating with decreased numbers of recruited 
neutrophils during infection and an overall increase in susceptibility to acute 
pyelonephritis 90. CXCR1 and Irf3 expression are only two factors that influence 
UTI susceptibility in humans. An elegant elaboration of other human genes 
associated with asymptomatic bacteriuria, cystitis, and pyelonephritis is reviewed 
by Ragnarsdóttir et al., 2011 45.  
The host immune system plays a crucial role in preventing and fighting 
UTI caused by UPEC, but it can also inadvertently contribute to the pathology of 
the disease. The majority of kidney scarring that results from chronic 
pyelonephritis is mediated by the host immune system. Constant neutrophil 
recruitment to the infected site results in an aggregation of innate immune cells, 
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and recruited macrophages form foam cells within the renal tissue—likely as a 
result of frustrated efforts to remove the over-abundant neutrophils from the 
tissue. Macrophages can also contribute to tissue damage by spewing lysosomal 
contents into the extracellular milieu, damaging both host cells and pathogenic 
microbes alike. 
Ironically, a few innate immune system components can actually facilitate 
bacterial adherence and entry into renal cells. For example, complement 
component C3 and TLR4 can catalyze adherence and invasion. Canonically, 
activated complement opsonizes bacteria to promote its clearance from the host, 
and TLR4 activation leads to inflammation and the influx of professional 
phagocytes. However, the association of complement component C3 with UPEC 
is sufficient to enhance UPEC adherence to renal epithelial cells, likely through 
binding of opsonized UPEC to host C3 receptor Crry. Consequently, there is an 
increase in the colonization of UPEC within the upper urinary tract 62. 
Additionally, the downregulation of TLR4 in cell culture assays drastically 
reduced the frequency of bacterial invasion, suggesting TLR4 may facilitate 
UPEC invasion of renal collecting duct cells 63. The utilization of host innate 
immune defenses to increase bacterial adherence or invasion illustrates the 
complexity of host-pathogen interactions that may take place during UTI. 
This dissertation was aimed at acquiring a better understanding of the 
UPEC-encoded genes that promote resistance to the stresses associated with 
infecting the urinary tract and persisting within that hostile niche. In Chapter 2, we 
examine the effects of global metabolic and stress response transcriptional 
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regulation on the virulence potential of UPEC within the murine urinary tract. 
Therein, we are able to better define the metabolic and stress response 
limitations affecting UPEC colonization of the urinary tract. In Chapter 3, we 
address the advantages of chromosomally encoded toxin-antitoxin systems in 
allowing for niche-specific colonization of the urinary tract and how they can 
specifically affect the stress resistance and antibiotic persistence of UPEC. This 
work specifically identifies a novel target for chemotherapeutic agents that would 
theoretically hone in on and hinder only uropathogenic subsets of E. coli, 
combating UTI while leaving commensal E. coli unphazed. Lastly, we attempt to 
better understand the evolutionary generation of UPEC stress resistance by 
studying the conserved genomic reduction of chromosomally encoded toxin-
antitoxin hicAB within these pathogens. We are able to show that the 
construction of the evolutionarily conserved hicAB truncation within the inferred 
ancestral E. coli strain MG1655 increases survival within envelope stressing 
conditions and imparts some measure of resistance to human serum 
complement. In total, this dissertation adds significant contributions to our 
fundamental understanding of UPEC stress resistance and persistence. 
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Adenylate Cyclase and the Cyclic AMP Receptor Protein Modulate
Stress Resistance and Virulence Capacity of Uropathogenic Escherichia
coli
Grant T. Donovan, J. Paul Norton, Jean M. Bower,* Matthew A. Mulvey
Division of Microbiology and Immunology, Pathology Department, University of Utah School of Medicine, Salt Lake City, Utah, USA
In many bacteria, the secondmessenger cyclic AMP (cAMP) interacts with the transcription factor cAMP receptor protein
(CRP), forming active cAMP-CRP complexes that can control a multitude of cellular activities, including expanded carbon
source utilization, stress response pathways, and virulence. Here, we assessed the role of cAMP-CRP as a regulator of stress resis-
tance and virulence in uropathogenic Escherichia coli (UPEC), the principal cause of urinary tract infections worldwide. Dele-
tion of genes encoding either CRP or CyaA, the enzyme responsible for cAMP synthesis, attenuates the ability of UPEC to colo-
nize the bladder in a mouse infectionmodel, dependent on intact innate host defenses. UPECmutants lacking cAMP-CRP grow
normally in the presence of glucose but are unable to utilize alternate carbon sources like amino acids, the primary nutrients
available to UPEC within the urinary tract. Relative to the wild-type UPEC isolate, the cyaA and crp deletion mutants are sensi-
tive to nitrosative stress and the superoxide generator methyl viologen but remarkably resistant to hydrogen peroxide (H2O2)
and acid stress. In the mutant strains, H2O2 resistance correlates with elevated catalase activity attributable in part to enhanced
translation of the alternate sigma factor RpoS. Acid resistance was promoted by both RpoS-independent and RpoS-dependent
mechanisms, including expression of the RpoS-regulated DNA-binding ferritin-like protein Dps. We conclude that balanced
input frommany cAMP-CRP-responsive elements, including RpoS, is critical to the ability of UPEC to handle the nutrient limi-
tations and severe environmental stresses present within the mammalian urinary tract.
Under homeostatic conditions, themammalian urinary tract ismaintained as a sterile environment through the production
of antimicrobial peptides and other toxic compounds, the bulk
flow of urine, innate immune cell surveillance mechanisms, and
nutrient limitations (1–5). However, select microbial pathogens
are capable of colonizing and infecting this normally inhospitable
niche. Uropathogenic Escherichia coli (UPEC) is the major cause
of urinary tract infections (UTI)worldwide, affectingmillions and
requiring billions of dollars for diagnosis and treatment annually
(6). To overcome host defenses and effectively colonize the uri-
nary tract, UPEC employs a variety of virulence factors and stress
resistance mechanisms, including adhesive and motility organ-
elles that mediate attachment to and invasion of host cells, toxins
that disarm innate immune responses, andmultiple iron-scaveng-
ing proteins (1, 7–9). The ability to sense and prioritize the use of
limited carbon sources within the nutrient-poor environment of
the urinary tract is also likely critical to the success of UPEC, but
our understanding of the impact that bacterial metabolic path-
ways have on the establishment and progression of a UTI is in-
complete.
Within the urinary tract, UPEC relies largely on the catabolism
of small peptides and amino acids for survival and growth (4).
UPEC strains that are defective in peptide and carbohydrate trans-
port systems, the tricarboxylic acid (TCA) cycle, and gluconeo-
genesis are unable to effectively colonize the urinary tract (10, 11).
Of note, many UPEC isolates are able to utilize the gluconeogenic
amino acid D-serine, which is typically present in urine (12, 13).
D-Serine not only provides substrates for the TCA cycle and glu-
coneogenesis but also serves as an environmental cue that can
regulate UPEC virulence. Interplay between bacterial metabolism
and virulence is also evident by analysis of the QseBC two-com-
ponent regulatory system, which was recently shown to modulate
carbon flux through keymetabolic pathways as well as the expres-
sion of UPEC-associated virulence factors like type 1 pili and fla-
gella (14, 15). It is likely that numerous other systems help coor-
dinate the expression of virulence and stress resistance factors
with the ability of UPEC to sense and respond to the various car-
bon sources encountered within the host.
Although E. coli strains are generalists with the capacity to me-
tabolizemyriadmetabolites, they preferentially utilize glucose as a
primary carbon source. Transitioning into glucose-limiting con-
ditions triggers the activation of the adenylate cyclase CyaA, pro-
ducing high levels of the second messenger molecule cyclic AMP
(cAMP) (16). Binding of cAMP to the transcription factor cAMP
receptor protein (CRP) forms the active cAMP-CRP complex,
which directly regulates expression of genes necessary for utiliza-
tion of alternative carbon sources. However, not all genes that are
regulated by cAMP-CRP function in bacterial metabolism (17,
18). Disruption of cAMP signaling within the prominent patho-
gens Vibrio cholerae, Mycobacterium tuberculosis, Salmonella en-
terica serovar Typhimurium, and Pseudomonas aeruginosa atten-
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uates virulence through the misregulation of key virulence genes
(18–22). Within pathogenic subsets of E. coli, the cAMP-CRP
complex has been shown tomodulate the expression of type 1 pili,
major facilitators of bacterial colonization of the bladder mucosa
(23). However, the cumulative effects of cAMP-CRP on the viru-
lence potential of UPEC within the urinary tract remain to be
elucidated.
Here, we report that the deletion of genes encoding either
CyaA or CRP within the UPEC reference strain UTI89 does not
affect growth in the presence of glucose but mutants with these
deletions are unable to utilize amino acids as the sole carbon
source. Furthermore, thesemutants are significantly attenuated in
the ability to colonize the bladders of mice, dependent upon the
presence of intact innate host defenses. In broth culture assays, the
cyaA and crp mutants are both sensitive to reactive nitrogen spe-
cies and superoxide radicals generated by methyl viologen but
highly resistant to hydrogen peroxide (H2O2) and acid stress. Re-
sistance of the mutants to H2O2 and acid stress is in part attribut-
able to increased translation of the alternate sigma factor RpoS
(!S) and RpoS-regulated gene products that include catalases and
the DNA-binding, iron storage protein Dps. In total, these data
indicate that balanced input from cAMP-CRP is critical to the
ability of UPEC to catabolize amino acids and appropriately han-
dle harsh environmental stresses, characteristics that are pertinent
to bacterial fitness and survival within the urinary tract.
MATERIALS AND METHODS
Bacterial strains and plasmids. All bacterial strains and plasmids are
listed in Table 1. The human cystitis isolate UTI89 has been described
previously (24, 25). Expression constructs were made using standardmo-
lecular biology techniqueswith the plasmid pRR48 (26).Where indicated,
gene expression from the Ptac promoter in the pRR48 backbone was in-
duced by addition of 0.5 or 1 mM isopropyl-"-D-thiogalactopyranoside
(IPTG). Primers used to construct all plasmids are indicated in Table 2,
along with primers used to verify each clone by sequencing. Antibiotics
(50#g/ml kanamycin, 20#g/ml chloramphenicol, or 100#g/ml ampicil-
lin) were added to plates and growth media to select for mutants and to
maintain plasmids when necessary. Targeted gene knockouts were gener-
ated in UTI89 using the lambda Red-mediated linear transformation sys-
tem (27, 28). Briefly, an antibiotic resistance cassette was amplified from
pKD3, pKD4, or the template strain TT23691 with 40-bp overhangs spe-
cific to sites at the 5= and 3= ends of each target gene. PCR products were
introduced via electroporation into UTI89 carrying pKM208, which en-
codes an IPTG-inducible lambda Red recombinase. Knockouts were con-
firmed by PCR using primers listed in Table 2.
Mouse infections. Seven- to 9-week-old female CBA/J or C3H/HeJ
mice (Jackson Laboratory) were used in accordance with IACUC-ap-
proved protocols as previously described (29). Mice were anesthetized
using isoflurane inhalation and inoculated via transurethral catheteriza-
tion with 50 #l of a bacterial suspension containing approximately 1 $
107 bacteria. For these noncompetitive infection assays, UTI89 and iso-
genic knockout mutants were grown statically for 24 h in Luria-Bertani
(LB) broth, pelleted by spinning at 10,000$ g for 8min, and resuspended
in phosphate-buffered saline (PBS) prior to inoculation. Bladders were
recovered at 6 h or 3 days postinoculation, weighed, and homogenized in
1 ml PBS containing 0.025% Triton X-100. Homogenates were serially
diluted and plated on LB agar plates to determine the number of bacteria
per gram of tissue. Mouse experiments were repeated at least twice, and
the total combined data from at least 11 animals are presented.
Growth assays. Bacteria were grown from frozen stocks at 37°C with
shaking overnight in 5 ml of LB broth, 100 mMmorpholineethanesulfo-
nic acid (MES)-buffered LB broth (MES-LB broth; pH 5.0), or modified
M9 minimal medium (6 g/liter Na2HPO4, 3 g/liter KH2PO4, 1 g/liter
NH4Cl, 0.5 g/liter NaCl, 1 mM MgSO4, 0.1 mM CaCl2, 0.1% glucose,
0.0025% nicotinic acid, 16.5 #g/ml thiamine, and 0.2% casein amino
acids). Bacteria were then diluted 1:100 into the appropriate correspond-
ingmediumwith or without additives as indicated. Growth of quadrupli-
cate 200-#l samples in shaking 100-well honeycomb plates was assessed at
37°C using a Bioscreen C instrument (Growth Curves USA). Stocks of
methyl viologen (MV) (also known as paraquat), acidified sodium nitrite
(ASN), trehalose, andH2O2were prepared fresh prior to addition to LB or
MES-LB broth cultures. Where indicated, IPTG was added to cultures to
TABLE 1 Bacterial strains and plasmids
Strain or plasmid Description Source
Strains
UTI89 UPEC strain (cystitis isolate, O18:K1:H7) 25
UTI89%cyaA UTI89cyaA::Clmr (pKD3) This study
UTI89%crp UTI89crp::Clmr (pKD3) This study
UTI89%dps UTI89dps::Kanr (TT23691) This study
UTI89%fimH UTI89fimH::Clmr (pKD3) 83
UTI89%otsBA UTI89otsBA::Kanr (pKD4) This study
UTI89%rpoS UTI89rpoS::Kanr (TT23691) This study
UTI89%cyaA%otsBA UTI89cyaA::Clmr (pKD3) otsBA::Kanr (pDK4) This study
UTI89%crp%rpoS UTI89crp::Clmr (pKD3) rpoS::Kanr (TT23691) This study
UTI89%crp%dps UTI89crp::Clmr (pKD3) dps::Kanr (TT23691) This study
TT23691 Strain with Kanr cassette flanked by universal primer sites 84
Plasmids
pRR48 Ampr cloning plasmid containing an IPTG-inducible Ptac promoter upstream of the MCS 26
pKM208 Ampr plasmid; encodes IPTG-inducible lambda red recombinase 27
pKD3 Template plasmid for gene disruption; contains FRTa-flanked Clmr cassette 28
pKD4 Template plasmid for gene disruption; contains FRT-flanked Kanr cassette 28
pcrp Ampr plasmid; crp (from UTI89) cloned into PstI, KpnI sites of pRR48 This study
pcyaA Ampr plasmid; cyaA (from UTI89) cloned into PstI, KpnI sites of pRR48 This study
pdps Ampr plasmid; IPTG-inducible expression of E. coli Dps 55
prpoS Ampr plasmid; rpoS (from UTI89) cloned into PstI, HindIII sites of pRR48 This study
a FRT, FLP recombination target.
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induce high-level expression of recombinant proteins frompdps or prpoS.
MacConkey agar and other reagents used in these assays were obtained
from Sigma-Aldrich.
Western blots. UTI89, UTI89!cyaA, and UTI89!crp were diluted
1:50 from overnight cultures into fresh LB broth and grown with shaking
at 37°C until an optical density at 600 nm (OD600) of 0.4 was reached. One
milliliter of each culture was pelleted, resuspended in 200 "l B-PER lysis
reagent (Thermo Scientific) containing 1 mM phenylmethylsulfonyl flu-
oride and protease inhibitor cocktail (Roche), and incubated for 15min at
room temperature. Protein concentrations within the lysates were deter-
mined using the BCA reagent system (Pierce), and equivalent protein
amounts were resolved by SDS-PAGE and transferred to an Immobilon
TABLE 2 Primer sequences
Primer Sequence
crp KOa
Forward GCGCATGGTGCTTGGCAAACCGCAAACAGACCCGACTCTCTGTGTAGGCTGGAGCTGCTTCG
Reverse CGCGCTACCAGGTAACGCGCCACTCTGACGGGATTAACGACATATGAATATCCTCCTTAG
crp KO confirmation
Forward GTATGCAAAGGACGCCACAT
Reverse TTCGCCAAGCATTAACCCAA
cyaA KO
Forward GCGGAATCACAGTCATGACGGGTAGCAAATCAGGCGATACTGTGTAGGCTGGAGCTGCTTCG
Reverse TACTGCTGCAACAGCGGCGCGTCATGCTCCTGATTGGCAGCATATGAATATCCTCCTTAG
cyaA KO confirmation
Forward AACCAGGCGCGAAAAGTGGT
Reverse CTGAAAGGCGACGAGTGGAT
otsBA KO
Forward ATGTCTGTAAAGCGCGTTCTGCGCAACACAATAAGAAATGTGTAGGCTGGAGCTGCTTCG
Reverse CTACGCAAGCTTAGGAAAGGTAGCAACTTTATCGCGCTGCCATATGAATATCCTCCTTAG
otsBA KO confirmation
Forward AGCGAAACGCACTGTCTGAT
Reverse TTGCCTACGGTGAGTTAAGC
dps KO
Forward TTATTCGATGTTAGACTCGATAAACCACAGGAATTTATCCAGGTCGCGAGCACCAAACACCCCCCAAAACC
Reverse GTGATAGGAACAGCCAGAATAGCGGAACACATAGCTGGTGCTATACTTAGCACACAACCACACCACACCAC
dps KO confirmation
Forward GATAGCAGATGGATGCACTA
Reverse TGACAGTACGCAAAGAGAGC
rpoS KO
Forward CCAGCCTCGCTTGAGACTGGCCTTTCTGACAGATGCTTACCACCAAACACCCCCCAAAACC
Reverse TGCCGCAGCGATAAATCGGCGGAACCAGGCTTTTGCTTGACACACAACCACACCACACCAC
rpoS KO confirmation
Forward AATGATGATTGCCGAATGTGACGCTG
Reverse GCATTGTGTCGTTATGGGCGTAGG
pcrp
Forward CCCCC CTGCAG ATGGTGCTTGGCAAACCGCA
Reverse CCCCC GGTACC TTAACGAGTGCCGTAAACGA
pcyaA
Forward CCCCC CTGCAG TTGTACCTCTATATTGAGAC
Reverse CCCCC GGTACC TCACGAAAAATACTGCTGCA
prpoS
Forward CATTC CTGCAG ATGTTCCGTCAAGGGATCA
Reverse AGTGC AAGCTT TTATTCGCGGAACAGCGCT
pRR48 sequencing primer
Forward CTGCTGAAGAGTACTTTGG
Reverse CCAAAGCTGAAGACATCCAG
a KO, knockout.
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PVDF-FL membrane (Millipore). Blots were probed using anti-RpoS
(Neoclone) and anti-E. coli antibodies (Biodesign International) and vi-
sualized using enhanced chemiluminescence as previously described (30).
pH stress resistance assays. Bacterial strains from overnight cultures
were diluted 1:100 in fresh LB broth and grown with shaking at 37°C for 3
h. LB broth containing 100 !g/ml ampicillin and 0.5 mM IPTG was used
for strains carrying plasmids pRR48, pdps, or prpoS. Strains were sub-
jected to acid stress (pH 3.5) by the addition of concentrated HCl for 30
min. Bacteria in 1 ml of culture were pelleted at 14,000" g for 5 min and
washed in PBS. Surviving bacteria were enumerated by plating serial di-
lutions on LB agar.
Catalase assays.Overnight bacterial cultures were diluted 1:100 in LB
broth and grown with shaking at 37°C to an OD600 of 1.0. UTI89/prpoS
was grown in broth containing 1 mM IPTG. Bacteria in 1 ml of culture
were pelleted, resuspended in 200 !l B-PER lysis reagent (Thermo Scien-
tific), and incubated at room temperature for 15 min. Catalase activity
present in the lysates was determined using a Fluoro Catalase kit (Cell
Technology) and a SynergyHTmultidetectionmicroplate reader (BioTek
Instruments, Inc.) according to instructions from the manufacturer.
Trehalose analysis.Chemicals and reagents were purchased from Sig-
ma-Aldrich, except forMSTFA [N-methyl-N-(trimethylsilyl) trifluoroac-
etamide], which was purchased from Thermo Scientific, and methoxy-
amine hydrochloride, which was purchased from MP Biomedicals.
Bacterial cultures were grown inmodifiedM9medium to anOD600 of 1.0,
pelleted by centrifugation, and frozen. Pellets were suspended in 5 ml of
boiling 75% ethanol (EtOH) (aqueous), vortexed, and then incubated at
90°C for 5min. Cell debris was removed by centrifugation at 5,000" g for
3min. Supernatants were transferred to new tubes and dried in vacuo.Gas
chromatography-mass spectrometry (GC-MS) analysis was performed
using a Waters GCT Premier mass spectrometer fitted with an Agilent
6890 gas chromatograph and a Gerstel MPS2 autosampler. Dried samples
were suspended in 40 !l of a pyridine solution containing 40 mg/ml
O-methoxylamine hydrochloride and incubated for 1 h at 30°C. Twenty
microliters of each sample was transferred to an autosampler vial and
incubatedwithMSTFA for 30min at 37°Cwith shaking.Onemicroliter of
sample was injected into the inlet at a 75:1 split ratio. The injector tem-
peraturewas held at 250°C. The gas chromatographwas obtained using an
initial temperature of 95°C for 1 min followed by a 40°C/min ramp up to
110°C, with a hold time of 2 min. This was followed by a second 5°C/min
ramp up to 250°C and then a third ramp up to 350°C, with a final hold
time of 3 min. A 30-m Restek Rxi-5 MS column with a 5-m-long guard
column was employed for analysis. Data were collected using MassLynx
4.1 software. To determine trehalose concentrations specifically, an exter-
nal calibration curve was developed by performing a 2-fold dilution series
starting at 10 !g/!l trehalose in pyridine. This series was analyzed to
determine the linear range of analysis, the upper and lower limits of de-
tection and quantitation, and the fragment ion to be utilized for analysis.
For quantification, the fragment ion of 331 m/z was monitored and the
linear range for analysis was determined to be from 100 to 1,000 !g/!l.
Metal stress assay.UTI89/pRR48, UTI89#dps/pRR48, and UTI89#dps/
pdpswere grown with shaking overnight at 37°C in LB broth containing 100
!g/ml ampicillin. Nine hundred microliters of each overnight culture was
added to a sterile microcentrifuge tube, followed by 100!l of 0.5 M CuSO4.
Tubes were then incubated for 15 min at room temperature, and surviving
bacteria were pelleted at 14,000" g for 5 min, washed in PBS, and enumer-
ated by plating serial dilutions on LB agar.
Statistics. Results from in vivomouse assays were analyzed by Mann-
Whitney two-tailed t tests. Results from the catalase and survival assays
were analyzed using two-tailed unpaired t tests. Data analysis was per-
formed using Prism 5.0c (GraphPad Software, Inc.). P values of less than
0.05 are considered significant.
RESULTS
cAMP-CRP is necessary for lactose and amino acid catabolism
by UPEC. Carbon catabolite repression—the preferential use of a
carbon source like glucose instead of other secondary carbon
sources—is regulated by the generation of cAMP-CRP (16). In the
classic example, decreased glucose levels result in enhanced pro-
duction of cAMP-CRP, which in turn activates the expression of
genes needed to catabolize alternate carbon sources like lactose.
Using MacConkey agar plates, we established that wild-type
UTI89 could consume lactose in the absence of glucose, creating
lactic acid and causing the pH indicator neutral red present in the
agar to produce a pink color (Fig. 1A). In contrast, the isogenic
cyaA and crpdeletionmutantsUTI89#cyaA andUTI89#crp could
not utilize lactose and instead had to ferment available peptone,
producing basic ammonia and turning the pH indicator yellow.
The ability of the #cyaA and #crpmutants to use lactose in these
assays was restored by complementation with plasmids pcyaA and
pcrp, respectively (data not shown).
Within the urinary tract, UPEC cells are mostly dependent on
the catabolism of small peptides and amino acids (10, 12, 13). In
modified M9 media containing both glucose and amino acids,
wild-type UTI89, UTI89#cyaA, and UTI89#crp grew with similar
kinetics (Fig. 1B). However, in modified M9 media containing
only amino acids as a carbon source, the#cyaA and#crpmutants
failed to grow unless appropriately complemented with plasmid
pcyaA or pcrp (Fig. 1C). The inability of UTI89#cyaA and
UTI89#crp to catabolize amino acids and other secondary carbon
sources such as lactose may affect the fitness of these mutants
within the urinary tract.
CRP and CyaA promote UPEC colonization of the bladder.
To assess the contribution of cAMP-CRP to UPEC pathogenicity,
wild-type UTI89, UTI89#cyaA, and UTI89#crpwere individually
inoculated via transurethral catheterization into adult female
FIG 1 Impaired use of alternative carbon sources by UTI89#cyaA and UTI89#crp. (A) MacConkey agar plate streaked with UTI89, UTI89#cyaA, and
UTI89#crp. Growth of UTI89, UTI89#cyaA, UTI89#crp, and complemented mutants in modified M9 medium (B) and modified M9 medium lacking glucose
(C).Mutant strains were complemented by uninduced expression of cyaA or crp from a Ptac promoter. Strains transformed with the empty vector pRR48 served
as controls. Each curve reflects the means of results from a single experiment and is representative of at least three independent experiments performed in
quadruplicate.
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CBA/J mice. In comparison with wild-type UTI89, significantly
reduced numbers of both the !cyaA and !crp mutants were re-
covered from bladders at 6 h and 3 days postinoculation (Fig. 2A
and B). Interestingly, differences between wild-type UTI89 and the
!cyaA and!crpmutants were blunted in C3H/HeJmice (Fig. 2C).
Due to defects in Toll-like receptor 4 (TLR4) and possibly other
host factors, C3H/HeJ mice have attenuated inflammatory re-
sponses and are consequently hypersensitive to UTIs (31–36). In
total, these data indicate that cAMP-CRP is critical to the fitness of
UPEC within the urinary tract of immunocompetent animals,
probably due to regulatory effects of cAMP-CRP on factors that
control bacterial resistance to stresses generated by stimulation of
host inflammatory cascades. These results prompted us to inves-
tigate further potential interplay between cAMP-CRP and stress
response mechanisms in UPEC.
UTI89!cyaA and UTI89!crp are sensitive to nitrosative
stress and methyl viologen but resistant to H2O2. Key stresses
encountered by UPEC during the course of a UTI include damage
elicited by reactive oxygen and nitrogen radicals that can be pro-
duced by both host and bacterial cells (37–42). To test the sensi-
tivity of UTI89!cyaA and UTI89!crp to nitrosative and oxidative
stresses, we utilized acidified sodium nitrite (ASN) and the super-
oxide generator methyl viologen (MV), respectively (Fig. 3). In
these assays, the addition of sodium nitrite to MES-LB broth (pH
5.0) to create ASN results in the production of nitrous acid, NO,
and other reactive nitrogen intermediates (43). InMES-LB broth,
the !cyaA and !crpmutants grew like the wild-type strain, but in
the presence of ASN growth of the mutants was markedly attenu-
ated (Fig. 3A and B). Likewise, the addition of MV to LB broth
severely impeded growth of both UTI89!cyaA and UTI89!crp
(Fig. 3D and E). Of note, the mutant cultures did not attain the
same optical density as the wild-type pathogen when grown with
shaking in nutrient-rich LB broth, but in stationary cultures the
mutant and wild-type strains reached equivalent bacterial titers,
consistent with results using laboratory K-12 strains (reference 44
and data not shown).WhileMV impaired growth of UTI89!cyaA
and UTI89!crp, the same mutants grew remarkably better than
the wild-type strain in the presence of H2O2 (Fig. 3C). This effect
was observed in both MES-LB and regular LB broth cultures,
though results weremore variable in the latter. Complementation
of UTI89!cyaA and UTI89!crp with plasmids pcyaA and pcrp,
respectively, caused the mutant strains to behave like wild-type
UTI89, rendering them sensitive toH2O2 and resistant toASNand
MV (Fig. 4 and data not shown).
H2O2 resistance correlates with elevated RpoS expression
and catalase activity in the absence of cAMP-CRP. cAMP-CRP
represses the transcription of the alternate sigma factor RpoS, a
master regulator of the general stress response in E. coli (45). In
FIG 2 UPEC requires functional cAMP-CRP for virulence in the murine urinary tract. Adult female CBA/J mice (A, B) or C3H/HeJ mice (C) were infected via
catheterization with 1" 107 CFU of wild-type UTI89 or isogenic mutants lacking cyaA or crp. Graphs show bacterial titers present in the bladder at 6 h (A) and
3 days (B, C) postinoculation. Bars indicate median values for each group; n! 11 mice. P values were determined using Mann-Whitney U tests.
FIG3 UTI89!cyaA andUTI89!crp are sensitive to nitrosative stress andmethyl viologen but resistant toH2O2. Growth ofUTI89,UTI89!cyaA, andUTI89!crp
inMES-LB broth (A),MES-LB broth# 1mMASN (B),MES-LB broth# 1mMH2O2 (C), LB broth (D), and LB broth containing 1mMMV (E). Growth curves
show the means of results from a single experiment and are representative of at least three independent experiments carried out in quadruplicate.
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enterohemorrhagicE. coli and laboratoryK-12mutant strains that
lack cAMP-CRP, RpoS levels are abnormally increased during the
exponential growth phase (44, 46, 47). By Western blot analyses,
we observed a similar phenomenon, with RpoS levels in
UTI89!cyaA andUTI89!crpnotably increased relative to those of
the wild-type strain during exponential growth in broth culture
(Fig. 5A). RpoS regulates the expression of various genes that en-
able bacteria to deal withmultiple environmental stresses, includ-
ing reactive oxygen species like H2O2 (45, 48). IPTG-induced ex-
pression of RpoS from the plasmid prpoS rescued growth of wild-
type UTI89 in the presence of H2O2, phenocopying the H2O2
resistance seen with the !cyaA and !crpmutants (Fig. 5B and C).
The high-level resistance of UTI89/prpoS, UTI89!cyaA, and
UTI89!crp to H2O2 correlated with increased catalase activity in
these strains (Fig. 5D). These results are in line with previous work
showing that RpoS can stimulate expression of stress-responsive
catalase genes necessary for the detoxification of H2O2 (48, 49).
While these data argue that enhanced expression of one or
more RpoS-regulated catalases promotes high-level resistance of
UTI89!cyaA and UTI89!crp toH2O2, it is feasible that other
RpoS-regulated genes also contribute to the resistance phenotype
of these mutants. To explore this possibility, we investigated two
additional loci—otsBA and dps—known to be regulated by RpoS
and previously linked with oxidative stress resistance. The first,
otsBA, encodes two enzymes used to catalyze the biosynthesis of
the disaccharide trehalose, a universal stress protectant produced
in abundance by many prokaryotic and eukaryotic organisms
(50). In yeast, trehalose protects against oxidative stress caused by
H2O2 (51, 52).We found that UTI89mutants lacking cAMP-CRP
generate sizeable amounts of trehalose relative to an isogenic
!otsAB mutant or a control mutant strain missing an unrelated
gene (!fimH) (Fig. 5E). However, the addition of exogenous tre-
halose (up to 3,783 "g/ml) failed to rescue growth of wild-type
UTI89 in broth cultures containing 1 mM H2O2, and the double
deletion mutant UTI89!cyaA!ostBA was as resistant to H2O2 as
UTI89!cyaA (data not shown). These results indicate that while
trehalose levels are greatly elevated in bacteria lacking cAMP-
CRP, this phenomenon is likely not essential to the heightened
H2O2 resistance associated with UTI89!cyaA and UTI89!crp.
We next examined Dps, an abundant RpoS- and cAMP-CRP-
regulated stationary-phase protein that can protect E. coli cells
from multiple stresses, including oxidants (44, 46, 53–55). Dps
can bind and shield DNA and also has ferritin-like properties,
enabling it to sequester and oxidize ferrous ions while detoxifying
H2O2 in the process (54). In consideration of this information, we
hypothesized that forced expression of recombinant Dps would
render wild-type UTI89more resistant to H2O2, potentially mim-
icking UTI89!cyaA andUTI89!crp. However, IPTG-induced ex-
pression of Dps from plasmid pdps had no effect on the growth of
either wild-type UTI89 or a !dps mutant in the presence or ab-
sence of H2O2 (Fig. 5F and G). Induced expression of Dps did
promote survival of UTI89!dps in a metal (CuSO4) stress resis-
tance assay, confirming the functionality of the pdps plasmid (Fig.
5H). In total, these data indicate that increased Dps expression is
surprisingly ineffective at promoting H2O2 resistance in UTI89.
Acid stress resistance of UTI89!cyaA and UTI89!crp is
linked with increased RpoS andDps expression.Within the uri-
nary tract, UPECwill likely come across pH extremes, both within
the urine and within host epithelial cells and infiltrating phago-
cytes (56, 57). In laboratory E. coli K-12 strains, cAMP-CRP,
RpoS, and Dps can mediate acid stress resistance (58–60). Poten-
tial involvement of cAMP-CRP as a regulator of acid stress resis-
tance in UTI89 was assessed using survival assays. Following a
30-min exposure of exponential-growth-phase cultures to acidic
(pH 3.5) conditions, we found that the !cyaA and !crp mutants
had a significant survival advantage over wild-typeUTI89 (Fig. 6).
In these assays, IPTG-induced expression of recombinant RpoS or
Dps was sufficient to enhance survival of the wild-type strain to
levels observed with UTI89!cyaA and UTI89!crp. To address
whether or not RpoS or Dps is necessary for acid resistance, we
constructed the mutant strains UTI89!rpoS, UTI89!dps,
UTI89!dps!crp, andUTI89!rpoS!crp. In agreement with results
observed with other E. coli strains (61–63), we found that
UTI89!rpoS is highly sensitive to acid stress (Fig. 6). This sensi-
tivity was reduced nearly 10,000-fold when crp was deleted along
with rpoS. However, the !rpoS !crpmutant was still more sensi-
tive than wild-type UTI89 and much more sensitive than UTI89
lacking only crp. In contrast, deletion of dps had only modest
effects on the acid resistance of either UTI89 or UTI89!crp. To-
gether, these data indicate that the acid stress resistance of UTI89
mutants lacking cAMP-CRP is likely attributable in part to in-
FIG 4 Complementation of UTI89!cyaA and UTI89!crp in the presence of nitrosative and oxidative stresses. Graphs show growth of UTI89 versus
UTI89!cyaA (A toC) andUTI89!crp (D to F) inMES-LB (A,D),MES-LB# 1mMASN (B, E), orMES-LB# 1mMH2O2 (C, F), all without added IPTG. Strains
carried pcyaA, pcrp, or the control plasmid pRR48, as indicated. Growth curves show the means of results from a single experiment and are representative of at
least three independent experiments carried out in quadruplicate.
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creased cellular levels of RpoS and RpoS-regulated factors like
Dps, in addition to other cAMP-CRP-repressible gene products.
DISCUSSION
Themisregulation of carbon flux throughmetabolic pathways can
restrict niche availability and alter the virulence potential of E. coli
and other bacterial species (4, 18, 64–66). cAMP-CRP—a central
regulator of carbon metabolism—has been implicated as an im-
portant facilitator of host colonization and virulence inmany bac-
terial pathogens, including the uropathogen Proteus mirabilis (18,
67). This is not entirely unexpected given the known capacity of
cAMP-CRP to modulate far-ranging activities in addition to me-
tabolism (16). Among these is the ability to influence key stress
response pathways such as those controlled by OxyR and RpoS
(44, 45, 68). Results presented here demonstrate that cAMP-CRP
is also critical to the ability of UPEC to effectively colonize the
urinary tract.
Earlier work indicated that E. coli strains that are deficient in
the production of cAMP-CRP expressmore type 1 pili (23). These
filamentous adhesive organelles promote bacterial colonization of
the bladder, suggesting that the defects observed with the !cyaA
and !crp mutants in our in vivo assays may be attributable to
misregulation of type 1 pilus expression. However, this possibility
is countered by recent work showing that elevated levels of type 1
pilus expression actually enhance the ability of UPEC to colonize
and persist within the bladder (69). Consequently, we conclude
that the inability of the !cyaA and !crp mutants to effectively
colonize the bladder is mostly due to the effects of diminished
cAMP-CRP levels on factors other than type 1 pili.
In our in vitro assays, deletion of either cyaA or crp increased
the ability of UPEC to withstand levels of H2O2 that prevent
growth of the wild-type strain. The!cyaA and!crpmutants were
also substantially more resistant to acid stress. UPEC likely comes
across similar stresses during the course of a UTI, but any increase
in stress resistance afforded by the deletion of cyaA or crp is ap-
parently countered and surpassed in vivo by detrimental effects on
other systems. For example, the !cyaA and !crp mutants are
highly sensitive to nitrosative stress and the superoxide generator
FIG 5 H2O2 resistance correlates with increased RpoS expression and catalase activity in UTI89!cyaA and UTI89!crp. (A)Western blot of RpoS ("
S) in UTI89,
UTI89!cyaA, and UTI89!crp after growth to mid-exponential phase in LB broth. Relative levels of RpoS normalized to loading control (Ctrl) are indicated. (B,
C) Curves show growth of UTI89 and UTI89!crp carrying empty vector pRR48 or prpoS, as indicated, inMES-LB# 1mMH2O2. (D) Graph of catalase activity
in UTI89, UTI89!cyaA, UTI89!crp, and UTI89/prpoS following growth to stationary phase in LB broth$ 1 mM IPTG. Data are expressed relative to wild-type
UTI89 as themeans# standard errors of three independent experiments carried out in triplicate. (E) Levels of trehalose present in UTI89!fimH, UTI89!otsBA,
UTI89!cyaA, andUTI89!crp following growth to stationary phase (OD600% 1.0). The!fimHmutant carries the same chloramphenicol resistance cassette as the
!cyaA and !crpmutants and served as the control. (F, G) Graphs show growth of UTI89 and its mutant derivatives (!cyaA, !crp, and !dpsmutants) carrying
pRR48 or pdps, as indicated, in MES-LB # 1 mM H2O2. Each growth curve (B, C, F, and G) shows the means of results from a single experiment and is
representative of at least three independent experiments carried out in quadruplicate.Dps andRpoS expression in these assayswas induced by addition of 0.5mM
IPTG. (H) Survival of UTI89!dps complemented with empty vector pRR48 or pdps following 15 min of exposure to 0.05 M CuSO4. Results were obtained
without addition of IPTG and are presented relative to those of wild-type UTI89/pRR48. The indicated P values were determined using two-tailed unpaired t
tests.
cAMP-CRP Regulates UPEC Pathogenicity
January 2013 Volume 81 Number 1 iai.asm.org 255
 on Decem
ber 21, 2012 by guest
http://iai.asm
.org/
Downloaded from
 
36 
 
 
MV. Both reactive nitrogen and reactive oxygen species like su-
peroxide are abundantly produced in response to aUTI and could
compromise the fitness of mutants lacking cAMP-CRP (5, 38, 39,
41, 70). An inability to utilize alternate carbon sources like amino
acidsmay also limit successful colonizationof the urinary tract by the
!cyaA and!crpmutants, as peptides and amino acids are a primary
energy source utilized by UPEC during a UTI (10, 12, 13). Further-
more, the massive upregulation of trehalose production by
UTI89!cyaA and UTI89!crp, while potentially offering a degree of
protection under some stressful conditions, may exact a high fitness
cost within the nutrient-poor confines of the urinary tract.
Results obtained using C3H/HeJ mice suggest that innate host
defenses, and not nutrient availability per se, are the primary fac-
tors that restrict UTI89!cyaA and UTI89!crp from effectively
colonizing the urinary tract. C3H/HeJmice are hyporesponsive to
lipopolysaccharide and are therefore unable to mount full-on
TLR4-dependent inflammatory responses (32–36, 71, 72). Spe-
cific defects associated with C3H/HeJ mice include poor expres-
sion of chemokines and greatly reduced infiltration of the bladder
mucosa by neutrophils in response to UTI (35, 73, 74). In our
assays, wild-type UTI89 and the !cyaA and !crp mutants colo-
nized C3H/HeJmicemuch better than immunocompetent CBA/J
animals, although the bladder-associated titers of the mutant
strains were more variable within C3H/HeJ mice (Fig. 2). Signifi-
cantly, the clear differences in bladder titers observed between
wild-type UTI89 and the !cyaA and !crpmutants in CBA/J mice
were markedly diminished in the C3H/HeJ strain, probably be-
causeC3H/HeJmice present themutantswith a less inflammatory
and therefore less stressful environment.
Cumulatively, our data indicate that the effects of cAMP-CRP
on multiple metabolic and stress response pathways must be bal-
anced in order for UPEC to effectively colonize the urinary tract.
This likely involves input frommany cAMP-CRP-responsive reg-
ulatory factors, including the alternate sigma factor RpoS. In vitro,
we found that UPEC mutants lacking cAMP-CRP have elevated
levels of RpoS expression, in line with results obtained using other
E. coli strains (44, 46, 47, 75, 76). The high-level resistance of
UTI89!cyaA and UTI89!crp to H2O2 could be phenocopied by
inducing the expression of RpoS in the wild-type pathogen. Other
researchers have reported that a laboratory E. coli K-12 mutant
lacking cAMP-CRP is also highly resistant to H2O2 (44). In this
case, it was suggested that resistance of the mutant to H2O2 was
partially attributable to increased RpoS-dependent expression of
the DNA binding, ferritin-like protein Dps. We found that IPTG-
induced expression of recombinant Dps is not sufficient to rescue
growth of wild-type UTI89 in the presence of H2O2, suggesting
that other, as-yet-undefined factor(s) acting downstream of RpoS
mediate H2O2 resistance in this pathogen. Chief among the can-
didate gene products that may promote H2O2 resistance are the
RpoS-inducible catalases (48, 49), which by inference appear to be
upregulated in UTI89!cyaA and UTI89!crp (Fig. 5D). Interest-
ingly, in our assays, the UTI89!cyaA mutant consistently had
higher levels of catalase activity than the !crpmutant, suggesting
that cAMP generated by CyaA may boost catalase activity in part
via CRP-independent mechanisms.
As with the H2O2 sensitivity assays, induced expression of re-
combinant RpoS increased the acid resistance of wild-type UTI89
to levels observed with the !cyaA and !crp mutants (Fig. 6). In
this case, overexpression of recombinant Dps gave similar results,
suggesting that enhanced production of RpoS in the absence of
cAMP-CRPpromotes acid stress resistance inUPECvia transcrip-
tional effects on dps. However, deletion of dps only slightly de-
creases the acid resistance of either UTI89 or the !crpmutant. In
contrast, deletion of rpoS greatly increased the acid sensitivity of
UTI89 and, to a far lesser extent, UTI89!crp. These observations
indicate that acid resistance in UPEC does not require Dps, im-
plying the possible involvement of other RpoS-regulated pH
stress-responsive genes such as asr, gadA, and gadBC (46, 59).
Furthermore, since UTI89!rpoS is much more sensitive to acid
stress than the !crp!rpoS double-knockout mutant, we conclude
that the absence of cAMP-CRP promotes acid resistance in UPEC
via both RpoS-dependent and RpoS-independent mechanisms.
The number of cAMP-CRP-repressible genes that could contrib-
ute to the observed acid resistance phenotypes independent of
RpoS is potentially high (77, 78).
At first glance, the high-level resistance of UTI89!cyaA and
UTI89!crp toH2O2 seems at odds with the increased sensitivity of
these mutants to MV. While H2O2 and MV both generate oxida-
tive stress, there are appreciable differences in their reactivities,
duration of activity, and side effects that may differentially influ-
ence their toxicity (79). Methyl viologen is a superoxide generator
that reduces diatomic oxygen to form superoxide. Oxidized MV
can then be reduced by cellular electron donors, creating a redox
cycle that consumes reducing equivalents like NADPHwhile con-
tinually producing superoxidemolecules (80). In comparison, the
oxidizing effects of H2O2 are not regenerated. Within E. coli, su-
peroxide dismutase (Sod) enzymes convert superoxide into oxy-
gen and H2O2. In turn, catalases convert H2O2 into innocuous
diatomic oxygen and water. Decreased repression of RpoS within
the !cyaA and !crpmutants results in increased catalase activity,
as reported here (Fig. 5D), and may also stimulate the expression
of cAMP-CRP- and RpoS-regulated enzymes like SodB and SodC
(81, 82). Consequently, mutants lacking cAMP-CRP are likely
better equipped to detoxify both superoxide and H2O2, which in
turnmay drive the redox cycle centered aroundMV so that reduc-
FIG 6 Expression of RpoS or Dps enables wild-type UTI89 to survive low-pH
stress at levels similar to those of the !cyaA and !crp mutants. After reaching
mid-logarithmic growth phase in LB broth, UTI89 and the UTI89!cyaA,
UTI89!crp, UTI89!dps, UTI89!rpoS, UTI89!crp!dps, and UTI89!crp!rpoS
mutants (" pRR48, pdps, and prpoS, as indicated) were exposed to acid (pH 3.5)
stress for 30 min. Following washes in PBS, numbers of surviving bacteria were
determined by dilution plating. Plasmid-containing strains were grown in the
presence of 0.5mM IPTG prior to challenge with pH stress. Data are expressed as
the means" standard deviations of three independent experiments. P values of
#0.05 are indicated by one asterisk (*) for comparison with UTI89 and by two
asterisks (**) for comparison with UTI89/pRR48, as determined by two-tailed
unpaired t tests.
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ing equivalents needed by the bacteria are consumed at a rate that
disrupts essential cellular processes. The exact mechanisms by
which the !cyaA and !crp mutants differentially deal with MV
and H2O2 require further investigation. However, the opposing
effects of these two oxidants on cAMP-CRP-dependent bacterial
growth and fitness highlight the complex interplay that is possible
between cAMP-CRP and the myriad metabolic and stress re-
sponse systems that can contribute to the pathogenicity of UPEC.
ACKNOWLEDGMENTS
We are grateful to James Cox in the Metabolomics Facility of the Univer-
sity of Utah for help with quantifying trehalose levels, and we thank James
Imlay for providing plasmid pdps and Sandy Parkinson for pRR48.We are
also grateful to Rich Kulesus for providing UTI89!rpoS.
This work was supported by grants AI095647, AI090369, and
AI088086 from the National Institute of Allergy and Infectious Diseases.
J.P.N. was supported by NIH Genetics Training Grant T32-GM007464.
REFERENCES
1. Wiles TJ, Kulesus RR, Mulvey MA. 2008. Origins and virulence mech-
anisms of uropathogenic Escherichia coli. Exp. Mol. Pathol. 85:11–19.
2. Zasloff M. 2007. Antimicrobial peptides, innate immunity, and the nor-
mally sterile urinary tract. J. Am. Soc. Nephrol. 18:2810–2816.
3. Gawel D, Seed PC. 2011. Urinary tract infection drives genome instability
in uropathogenic Escherichia coli and necessitates translesion synthesis
DNA polymerase IV for virulence. Virulence 2:222–232.
4. Alteri CJ, Mobley HL. 2012. Escherichia coli physiology and metabolism
dictates adaptation to diverse host microenvironments. Curr. Opin. Mi-
crobiol. 15:3–9.
5. Li B, Smith P, Horvath DJ, Jr, Romesberg FE, Justice SS. 2010. SOS
regulatory elements are essential for UPEC pathogenesis. Microbes Infect.
12:662–668.
6. Foxman B. 2010. The epidemiology of urinary tract infection. Nat. Rev.
Urol. 7:653–660.
7. Sivick KE, Mobley HL. 2010. Waging war against uropathogenic Esche-
richia coli: winning back the urinary tract. Infect. Immun. 78:568–585.
8. Hunstad DA, Justice SS. 2010. Intracellular lifestyles and immune eva-
sion strategies of uropathogenic Escherichia coli. Annu. Rev. Microbiol.
64:203–221.
9. Dhakal BK, Kulesus RR, Mulvey MA. 2008. Mechanisms and conse-
quences of bladder cell invasion by uropathogenic Escherichia coli. Eur. J.
Clin. Invest. 38(S2):2–11.
10. Alteri CJ, Smith SN, Mobley HL. 2009. Fitness of Escherichia coli during
urinary tract infection requires gluconeogenesis and the TCA cycle. PLoS
Pathog. 5:e1000448. doi:10.1371/journal.ppat.1000448.
11. Martinez-Jehanne V, Pichon C, du Merle L, Poupel O, Cayet N,
Bouchier C, Le Bouguenec C. 2012. Role of the Vpe carbohydrate per-
mease in Escherichia coli urovirulence and fitness in vivo. Infect. Immun.
80:2655–2666.
12. Anfora AT, Haugen BJ, Roesch P, Redford P, Welch RA. 2007. Roles of
serine accumulation and catabolism in the colonization of the murine
urinary tract by Escherichia coli CFT073. Infect. Immun. 75:5298–5304.
13. Roesch PL, Redford P, Batchelet S, Moritz RL, Pellett S, Haugen BJ,
Blattner FR, Welch RA. 2003. Uropathogenic Escherichia coli use d-ser-
ine deaminase to modulate infection of the murine urinary tract. Mol.
Microbiol. 49:55–67.
14. Hadjifrangiskou M, Kostakioti M, Chen SL, Henderson JP, Greene SE,
Hultgren SJ. 2011. A central metabolic circuit controlled by QseC in
pathogenic Escherichia coli. Mol. Microbiol. 80:1516–1529.
15. Kostakioti M, Hadjifrangiskou M, Pinkner JS, Hultgren SJ. 2009. QseC-
mediated dephosphorylation of QseB is required for expression of genes
associated with virulence in uropathogenic Escherichia coli. Mol. Micro-
biol. 73:1020–1031.
16. Gorke B, Stulke J. 2008. Carbon catabolite repression in bacteria: many
ways to make the most out of nutrients. Nat. Rev. Microbiol. 6:613–624.
17. Poncet S, Milohanic E, Maze A, Nait Abdallah J, Ake F, Larribe M,
Deghmane AE, Taha MK, Dozot M, De Bolle X, Letesson JJ, Deutscher
J. 2009. Correlations between carbon metabolism and virulence in bacte-
ria. Contrib. Microbiol. 16:88–102.
18. McDonough KA, Rodriguez A. 2012. The myriad roles of cyclic AMP in
microbial pathogens: from signal to sword.Nat. Rev.Microbiol. 10:27–38.
19. Nielsen AT, Dolganov NA, Rasmussen T, Otto G, Miller MC, Felt SA,
Torreilles S, Schoolnik GK. 2010. A bistable switch and anatomical site
control Vibrio cholerae virulence gene expression in the intestine. PLoS
Pathog. 6:e1001102. doi:10.1371/journal.ppat.1001102.
20. Rickman L, Scott C, Hunt DM, Hutchinson T, Menendez MC, Whalan
R, Hinds J, Colston MJ, Green J, Buxton RS. 2005. A member of the
cAMP receptor protein family of transcription regulators in Mycobacte-
rium tuberculosis is required for virulence inmice and controls transcrip-
tion of the rpfA gene coding for a resuscitation promoting factor. Mol.
Microbiol. 56:1274–1286.
21. Curtiss R, III, Kelly SM. 1987. Salmonella typhimurium deletion mu-
tants lacking adenylate cyclase and cyclic AMP receptor protein are avir-
ulent and immunogenic. Infect. Immun. 55:3035–3043.
22. Smith RS, Wolfgang MC, Lory S. 2004. An adenylate cyclase-controlled
signaling network regulates Pseudomonas aeruginosa virulence in a
mouse model of acute pneumonia. Infect. Immun. 72:1677–1684.
23. Muller CM, Aberg A, Straseviciene J, Emody L, Uhlin BE, Balsalobre C.
2009. Type 1 fimbriae, a colonization factor of uropathogenic Escherichia
coli, are controlled by the metabolic sensor CRP-cAMP. PLoS Pathog.
5:e1000303. doi:10.1371/journal.ppat.1000303.
24. Chen SL, Hung CS, Xu J, Reigstad CS, Magrini V, Sabo A, Blasiar D,
Bieri T, Meyer RR, Ozersky P, Armstrong JR, Fulton RS, Latreille JP,
Spieth J, Hooton TM, Mardis ER, Hultgren SJ, Gordon JI. 2006.
Identification of genes subject to positive selection in uropathogenic
strains of Escherichia coli: a comparative genomics approach. Proc. Natl.
Acad. Sci. U. S. A. 103:5977–5982.
25. Mulvey MA, Schilling JD, Hultgren SJ. 2001. Establishment of a persis-
tent Escherichia coli reservoir during the acute phase of a bladder infec-
tion. Infect. Immun. 69:4572–4579.
26. Zhou Q, Ames P, Parkinson JS. 2009. Mutational analyses of HAMP
helices suggest a dynamic bundle model of input-output signalling in
chemoreceptors. Mol. Microbiol. 73:801–814.
27. Murphy KC, Campellone KG. 2003. Lambda Red-mediated recombino-
genic engineering of enterohemorrhagic and enteropathogenic E. coli.
BMCMol. Biol. 4:11. doi:10.1186/1471-2199-4-11.
28. Datsenko KA, Wanner BL. 2000. One-step inactivation of chromosomal
genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci.
U. S. A. 97:6640–6645.
29. Blango MG, Mulvey MA. 2010. Persistence of uropathogenic Escherichia
coli in the face of multiple antibiotics. Antimicrob. Agents Chemother.
54:1855–1863.
30. Eto DS, Gordon HB, Dhakal BK, Jones TA, Mulvey MA. 2008. Clathrin,
AP-2, and the NPXY-binding subset of alternate endocytic adaptors facil-
itate FimH-mediated bacterial invasion of host cells. Cell. Microbiol. 10:
2553–2567.
31. Hopkins W, Gendron-Fitzpatrick A, McCarthy DO, Haine JE, Uehling
DT. 1996. Lipopolysaccharide-responder and nonresponder C3H mouse
strains are equally susceptible to an induced Escherichia coli urinary tract
infection. Infect. Immun. 64:1369–1372.
32. Hagberg L, Hull R, Hull S, McGhee JR, Michalek SM, Svanborg Eden
C. 1984. Difference in susceptibility to gram-negative urinary tract infec-
tion between C3H/HeJ and C3H/HeNmice. Infect. Immun. 46:839–844.
33. Suhs KA, Marthaler BR, Welch RA, Hopkins WJ. 2011. Lack of associ-
ation between the Tlr4 (Lpsd/Lpsd) genotype and increased susceptibility
to Escherichia coli bladder infections in female C3H/HeJ mice. mBio
2:e00094–11. doi:10.1128/mBio.00094-11.
34. Hopkins WJ, Elkahwaji J, Kendziorski C, Moser AR, Briggs PM, Suhs
KA. 2009. Quantitative trait loci associated with susceptibility to bladder
and kidney infections induced by Escherichia coli in female C3H/HeJ
mice. J. Infect. Dis. 199:355–361.
35. Haraoka M, Hang L, Frendéus B, Godaly G, Burdick M, Strieter R,
Svanborg C. 1999. Neutrophil recruitment and resistance to urinary tract
infection. J. Infect. Dis. 180:1220–1229.
36. Schilling JD, Martin SM, Hung CS, Lorenz RG, Hultgren SJ. 2003.
Toll-like receptor 4 on stromal and hematopoietic cells mediates innate
resistance to uropathogenic Escherichia coli. Proc. Natl. Acad. Sci. U. S. A.
100:4203–4208.
37. Aubron C, Glodt J, Matar C, Huet O, Borderie D, Dobrindt U, Du-
ranteau J, Denamur E, Conti M, Bouvet O. 2012. Variation in endoge-
nous oxidative stress in Escherichia coli natural isolates during growth in
urine. BMCMicrobiol. 12:120. doi:10.1186/1471-2180-12-120.
cAMP-CRP Regulates UPEC Pathogenicity
January 2013 Volume 81 Number 1 iai.asm.org 257
 on Decem
ber 21, 2012 by guest
http://iai.asm
.org/
Downloaded from
 
38 
 
 
38. Bower JM, Gordon-Raagas HB, Mulvey MA. 2009. Conditioning of
uropathogenic Escherichia coli for enhanced colonization of host. Infect.
Immun. 77:2104–2112.
39. Johnson JR, Clabots C, Rosen H. 2006. Effect of inactivation of the global
oxidative stress regulator oxyR on the colonization ability of Escherichia
coli O1:K1:H7 in a mouse model of ascending urinary tract infection.
Infect. Immun. 74:461–468.
40. Korshunov S, Imlay JA. 2006. Detection and quantification of superoxide
formed within the periplasm of Escherichia coli. J. Bacteriol. 188:6326–
6334.
41. Lundberg JO, Ehren I, Jansson O, Adolfsson J, Lundberg JM, Weitzberg
E, Alving K, Wiklund NP. 1996. Elevated nitric oxide in the urinary
bladder in infectious and noninfectious cystitis. Urology 48:700–702.
42. Poljakovic M, Svensson ML, Svanborg C, Johansson K, Larsson B,
Persson K. 2001. Escherichia coli-induced inducible nitric oxide synthase
and cyclooxygenase expression in the mouse bladder and kidney. Kidney
Int. 59:893–904.
43. Woolford G, Casselden RJ, Walters CL. 1972. Gaseous products of the
interaction of sodium nitrite with porcine skeletal muscle. Biochem. J.
130:82P–83P.
44. Barth E, Gora KV, Gebendorfer KM, Settele F, Jakob U, Winter J. 2009.
Interplay of cellular cAMP levels, {sigma}S activity and oxidative stress
resistance in Escherichia coli. Microbiology 155:1680–1689.
45. Hengge-Aronis R. 2002. Signal transduction and regulatory mechanisms
involved in control of the sigma(S) (RpoS) subunit of RNA polymerase.
Microbiol. Mol. Biol. Rev. 66:373–395.
46. Jeong KC, Baumler DJ, Kaspar CW. 2006. dps expression in Escherichia
coli O157:H7 requires an extended !10 region and is affected by the
cAMP receptor protein. Biochim. Biophys. Acta 1759:51–59.
47. Lange R, Hengge-Aronis R. 1994. The cellular concentration of the sigma
S subunit of RNA polymerase in Escherichia coli is controlled at the levels
of transcription, translation, and protein stability. Genes Dev. 8:1600–
1612.
48. Eisenstark A, Calcutt MJ, Becker-Hapak M, Ivanova A. 1996. Role of
Escherichia coli rpoS and associated genes in defense against oxidative
damage. Free Radic. Biol. Med. 21:975–993.
49. Schellhorn HE. 1995. Regulation of hydroperoxidase (catalase) expres-
sion in Escherichia coli. FEMS Microbiol. Lett. 131:113–119.
50. Strom AR, Kaasen I. 1993. Trehalose metabolism in Escherichia coli:
stress protection and stress regulation of gene expression.Mol.Microbiol.
8:205–210.
51. Alvarez-Peral FJ, Zaragoza O, Pedreno Y, Arguelles JC. 2002. Protective
role of trehalose during severe oxidative stress caused by hydrogen perox-
ide and the adaptive oxidative stress response in Candida albicans. Micro-
biology 148:2599–2606.
52. Benaroudj N, Lee DH, Goldberg AL. 2001. Trehalose accumulation
during cellular stress protects cells and cellular proteins from damage by
oxygen radicals. J. Biol. Chem. 276:24261–24267.
53. Martinez A, Kolter R. 1997. Protection of DNA during oxidative stress by
the nonspecific DNA-binding protein Dps. J. Bacteriol. 179:5188–5194.
54. Almiron M, Link AJ, Furlong D, Kolter R. 1992. A novel DNA-binding
protein with regulatory and protective roles in starved Escherichia coli.
Genes Dev. 6:2646–2654.
55. Park S, You X, Imlay JA. 2005. Substantial DNA damage from submi-
cromolar intracellular hydrogen peroxide detected in Hpx- mutants of
Escherichia coli. Proc. Natl. Acad. Sci. U. S. A. 102:9317–9322.
56. Eto DS, Sundsbak JL, Mulvey MA. 2006. Actin-gated intracellular
growth and resurgence of uropathogenic Escherichia coli. Cell.Microbiol.
8:704–717.
57. Vergne I, Constant P, Laneelle G. 1998. Phagosomal pH determination
by dual fluorescence flow cytometry. Anal. Biochem. 255:127–132.
58. Foster JW. 2004. Escherichia coli acid resistance: tales of an amateur
acidophile. Nat. Rev. Microbiol. 2:898–907.
59. Castanie-Cornet MP, Penfound TA, Smith D, Elliott JF, Foster JW.
1999. Control of acid resistance in Escherichia coli. J. Bacteriol. 181:3525–
3535.
60. Calhoun LN, Kwon YM. 2011. Structure, function and regulation of the
DNA-binding protein Dps and its role in acid and oxidative stress resis-
tance in Escherichia coli: a review. J. Appl. Microbiol. 110:375–386.
61. Small P, Blankenhorn D, Welty D, Zinser E, Slonczewski JL. 1994. Acid
and base resistance in Escherichia coli and Shigella flexneri: role of rpoS
and growth pH. J. Bacteriol. 176:1729–1737.
62. Cheville AM, Arnold KW, Buchrieser C, Cheng CM, Kaspar CW. 1996.
rpoS regulation of acid, heat, and salt tolerance in Escherichia coli O157:
H7. Appl. Environ. Microbiol. 62:1822–1824.
63. Waterman SR, Small PL. 1996. Characterization of the acid resistance
phenotype and rpoS alleles of Shiga-like toxin-producing Escherichia coli.
Infect. Immun. 64:2808–2811.
64. Le Bouguenec C, Schouler C. 2011. Sugar metabolism, an additional
virulence factor in enterobacteria. Int. J. Med. Microbiol. 301:1–6.
65. Loughman JA, Hunstad DA. 2012. Induction of indoleamine 2,3-
dioxygenase by uropathogenic bacteria attenuates innate responses to ep-
ithelial infection. J. Infect. Dis. 205:1830–1839.
66. Rouquet G, Porcheron G, Barra C, Reperant M, Chanteloup NK,
Schouler C, Gilot P. 2009. A metabolic operon in extraintestinal patho-
genic Escherichia coli promotes fitness under stressful conditions and in-
vasion of eukaryotic cells. J. Bacteriol. 191:4427–4440.
67. Himpsl SD, Lockatell CV, Hebel JR, Johnson DE, Mobley HL. 2008.
Identification of virulence determinants in uropathogenic Proteus mirabilis
using signature-taggedmutagenesis. J. Med.Microbiol. 57:1068–1078.
68. Gonzalez-Flecha B, Demple B. 1997. Transcriptional regulation of the
Escherichia coli oxyR gene as a function of cell growth. J. Bacteriol. 179:
6181–6186.
69. Kostakioti M, Hadjifrangiskou M, Cusumano CK, Hannan TJ, Janetka
JW,Hultgren SJ. 2012. Distinguishing the contribution of type 1 pili from
that of other QseB-misregulated factors when QseC is absent during uri-
nary tract infection. Infect. Immun. 80:2826–2834.
70. Poljakovic M, Karpman D, Svanborg C, Persson K. 2002. Human renal
epithelial cells express iNOS in response to cytokines but not bacteria.
Kidney Int. 61:444–455.
71. Poltorak A, He X, Smirnova I, Liu MY, Huffel CV, Du X, Birdwell D,
Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P,
Layton B, Beutler B. 1998. Defective LPS signaling in C3H/HeJ and
C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282:2085–2088.
72. McAdam KP, Ryan JL. 1978. C57BL/10/CR mice: nonresponders to
activation by the lipid a moiety of bacterial lipopolysaccharide. J. Immun.
120:249–253.
73. Justice SS, Hung C, Theriot JA, Fletcher DA, Anderson GG, Footer MJ,
Hultgren SJ. 2004. Differentiation and developmental pathways of uro-
pathogenic Escherichia coli in urinary tract pathogenesis. Proc. Natl.
Acad. Sci. U. S. A. 101:1333–1338.
74. Svanborg C, Frendeus B, Godaly G, Hang L, Hedlund M, Wachtler C. 2001.
Toll-like receptor signaling and chemokine receptor expression influence the se-
verity of urinary tract infection. J. Infect.Dis. 183(Suppl 1):S61–S65.
75. Ma Z, Gong S, Richard H, Tucker DL, Conway T, Foster JW. 2003.
GadE (YhiE) activates glutamate decarboxylase-dependent acid resistance
in Escherichia coli K-12. Mol. Microbiol. 49:1309–1320.
76. Ma Z, Richard H, Foster JW. 2003. pH-dependent modulation of cyclic
AMP levels and GadW-dependent repression of RpoS affect synthesis of
the GadX regulator and Escherichia coli acid resistance. J. Bacteriol. 185:
6852–6859.
77. Raghavan R, Sage A, Ochman H. 2011. Genome-wide identification of
transcription start sites yields a novel thermosensing RNA and new cyclic
AMP receptor protein-regulated genes in Escherichia coli. J. Bacteriol.
193:2871–2874.
78. Zheng D, Constantinidou C, Hobman JL, Minchin SD. 2004. Identifi-
cation of the CRP regulon using in vitro and in vivo transcriptional pro-
filing. Nucleic Acids Res. 32:5874–5893.
79. Farr SB, Kogoma T. 1991. Oxidative stress responses in Escherichia coli
and Salmonella typhimurium. Microbiol. Rev. 55:561–585.
80. Bus JS, Gibson JE. 1984. Paraquat: model for oxidant-initiated toxicity.
Environ. Health Perspect. 55:37–46.
81. Lacour S, Landini P. 2004. SigmaS-dependent gene expression at the
onset of stationary phase in Escherichia coli: function of sigmaS-
dependent genes and identification of their promoter sequences. J. Bacte-
riol. 186:7186–7195.
82. Zhang Z, Gosset G, Barabote R, Gonzalez CS, Cuevas WA, Saier MH,
Jr. 2005. Functional interactions between the carbon and iron utilization
regulators, Crp and Fur, in Escherichia coli. J. Bacteriol. 187:980–990.
83. Wiles TJ, Bower JM, Redd MJ, Mulvey MA. 2009. Use of zebrafish to
probe the divergent virulence potentials and toxin requirements of ex-
traintestinal pathogenic Escherichia coli. PLoS Pathog. 5:e1000697. doi:
10.1371/journal.ppat.1000697.
84. Kulesus RR, Diaz-Perez K, Slechta ES, Eto DS, Mulvey MA. 2008.
Impact of the RNA chaperoneHfq on the fitness and virulence potential of
uropathogenic Escherichia coli. Infect. Immun. 76:3019–3026.
Donovan et al.
258 iai.asm.org Infection and Immunity
 on Decem
ber 21, 2012 by guest
http://iai.asm
.org/
Downloaded from
 
  
 
 
 
 
 
CHAPTER 3 
 
 
 
TOXIN-ANTITOXIN SYSTEMS ARE IMPORTANT FOR NICHE  
 
SPECIFIC COLONIZATION AND STRESS RESISTANCE  
 
OF UROPATHOGENIC ESCHERICHIA COLI 
 
 
 
Reprinted with permission from Public Library of Science 
 
Norton, J.P., and Mulvey, M. A. Toxin-antitoxin systems are important 
 for niche specific colonization and stress resistance of uropathogenic 
Escherichia coli. PloS Pathog 8(10): e1002954, 
doi:10.1371/journal.ppat.1002954 (2012). 
 
40 
 
 
Toxin-Antitoxin Systems Are Important for Niche-Specific
Colonization and Stress Resistance of Uropathogenic
Escherichia coli
J. Paul Norton, Matthew A. Mulvey*
Division of Microbiology and Immunology, Pathology Department, University of Utah School of Medicine, Salt Lake City, Utah, United States of America
Abstract
Toxin-antitoxin (TA) systems are prevalent in many bacterial genomes and have been implicated in biofilm and persister cell
formation, but the contribution of individual chromosomally encoded TA systems during bacterial pathogenesis is not well
understood. Of the known TA systems encoded by Escherichia coli, only a subset is associated with strains of extraintestinal
pathogenic E. coli (ExPEC). These pathogens colonize diverse niches and are a major cause of sepsis, meningitis, and urinary
tract infections. Using a murine infection model, we show that two TA systems (YefM-YoeB and YbaJ-Hha) independently
promote colonization of the bladder by the reference uropathogenic ExPEC isolate CFT073, while a third TA system
comprised of the toxin PasT and the antitoxin PasI is critical to ExPEC survival within the kidneys. The PasTI TA system also
enhances ExPEC persister cell formation in the presence of antibiotics and markedly increases pathogen resistance to
nutrient limitation as well as oxidative and nitrosative stresses. On its own, low-level expression of PasT protects ExPEC from
these stresses, whereas overexpression of PasT is toxic and causes bacterial stasis. PasT-induced stasis can be rescued by
overexpression of PasI, indicating that PasTI is a bona fide TA system. By mutagenesis, we find that the stress resistance and
toxic effects of PasT can be uncoupled and mapped to distinct domains. Toxicity was specifically linked to sequences within
the N-terminus of PasT, a region that also promotes the development of persister cells. These results indicate discrete,
multipurpose functions for a TA-associated toxin and demonstrate that individual TA systems can provide bacteria with
pronounced fitness advantages dependent on toxin expression levels and the specific environmental niche occupied.
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Introduction
Toxin-antitoxin (TA) systems consist of stable toxic proteins that
are held in check by co-expression of labile antitoxin molecules,
the nature of which distinguishes three classes of TA systems [1,2].
Antitoxins made by type I TA loci are small antisense RNAs that
suppress translation of the toxin genes [3], while the antitoxins
encoded by type II and type III TA loci are, respectively, proteins
and small RNAs that complex with and inactivate their cognate
protein toxins [2,4]. When freed to act, toxins encoded by TA loci
can disrupt diverse bacterial cell processes, including peptidogly-
can synthesis, the polymerization of cytoskeletal components,
ribosome assembly, tRNA availability, and mRNA stability
[5,6,7,8,9]. TA systems were initially characterized as plasmid-
encoded genes that serve as addiction molecules, promoting the
heritable maintenance of extra-chromosomal DNA within a
bacterial population [10,11]. However, TA systems are not solely
plasmid-associated, and have been found in abundance within
bacterial chromosomes from diverse species. The functional
relevance of individual chromosomally encoded TA systems to
bacterial fitness within the environment is oftentimes ambiguous,
and even less understood is the impact of these systems on
bacterial pathogenesis [12,13].
Environmental stresses have been shown to stimulate the
transcription of multiple chromosomal TA loci, leading to the
idea that these systems may enhance bacterial survival under
adverse conditions [14,15,16]. Others suggest that chromosomal
TA loci represent junk DNA or selfish genetic elements, or that
they primarily function akin to plasmid-encoded addiction
molecules, acting to stabilize genomic parasites such as conjugative
transposons and prophages [17,18]. A recent bioinformatics-based
study supporting this hypothesis concluded that TA loci are selfish
genetic elements that likely do not bestow any fitness advantage to
the bacteria in which they reside [19]. In some cases this may be
true, but there is mounting evidence that some chromosomal TA
systems play larger roles in bacterial physiology and pathogenesis.
Much of this evidence is circumstantial, based on expression
analysis of TA systems in bacteria in the presence of various
environmental stresses. For example, paralogous TA systems
within the Caulobacter crescentus genome are differentially expressed
in response to heavy metal-, heat-, and nitric oxide-induced
stresses [14], while in Mycobacterium tuberculosis several TA systems
are upregulated under hypoxic conditions or following bacterial
entry into macrophages [16]. One of these, VapBC, was recently
shown to regulate the balance of metabolic processes within
mycobacteria [20].
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Among strains of E. coli at least 17 type II chromosomal TA
systems have been identified [2]. A large subset of these was recently
shown to act redundantly in vitro to enhance survival of a K-12 E. coli
strain in the presence of antibiotics by driving the formation of
dormant, stress resistant cells known as persisters [9]. Type II TA
systems may also promote biofilm formation by some K-12 strains
[21,22,23], and can be differentially expressed in response to DNA
damage and nutrient deprivation [15]. Considering these observa-
tions, we were interested in understanding possible links between
chromosomal type II TA systems and the fitness and virulence
potential of extraintestinal pathogenic E. coli (ExPEC). These
pathogens are able to colonize diverse niches within humans and
other host animals and are a major cause of bacteremia, sepsis,
peritonitis, neonatal meningitis, and urinary tract infections (UTIs)
[24]. Here we report that, as a group, ExPEC isolates encode a
discrete repertoire of type II TA systems, three of which can
individually impact the fitness and persistence of a reference ExPEC
isolate in vivo within the urinary tract. In addition, the toxin PasT
encoded by one of these TA systems is shown to possess dual,
concentration-dependent activities that either enhance bacterial stress
resistance and growth or, alternatively, promote bacterial stasis and
persister cell formation.
Results
ExPEC Encode a Limited Number of Known Type II TA
Systems
To ascertain potential patterns in the distribution and makeup
of chromosomal type II TA systems among E. coli strains, the
allelic profiles of 35 fully sequenced E. coli isolates were compared
and organized based on similarities among 17 type II TA loci
using the eBURST algorithm (Dataset S1) [25]. This allelic-based
cluster analysis, which is often used to discern patterns of descent
within bacterial populations in which horizontal gene transfer is
widespread [19], identified two sizable groups of E. coli strains that
differ in the number and composition of their type II TA systems
(Figure 1A). One of these groups is comprised entirely of isolates
belonging to the B2 phylotype, a specific subset of phylogenetically
similar E. coli strains that includes most ExPEC isolates [26].
Interestingly, in our analysis the enteropathogenic E. coli (EPEC)
strain E2348/69 was also grouped with the ExPEC isolates. This
is, however, in line with a previous report that classified this EPEC
strain as a member of the B2 phylotype [27]. These data indicate
that, at least in the case of B2 strains, the composition of type II
TA systems within E. coli isolates can reflect their phylogenetic
origin, suggesting that specific TA systems may serve an
evolutionarily conserved purpose within this cohort.
Relative to K-12 E. coli strains, we found that ExPEC
generally have a reduced repertoire of intact type II TA loci, as
exemplified by comparative analysis of the lab-adapted K-12
reference strain MG1655 and the ExPEC isolate CFT073
(Figure 1B). This pathogen was isolated from the blood of a
patient with pyelonephritis and is part of a large sub-category of
ExPEC known as uropathogenic E. coli (UPEC), the primary
cause of UTIs worldwide [28]. Of the 16 type II TA loci
encoded by MG1655, only seven are found in CFT073. The
TA loci in CFT073 are syntenic with their counterparts in
MG1655, although five additional, imperfect copies of one
locus (yeeUV) are also present at sites around the CFT073
chromosome.
TA Systems Provide Niche-Specific Benefits to ExPEC
within the Host
The relative conservation of the type II TA loci subsets
among ExPEC isolates indicates that select TA systems may be
important fitness determinants for these pathogens. To address
this possibility, each single-copy type II TA locus in CFT073
was deleted and tested in competition with the wild type strain
using a well-established mouse UTI model system [29,30].
Cultures of wild type CFT073 and TA system mutant strains
were mixed in a 1:1 ratio and injected via transurethral
catheterization into adult female CBA/J mice, and three days
later bacterial titers in the bladder and kidneys were
determined. In these assays, half of the six TA system mutants
(DhigBA, DhipBA, and DsohA(prlF)-yhaV) tested showed no
significant defects relative to the wild type strain (Figure 2A
and B). In contrast, mutants lacking either the ybaJ-hha (tomB-
hha) or the yefM-yoeB TA locus were clearly outcompeted by
wild type CFT073 in the bladder, but not the kidneys
(Figure 2C and D), while the DpasTI mutant (CFT073DpasTI)
was outcompeted only in the kidneys (Figure 2E and F). It
should be noted that pasTI was originally dubbed yfjGF and
then ratAB, but has been renamed here for reasons described
later.
The competitive defect in kidney colonization by CFT073
DpasTI was evident within 24 h post-inoculation and significantly
worsened by the 3 d time point (Figure 2F). Over the same time
frame, wild type CFT073 titers within the kidneys were not
significantly diminished. We found that CFT073DpasTI is also
significantly impaired in kidney colonization during non-compet-
itive assays (Figure 2G and H). In contrast, defects observed with
the DybaJ-hha and DyefM-yoeB mutants in competitive assays
(Figure 2C and D) were not manifest in non-competitive assays
(Figure S1). The inability of CFT073DpasTI to effectively colonize
the kidneys of CBA/J mice was recapitulated in experiments using
two additional host strain backgrounds, C3H/HeN and C3H/HeJ
(Figure 3). Of note, the DpasTI mutant was similar to wild type
CFT073 in its ability to colonize and persist within the
gastrointestinal tract of CBA/J mice (Fig. S2). Together, these
results demonstrate that chromosomal type II TA systems like
PasTI can provide significant advantages to UPEC within specific
host environments.
Author Summary
Toxin-antitoxin (TA) systems are widespread among
prokaryotes, including many important human pathogens.
It has long been hypothesized that TA systems contribute
to bacterial pathogenesis, but clear-cut phenotypes
associated with any individual TA system have not been
described. Using bioinformatics, we demonstrate that
distinct subsets of TA systems are linked with a major
group of bacterial pathogens known as Extraintestinal
Pathogenic E. coli (ExPEC). These bacteria are responsible
for the majority of urinary tract infections worldwide, and
are major causes of sepsis and meningitis. Using murine
infection models with a reference uropathogenic ExPEC
isolate, we found that three of the ExPEC-associated TA
systems act independently to promote bacterial survival
and persistence within the host urinary tract. Furthermore,
we show that the toxin protein associated with one of
these TA systems increases ExPEC stress resistance and
persistence in the face of antibiotics. This work demon-
strates the functional importance of specific TA systems
to ExPEC pathogenesis, highlighting their potential as
therapeutic targets.
Critical Importance of TA Systems for UPEC
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The PasTI TA System Promotes the Development of
Persister Cells
In K-12 E. coli strains, TA systems are proposed to act
redundantly in the formation of persister cells in the presence of
antibiotics and other harsh environmental stresses [31,32]. For
example, deletion of any one of the 10 mRNA endonuclease-
encoding TA loci in the K-12 strain MG1655, individually, has no
effect on bacterial persistence in the presence of either ampicillin
or ciprofloxacin, whereas the successive deletion of five or more of
these loci results in progressively decreased numbers of persisters
[9]. In similar assays with CFT073 grown in LB broth, we found
that deletion of the pasTI TA locus, alone, decreased bacterial
persistence in the face of antibiotics by about 100-fold, while all
other type II TA knockout mutants behaved like the wild type
pathogen (Figure 4A). The minimal inhibitory concentrations of
ampicillin and ciprofloxacin were the same for both wild type
CFT073 and the DpasTI mutant (data not shown). MG1655,
which has a larger pool of TA systems, was much more adept at
forming persisters than CFT073, and the deletion of pasTI did not
affect the ability of MG1655 to form persisters in our assays
(Figure 4B). These data reveal that pasTI is dispensable for the
development of persister cells by the K-12 strain, while in CFT073
the PasTI TA system acts in a more non-redundant fashion to
promote persister cell formation. These results do not rule out the
possibility that other gene products, including additional as-yet
defined TA systems, may also contribute to the formation of
persister cells by CFT073 and other UPEC isolates.
PasT Enhances the Stress Resistance of UPEC
During the course of a UTI, UPEC encounter multiple stresses,
including nutrient deprivation and reactive nitrogen and oxygen
species [30,33,34]. In standard LB broth and in M9 minimal
medium supplemented with 0.2% casein amino acids,
CFT073DpasTI grew like the wild type strain, but in M9 medium
supplemented with only a single amino acid (40 mg/mL threo-
nine), growth of the DpasTI mutant was significantly delayed
(Figure 5A–C). CFT073DpasTI also displayed increased sensitivity
to both oxidative and nitrosative stresses generated in broth
cultures by addition of methyl viologen (MV) and acidified sodium
nitrite (ASN), respectively (Figure 5D, F). Use of ASN in these
assays involves the addition of sodium nitrite to MES-buffered LB
broth (MES-LB, pH 5.0), leading to the generation of nitrous acid,
NO, and other reactive nitrogen intermediates [35]. In control
experiments, CFT073DpasTI grew normally in MES-LB without
addition of ASN (Figure 5E). Corroborating these data, we
observed on LB agar plates—which E. coli sense as a certifiable
stress due in part to the presence of oxygen radicals [36]—that
growth of CFT073DpasTI lags behind the wild type strain,
resulting in a small colony phenotype (Figure 6A–B). Deletion of
pasTI in other ExPEC isolates (including the neonatal meningitis
isolate S88 and the UPEC strains F11 and UTI89) also resulted in
small colony phenotypes as well as increased sensitivity to ASN
(Figure 6E–G). None of the other type II TA system mutants in
CFT073 were defective in these growth assays (Figure 5 and data
not shown).
The growth defects observed with CFT073DpasTI were
attributable to loss of pasT, as low-level, leaky expression of PasT,
but not PasI, from an un-induced Ptac promoter complemented all
growth defects observed with the DpasTI mutant (Figure 7A,
Figure 6C–D, and data not shown). Leaky expression of PasT did
not alter bacterial growth in standard LB broth (Figure S3A).
Furthermore, expression of the entire pasTI operon under control
of its native promoter complements the DpasTI mutant similar to
expression of PasT alone, restoring wild type growth on LB agar
plates and providing wild type levels of ASN resistance (Figure S3B
Figure 1. ExPEC encode distinct subsets of type II TA systems. (A) Based on similarities among 21 type II TA alleles, the eBURST algorithm
clusters members of phylotype B2 (yellow) together, separate from other sequenced E. coli strains (blue). Strains connected by a line differ by a single
TA allele. (B) Genomic maps denoting the relative locations of the type II TA systems encoded by MG1655 and CFT073. Red denotes TA systems that
are present in both genomes; yeeUV and its allelic variants are shown in blue.
doi:10.1371/journal.ppat.1002954.g001
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and data not shown). PasT thus appears to enhance UPEC growth
in the presence of diverse stresses, a phenomenon that is seemingly
at odds with recent work showing that PasT (a.k.a. RatA) in K-12
E. coli acts as a toxin capable of binding 50S ribosomal subunits
and thereby inhibiting translation and bacterial growth [7]. This
discrepancy is partially reconciled by observations that high-level
expression of PasT in CFT073 is toxic, resulting in growth arrest
(Figure 7B). The induced expression of PasI counters the toxic
effects of PasT, demonstrating that PasI can function as a bona fide
antitoxin to PasT (Figure 7C). PasT is, therefore, conditionally
toxic, depending in part on its expression levels and regulatory
input from PasI.
The Toxic and Stress Resistance Effects of PasT Are
Separable
The pasTI locus is well conserved in all sequenced E. coli strains,
with the exception of 23 nucleotide changes within the pasT gene
that are found primarily in ExPEC isolates (Figure 7E). These
ExPEC-associated alterations are silent, except for two that result
in amino acid changes (S90N and D111E) relative to the K-12
sequence. Despite these differences, both K-12 and ExPEC
versions of pasT enhanced the resistance of CFT073DpasTI to
stresses like ASN, and both were similarly toxic when expressed at
high levels (Figure 7A–B). Deletion of pasTI did not increase the
sensitivity of MG1655 to ASN (Figure 7D), possibly due to input
from other TA systems acting redundantly in this K-12 strain.
However, low-level expression of pasT alleles did increase the
resistance of MG1655 to ASN, indicating that the salubrious, non-
toxic effects of PasT can be discerned in K-12 strains as well as
pathogens under appropriate conditions.
Using a series of genetic truncations and fusions, we next asked
if the stress resistance and toxic, growth-inhibiting effects of PasT
could be mapped to separable regions (Figure 8A). Removal of the
N-terminal 9 to 13 amino acids of PasT completely abrogated its
toxicity when overexpressed in CFT073DpasTI, as did fusion with
N-terminal FLAG or His6 epitope tags or an even smaller two-
Figure 2. Distinct TA systems enhance UPEC fitness within the urinary tract. (A–H) Adult female CBA/J mice were infected via
catheterization with equal numbers of wild type CFT073 and isogenic mutants lacking the indicated type II TA systems as part of either (A–F)
competitive or (G and H) non-competitive assays. (A–H) Graphs show bacterial titers present in the bladder or kidneys, as indicated, at 3 d post-
inoculation. (E and F) For competitive assays involving wild type CFT073 and CFT073DpasTI, bacterial titers recovered from mice at 1 d post-
inoculation are also indicated. Bars denote median values for each group; n$10 mice. P values determined using (A–F) Wilcoxon-matched paired
signed rank and (G–H) Mann-Whitney U tests.
doi:10.1371/journal.ppat.1002954.g002
Figure 3. Defective colonization of the kidneys by CFT073DpasTI in C3H/HeN and C3H/HeJ mice. Adult female (A–B) C3H/HeN and (C–D)
C3H/HeJ mice were infected via catheterization with equal numbers of wild type CFT073 and CFT073DpasTI. Graphs show bacterial titers present in
the (A, C) bladders and (B, D) kidneys at 3 d post-inoculation. Bars indicate median values for each group; n$10 mice per competitive assay. P values
were determined using the Wilcoxon-matched paired signed rank test.
doi:10.1371/journal.ppat.1002954.g003
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PLOS Pathogens | www.plospathogens.org 5 October 2012 | Volume 8 | Issue 10 | e1002954
45 
 
 
amino acid (DP) addition. Although no longer toxic, these PasT
variants were still able to restore wild type growth of
CFT073DpasTI on agar plates and in the presence of ASN
(Figure 8A). Overexpression of a non-toxic version of PasT (DP-
PasT) also enhanced the resistance of MG1655 to nitrosative stress
(Figure 7D). The addition of C-terminal epitope tags had no effect
on PasT functionality (Figure 8A). Overexpression of just the N-
terminal 69 residues of PasT was sufficient to induce growth arrest,
but low-level expression of this PasT fragment provided no
benefits on agar plates or upon exposure to ASN. As assessed by
Western blot analysis, loss of PasT toxicity by modification of its
N-terminus was not due to reduced expression of the non-toxic
PasT variants relative to the full-length protein (Figure 8B).
However, removal of the N-terminal 29 residues of PasT did
render it barely detectable by western blot (Figure 8B), coordinate
with loss of both the toxic and stress-resistance activities of this
PasT mutant (Figure 8A). In total, these results demonstrate that
the toxic and stress resistance effects of PasT can be uncoupled.
In light of these results, we next assessed the role of PasT in the
development of persister cells by CFT073. The attenuated ability
of CFT073DpasTI to form persisters in the presence of ciproflox-
acin (Figure 4A), was rescued by low-level expression of either full-
length PasT or the N-terminal 69 amino acid toxic domain
(Figure 8A and Figure S4). In contrast, expression of non-toxic
variants of PasT did not complement the DpasTI mutant in
persister assays. We conclude that the same N-terminal toxic
domain of PasT that halts bacterial growth when overexpressed
also promotes the development of persister cells in the presence of
antibiotic stress.
Discussion
Chromosomal TA systems are widespread and functionally
diverse, having the capacity to modulate an array of bacterial
activities including phage resistance, biofilm formation, and
persister cell development [17,23,37]. Results presented here
extend these findings, demonstrating that type II TA systems can
act independently within ExPEC to increase stress and antibiotic
resistance as well as pathogen colonization and persistence within
host tissues. Using a mouse UTI model we found that the YefM-
YoeB and YbaJ-Hha TA systems each enhanced bladder
colonization by the ExPEC isolate CFT073, but had no significant
effect on bacterial colonization of the kidneys in competitive assays
(Figure 2C–D). On the other hand, the PasTI TA system was not
required for CFT073 survival within the bladder or intestinal tract
but did promote pathogen colonization and persistence within the
kidneys in both competitive and non-competitive assays (Figs. 2E–
H, 3, and S2). These results indicate that individual TA systems
can have profound effects on bacterial fitness within distinct host
environments. It is feasible that phenotypes associated with some
of the TA system mutants, but not discernable in the assays used in
this study, may become evident by analysis of additional time
points and possibly other hosts and environmental challenges.
The specific mechanisms by which these TA systems stimulate
UPEC colonization of the host are likely complex. YoeB is an
endoribonuclease that cleaves mRNA situated within the ribo-
somal A site [38], and the yefM-yoeB locus is one of 10 type II TA
loci that can work cooperatively to facilitate persister cell
formation by the K-12 E. coli strain MG1655 [9]. The toxin
Hha acts differently, repressing the transcription of rare codon
tRNAs and consequently inhibiting the expression of type 1 pili
and the pore-forming toxin HlyA, among other genes [8,39]. In
K-12 E. coli, Hha activity can also stimulate bacterial cell lysis and
biofilm dispersal [8]. In our assays, none of the type II TA system
mutants, including DyefM-yoeB and DybaJ-hha, were negatively
affected in their ability to express type 1 pili or HlyA, and none
were impaired in biofilm production in microtiter plate assays
(data not shown). Furthermore, deletion of either yefM-yoeB or
ybaJ-hha individually did not affect the development of persister
cells in the face of ciprofloxacin or ampicillin (Figure 4A), leaving
open the question of how these two TA systems contribute to
UPEC survival within the bladder.
In contrast to the DyefM-yoeB and DybaJ-hha strains, CFT073
lacking pasTI was significantly compromised in its capacity to form
persister cells (Figure 4A). Our ability to detect clear phenotypic
defects in these assays with CFT073DpasTI, but not with
MG1655DpasTI, is likely attributable to decreased functional
redundancy among the fewer TA systems carried by CFT073
relative to the K-12 strain [9]. The generation of persisters
mediated by TA systems like PasTI may enhance the long-term
survival of UPEC under hostile conditions within the host,
including the administration of antibiotics used to treat UTIs
[29]. However, persister cell formation does not appear to be the
only way by which PasTI may promote UPEC survival in vivo.
Specifically, low-level expression of PasT substantially increased
the resistance of CFT073 to nitrosative and oxidative stresses, and
enhanced growth of the pathogen under nutrient-limiting condi-
tions. These environmental stresses are commonly encountered by
UPEC during the course of a UTI [30,40,41,42,43]. Inherent
differences between the bladder and kidney environments, such as
the distribution of pathogen recognition receptors and dissimilar
concentrations of various antimicrobial factors [44,45], may
account for the differential effects of pasTI deletion on bacterial
fitness in the bladder versus the kidneys.
In this study, host defenses that may limit colonization of the
kidneys by the DpasTI mutant were further assessed using C3H/
HeJ mice (Figure 3). These animals have an impaired ability to
respond to lipopolysaccharide (LPS) and increased susceptibility to
both bladder and kidney infections [46,47]. The increased
sensitivity of C3H/HeJ mice to kidney infections has been linked
by quantitative trait loci analysis to a site on chromosome 6, with
possible input from loci on chromosomes 1, 4, and 9 [46]. Specific
genes suggested to mediate host resistance to kidney infections
include those encoding Toll-like receptor 5 (Tlr5) and the
antimicrobial peptide cathelicidin. In our assays, we observed
elevated levels of both wild type CFT073 and the DpasTI mutant
Figure 4. Persister cell formation by CFT073, but not MG1655,
requires PasTI. Development of persister cells by (A) wild type CFT073
and associated type II TA system knockout mutants or (B) MG1655 and
associated DpasTI mutant 5 h after the addition of 100 mg/mL ampicillin
or 10 mg/mL ciprofloxacin to cultures in exponential growth phase.
Data represent mean results 6 SD from three independent exper-
iments. P values were determined by Student’s t test.
doi:10.1371/journal.ppat.1002954.g004
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in the bladders and kidneys of infected C3H/HeJ mice, relative to
control immunocompetent C3H/HeN animals. However, kidney
colonization by CFT073DpasTI was significantly attenuated in
both types of mice, despite the overall increased sensitivity of the
C3H/HeJ animals to UTI. These results indicate that the PasTI
system promotes UPEC resistance to factors present in the kidneys
of both the C3H/HeJ and C3H/HeN strains. Our in vitro assays
(Figure 5) suggest that these defensive host factors may include
amino acid limitation, superoxide radicals, and reactive nitrogen
species.
The pasT locus is predicted to encode an oligoketide cyclase,
while the pasI gene product is predicted to assume a ubiquitin-like
b-grasp fold, a structural motif that is present in a wide variety of
functionally distinct proteins [48,49]. Previous work demonstrated
that PasT could bind 50S ribosomal subunits and thereby inhibit
protein translation [7]. In that study, PasT was referred to as
RatA, for Ribosomal associated toxin A. We opted to avoid use of
this name in the current study to reduce confusion with i) the ratA
antitoxin encoded by Bacillus subtilis [50] and ii) the unrelated
RatA and RatA-like proteins that are expressed by Salmonella
species as well as many ExPEC isolates (e.g. NP_754911).
Consequently, we refer to RatAB here as PasTI, for Persistence
and stress-resistance Toxin and Immunity proteins.
PasT functioned like a toxin and inhibited bacterial growth in
our assays only when expressed at high levels, similar to toxins
within other TA systems. The toxic effects of PasT were
completely reversible by induced expression of PasI, confirming
that these two proteins can function as a TA pair (Figure 7). The
Figure 5. PasTI promotes the stress resistance of CFT073. Growth of wild type CFT073 and type II TA system knockouts in (A) M9
medium+0.2% casein amino acids, (B) a modified, lower-nutrient M9 medium+Thr, (C) LB broth, (D) LB broth containing 0.5 mM MV, (E) LB buffered to
pH 5.0 with MES (MES-LB), and (F) MES-LB with 1 mM ASN. Graphs are representative of at least three independent experiments performed in
quadruplicate.
doi:10.1371/journal.ppat.1002954.g005
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toxic effects of PasT were also ameliorated by modification of its
N-terminus, either by the removal or addition of amino acids.
Although no longer toxic when overexpressed, many of these PasT
variants still maintained their salubrious functions, enhancing
bacterial resistance to oxidative and nitrosative stresses. Loss of
toxicity associated with these mutant proteins was not due to
diminished PasT levels within the bacteria, but instead likely
results from altered substrate recognition and/or activity.
Regardless of the mode of action, these data show that the toxic
and salubrious effects of PasT are separable. Consequently, it is
feasible that the disparate functions of PasT may be differentially
regulated in order to optimize bacterial stress resistance and
persister cell phenotypes in response to changing environmental
pressures. This may be especially important to the PasTI-
dependent development of persister cells in the presence of
antibiotics, a process that requires the N-terminal toxic domain of
PasT.
Relative to other E. coli isolates, ExPEC and other members of
the B2 phylotype encode a condensed set of the known type II TA
systems. E. coli strains are traditionally grouped within the B2
phylotype based in part on the presence of distinct virulence
factors, such as fimbrial and toxin genes like papA, sfa/foc, hly, and
cnf1 [51,52]. It is remarkable that members of the B2 phylotype
can also be distinguished from other E. coli isolates based solely on
the makeup of their type II TA systems (see Figure 1A and Dataset
S1). This suggests a common lineage among B2 strains in which a
core set of TA systems has been selected. The ability to discern
clear-cut phenotypes associated with the deletion of individual TA
Figure 6. Deletion of pasTI reduces the stress resistance of multiple ExPEC isolates. (A–B) Images show wild type and CFT073DpasTI
colonies on LB agar after overnight growth at 37uC; inset images show images of individual wild type and CFT073DpasTI colonies at identical
magnification. (C–D) Colony sizes of CFT073DpasTI complemented with empty vector (pRR48) or pPN007, which allows for leaky expression of PasT
from a Ptac promoter. (E–G, left) Images show colonies of ExPEC strains and associated DpasTI mutants on LB agar after overnight growth at 37uC. (E–
G, right) Growth of the ExPEC DpasTI mutants in 1 mM ASN is delayed compared to wild type. In each graph, solid lines represent the wild type
strains and dashed lines indicate the DpasTI mutants. Images in A–G were taken at the same magnification (scale bar, 1 cm). All DpasTI colonies
eventually reach wild type size.
doi:10.1371/journal.ppat.1002954.g006
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loci in ExPEC indicates that the fitness of these pathogens is likely
more dependent on specific TA systems than K-12 strains like
MG1655. These findings reveal the potential utility of ExPEC for
defining the functional relevance of discrete TA systems, while also
highlighting TA systems as compelling targets for therapeutic
intervention. For example, compounds that selectively disrupt TA
systems like PasTI may effectively attenuate the survival and
growth of ExPEC within the host while having nominal effects on
commensal E. coli strains that encode a larger, seemingly more
redundant repertoire of TA systems.
Materials and Methods
Ethics Statement
Mice used in this study were handled in accordance with
protocols approved by the Institutional Animal Care and Use
Committee at the University of Utah (Protocol number 10-02014),
following US federal guidelines indicated by the Office of
Laboratory Animal Welfare (OLAW) and described in the Guide
for the Care and Use of Laboratory Animals, 8th Edition.
Cluster Analysis of Type II TA Loci in Sequenced E. coli
Strains
Specific allelic values were assigned to indicate the presence,
absence, or truncation of the known type II TA loci encoded by E.
coli strains. These values were used to create an allelic profile for
each fully sequenced E. coli isolate. The compiled allelic profiles
were analyzed using the eBURST algorithm (http://eburst.mlst.
net/) with 1,000 bootstrap iterations to organize strains into
clusters within groups that share 17 out of 21 alleles [25]. See
Dataset S1 (Excel) for further details on the assembly, grouping,
and analysis of type II TA alleles by the eBURST algorithm.
Genomic Localization of Type II TA Systems
Genomic locations of known type II TA systems encoded by
MG1655 and CFT073 were obtained from NCBI and mapped
onto circles that are proportional to the genome size of each strain.
Origins of replication (OriC) were determined based on homology
to ‘‘oriC’’ sequence: ATCTATTTATTTAGAGATCTGTTC-
TATTGTGATCTCTTATTAGGATCGCACTGCCCTGTGG
ATAACAAGGATCCGGCTTTTAAGATCAACAACCTGGA
AAGGATCATTAACTGTGAATGATCGGTGATCCTGGAC
CGTATAAGCTGGGATCAGAATGAGGGGTTATACACAA
CTCAAAAACTGAACAACAGTTGTTCTTTGGATAACTA
CCGGTTGATCCAAGCTTCCTGA.
Bacterial Strains and Plasmids
All bacterial strains and plasmids used in this study are listed in
Tables S1 and S2. E. coli strains MG1655, CFT073, UTI89, F11,
and S88 have been described previously [28,53,54,55]. PasT and
PasI expression constructs were made using standard molecular
biology techniques employing the plasmids pRR48 and pBAD33
[56,57]. Gene expression from the Ptac promoter in the pRR48
backbone was induced by addition of 500 mM isopropyl-b-D-
thiogalactopyranoside (IPTG), while gene expression from the
pBAD33 promoter was induced using 0.2% L-arabinose. Primers
Figure 7. PasT has stress resistance and toxic effects, the latter of which can be countered by PasI. (A–C) Graphs show growth of
recombinant CFT073 strains in (A) 1 mM ASN or (B, C) standard LB broth. (D) Curves show growth of recombinant MG1655 strains in 1 mM ASN. In B
and C, IPTG and arabinose were added as indicated to induce high-level expression of PasT and PasI, respectively. (A, D) Alternatively, recombinant
PasT and PasI were expressed at lower levels from a leaky Ptac promoter. The pasT gene cloned from MG1655 was used as indicated. Otherwise,
recombinant genes were derived from CFT073. Graphs are representative of at least 3 independent experiments performed in quadruplicate. (E)
Bottom, the pasT gene carried by CFT073 and other ExPEC has a conserved set of synonymous (purple hashes) and two non-synonymous (red
hashes) base pair changes relative to pasT encoded by MG1655 and many other E. coli strains. Top, the predicted secondary structure of PasT, with
two conserved amino acid differences between the MG1655 and ExPEC-associated protein sequences highlighted.
doi:10.1371/journal.ppat.1002954.g007
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and restriction sites used to construct all plasmids are indicated in
Table S3, along with primers used to verify each clone by
sequencing. Antibiotics (50 mg/mL kanamycin, 20 mg/mL chlor-
amphenicol, or 100 g/mL ampicillin) were added to plates and
growth medium to select for and maintain plasmids when
necessary.
Targeted gene knockouts were generated in CFT073, MG1655,
UTI89, F11, and S88 using the lambda Red-mediated linear
transformation system [58,59]. Briefly, a kanamycin resistance
cassette was amplified from pKD4 with 40-base pair overhangs
specific to the 59 and 39 ends of each target TA system locus (higBA,
hipBA, sohA-yhaV, ybaJ-hha, yefM-yoeB, or pasTI). PCR products were
introduced via electroporation into the strains carrying pKM208,
which encodes for an IPTG-inducible lambda red recombinase.
Knockouts were confirmed by PCR using the primers listed in
Table S3. The chloramphenicol resistant cassette amplified from
pKD3 was similarly added to the chromosome of CFT073, inserted
within the intergenic region between genes c3028 and c3029 to
create CFT073-ClmR. This strain serves as a tagged wild type
control in the gastrointestinal tract colonization assays.
Mouse UTI Model
Seven- to nine-week old female CBA/J mice (Jackson Labs),
C3H/HeN mice (Harlan Laboratories), or C3H/HeJ mice
(Jackson Labs) were used in accordance with IACUC-approved
protocols as previously described [29,60,61]. Mice were anesthe-
tized using isoflurane inhalation and inoculated via transurethral
catheterization with 50 mL of a bacterial suspension containing
approximately 16107 bacteria. CFT073 and isogenic knockout
mutants were grown statically for 24 h in M9 medium, pelleted by
spinning at 10,000 r.c.f. for 8 min, and resuspended in phosphate
buffered saline (PBS) prior to inoculation. For competition assays,
wild type and mutant strains were mixed 1:1 prior to inoculation.
The 1:1 inoculation dosage was confirmed by plating serial
dilutions on LB plates and LB plates containing 50 mg/mL
kanamycin. Bladders and kidneys were recovered 1 or 3 d later, as
indicated, and each was weighed and homogenized in 1 mL
containing 0.025% Triton X-100. Homogenates were serially
diluted and plated on LB agar plates to determine the number of
bacteria per gram of tissue. For competition assays, plates
containing kanamycin (50 mg/mL) were used to identify and
enumerate the TA system knockout mutants, which carried KanR
cassettes. Mouse experiments were repeated at least twice, and the
total combined data from 10 or more animals is presented.
UPEC Colonization of the Murine Gastrointestinal Tract
Cultures of CFT073-ClmR (containing a chromosomal chlor-
amphenicol-resistance cassette, clmR) and CFT073DpasTI (kanR)
grown 20 mL static in M9 broth were pelleted and resuspended in
PBS. Adult female CBA/J mice were each gavaged with 50 mL of
the bacterial suspension containing 16109 CFU. Feces (,100 mg)
were collected at the indicated time points, weighed, and
resuspended in 1 mL 0.7% NaCl. Serial dilutions were plated
on LB agar containing either chloramphenicol (10 mg/mL) or
kanamycin (50 mg/mL) in order to distinguish the DpasTI mutant
and the ClmR-tagged strains. Mice receiving the CFT073 strains
showed no overt signs of sickness. No chloramphenicol- or
kanamycin-resistant bacteria were recovered in the feces of
untreated mice.
Statistics
Results from in vivo competition assays were analyzed by
Wilcoxon matched-pairs signed rank test. Results from non-
competitive assays in mice, including comparisons between 1- and
3-day titers of wild type CFT073 and CFT073DpasTI in the
kidneys, were analyzed by Mann-Whitney two-tailed t tests. All
statistical tests were performed using Prism 5.0c (GraphPad
Software, Inc.). P values less than 0.05 are considered significant.
Persister Assays
Persister assays were carried out with CFT073, MG1655, and
their derivatives as previously described [9]. Briefly, 1 mg/mL
Figure 8. The toxic and salubrious effects of PasT can be genetically uncoupled. (A) Table indicates if the specified PasT truncation mutants
and fusions display toxic, growth inhibitory effects when overexpressed in CFT073DpasTI, if their leaky expression rescues wild type (WT) growth of
the DpasTI mutant in 1 mM ASN and on LB agar plates, and if their leaky expression rescues the ability of CFT073DpasTI to form persisters in the
presence of ciprofloxacin (10 mg/mL). ND, not determined. (B) Western blot shows expression levels of C-terminal FLAG-tagged PasT constructs—
denoted (ii)–(vi), as in (A)—following induction with IPTG. Lane (i) represents an empty vector control. A nonspecific band recognized by the anti-
FLAG antibody was used as loading control. Equal loading was also verified by Coomassie staining (data not shown).
doi:10.1371/journal.ppat.1002954.g008
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ciprofloxacin or 100 mg/mL ampicillin was added to logarithmi-
cally growing bacterial cultures in LB broth and 5 h later the
cultures were pelleted, washed once with PBS, and surviving
bacteria were serially diluted and plated on LB agar. Total
numbers of persister cells were calculated by dividing the number
of viable bacteria present after antibiotic treatment by the number
present prior to antibiotic addition.
Growth Assays
Cultures of CFT073, MG1655 and their derivatives were grown
shaking overnight at 37uC in 5 mL of LB broth, 100 mM
morpholineethanesulfonic acid (MES)-buffered LB (MES-LB;
pH 5.0), or modified M9 minimal medium+casein amino acids
(6 g/L Na2HPO4, 3 g/L KH2PO4, 1 g/L NH4Cl, 0.5 g/L NaCl,
1 mM MgSO4, 0.1 mM CaCl2, 0.1% glucose, 0.0025% nicotinic
acid, 16.5 mg/mL thiamine, and 0.2% casein amino acids).
Overnight cultures were diluted 1:100 and growth of quadrupli-
cate 200-ml samples in 100-well honeycomb plates was assessed at
37uC using a Bioscreen C instrument (Growth Curves USA).
Bacteria assayed for growth in 1 mM acidified sodium nitrite
(ASN) were first grown from frozen stocks overnight in MES-LB.
Strains assayed for growth in more nutrient-limited, M9 medium
supplemented with threonine (6 g/L Na2HPO4, 3 g/L KH2PO4,
1 g/L NH4Cl, 0.5 g/L NaCl, 1 mM MgSO4, 0.1 mM CaCl2,
0.2% glucose, 0.0025% nicotinic acid, 40 mg/mL threonine, and
16.5 mg/mL thiamine) were initiated from cultures grown
overnight in standard M9 medium. IPTG (500 mM) and 0.2%
L-arabinose were added to cultures to induce high-level expression
of PasT or PasI, as indicated. Methyl viologen (MV; a.k.a.
paraquat) and ASN were prepared fresh prior to addition to LB or
MES-LB broth cultures, respectively. All reagents were obtained
from Sigma-Aldrich.
Allelic Variants of pasT and Predicted Domain Structure
of the Protein
The pasT nucleotide sequences of from ExPEC and K-12 strains
were aligned and compared using ClustalX (downloaded at
http://www.clustal.org/clustal2/) [62]. The secondary structure
of PasT was predicted using Protein Homology/analogY Recog-
nition Engine V 2.0 (Phyre2; http://www.sbg.bio.ic.ac.uk/
phyre2/html/page.cgi?id = index) [49].
Protein Analysis
Cultures of each strain indicated were grown overnight shaking
in LB broth plus 100 mg/mL ampicillin (added for plasmid
retention). Cultures were diluted 1:50 into fresh LB broth and
grown shaking at 37uC for 5 h, at which point IPTG was added to
each culture to a final concentration of 500 mM. After an
additional 1 h incubation, 1 mL of each culture was pelleted
and resuspended in 200 mL SDS-TE (0.5% SDS in Tris-EDTA,
pH 8.0). Proteins were resolved by SDS-PAGE and transferred to
Immobilon PVDF-FL membrane (Millipore). Western blots were
probed using ANTI-FLAG M2 antibody (Sigma-Aldrich) and
visualized by enhanced chemiluminescence as previously de-
scribed [63].
Supporting Information
Dataset S1 Tables used to define the Type II TA system
allelic profiles of E. coli by eBURST analysis. (Tab 1)
Table showing TA system content among sequenced E. coli. (Tab
2) Table showing TA system content among phylotype B2
ExPEC strains. (Tab 3) Graph of the relative abundance of TA
systems among all sequenced E. coli strains versus phylotype B2
isoaltes. (Tab 4) Table shows the individual allelic profiles of type
II TA systems generated from Tab 1. (Tab 5) Table of allelic
profiles that were used for input into the eBURST algorithm.
(Tab 6) Separate tables with representative output from the
eBURST algorithm, showing how the strains that are clustered
together shift dependent upon based on the number of shared
type II TA alleles considered.
(XLS)
Figure S1 The CFT073DyefM-yoeB and CFT073DybaJ-
hhamutants colonize the murine urinary tract at similar
levels to wild type CFT073 in noncompetitive assays. (A–
D) Adult female C3H/HeN and C3H/HeJ mice were infected via
catheterization with 107 CFU of wild type CFT073,
CFT073DyefM-yoeB or CFT073DybaJ-hha. Graphs show bacterial
titers present in the (A) bladders and (B) kidneys at 3 d post-
inoculation. Bars indicate median values for each group; n$10
mice. P values were determined using Mann-Whitney U tests.
(TIF)
Figure S2 CFT073 does not require pasTI for coloniza-
tion of the murine gastrointestinal tract. Adult female
CBA/J mice were each gavaged with 50 mL of a bacterial
suspension containing 16109 CFU CFT073-ClmR or
CFT073DpasTI (kanR). CFT073-ClmR served as the wild type
control in these assays. Gastrointestinal tract colonization was
assessed by enumerating total CFU of the mutant and wild type
strains per gram of feces collected at the indicated time points.
Data represent mean CFU/g feces 6 SEM. n= 3 to 5 mice.
(TIF)
Figure S3 Low-level expression of PasT does not alter
growth of the DpasTI mutant, while transcription of
PasTI from its native promoter provides resistance to
ASN. Curves show growth of CFT073 and its derivatives in (A) LB
broth and (B) MES-LB broth+1 mM ASN. (A) Leaky expression of
pasT from a Ptac promoter or expression of pasTI from its native
promoter does not affect the growth of CFT073DpasTI in standard
LB broth. In these assays, pRR48 served as an empty vector
control. (B) Complementation of the DpasTI mutant growth defect
in 1 mM ASN by the pasTI operon from its native promoter.
Graphs are representative of at least two independent experiments
performed in quadruplicate.
(TIF)
Figure S4 Persister cell formation by CFT073 requires
the toxic domain of PasT. Graph shows numbers of viable
bacteria (persisters) recovered 5 h after the addition of ciproflox-
acin (10 mg/L) to broth cultures in exponential growth phase. The
plasmid pRR48 serves as an empty vector control. Plasmid
pPN007 encodes full-length PasT, pPN055 encodes the N-
terminal 69 amino acids of PasT, and pPN068–069 encode non-
toxic PasT variants lacking portions of the PasT N-terminus (see
Figure 8). Data represent mean results 6 SD from three
independent experiments. P values were determined by Student’s
t test; ns indicates non-significant differences between the
complemented strain and CFT073DpasTI/pRR48.
(TIF)
Table S1 Strains used in this study.
(PDF)
Table S2 Plasmids used in this study.
(PDF)
Table S3 Primers used in this study.
(PDF)
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Figure 3.S1. The CFT073ΔyefM-yoeB and CFT073ΔybaJ-hha mutants colonize 
the murine urinary tract at similar levels to wild type CFT073 in noncompetitive 
assays. (A–D) Adult female C3H/HeN and C3H/HeJ mice were infected via 
catheterization with 107 CFU of wild type CFT073, CFT073ΔyefM-yoeB or 
CFT073ΔybaJ-hha. Graphs show bacterial titers present in the (A) bladders and 
(B) kidneys at 3 days postinoculation. Bars indicate median values for each 
group; n≥10 mice. P values were determined using Mann-Whitney U tests. 
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Figure 3.S2. CFT073 does not require pasTI for colonization of the murine 
gastrointestinal tract. Adult female CBA/J mice were each gavaged with 50 µL of 
a bacterial suspension containing 1×109CFU CFT073-ClmR or 
CFT073ΔpasTI (kanR). CFT073-ClmR served as the wild type control in these 
assays. Gastrointestinal tract colonization was assessed by enumerating total 
CFU of the mutant and wild type strains per gram of feces collected at the 
indicated time points. Data represent mean CFU/g feces ± SEM. N = 3 to 5 mice. 
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Figure 3.S3. Low-level expression of PasT does not alter growth of the 
ΔpasTI mutant, while transcription of PasTI from its native promoter provides 
resistance to ASN. Curves show growth of CFT073 and its derivatives in (A) LB 
broth and (B) MES-LB broth+1 mM ASN. (A) Leaky expression of 55ast from a 
Ptac promoter or expression of pasTI from its native promoter does not affect the 
growth of CFT073ΔpasTI in standard LB broth. In these assays, pRR48 served 
as an empty vector control. (B) Complementation of the ΔpasTI mutant growth 
defect in 1 mM ASN by the pasTI operon from its native promoter. Graphs are 
representative of at least two independent experiments performed in 
quadruplicate. 
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Figure 3.S4. Persister cell formation by CFT073 requires the toxic domain of 
PasT. Graph shows numbers of viable bacteria (persisters) recovered 5 h after 
the addition of ciprofloxacin (10 µg/L) to broth cultures in exponential growth 
phase. The plasmid pRR48 serves as an empty vector control. Plasmid pPN007 
encodes full-length PasT, pPN055 encodes the N-terminal 69 amino acids of 
PasT, and pPN068–069 encode nontoxic PasT variants lacking portions of the 
PasT N-terminus (see Figure 3.8). Data represent mean results ± SD from three 
independent experiments. P values were determined by Student’s t test; ns 
indicates nonsignificant differences between the complemented strain and 
CFT073ΔpasTI/pRR48. 
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Introduction 
 Escherichia coli represent a diverse group of Gram-negative bacteria that 
are typically associated with the intestinal tract of warm-blooded vertebrates. 
Most strains of E. coli are nonpathogenic in nature and exist with their host in a 
commensal relationship. However, pathogenic subsets of E. coli can cause 
infections both within and outside the gastrointestinal tract. The number of 
experimentally characterized phenotypic differences (i.e., nonpathogenic versus 
pathogenic) that distinguish E. coli strains is somewhat limiting compared to the 
genetic diversity of this species. Isolates of E. coli can differ from one another by 
up to 30% in their coding sequence 1. Despite this extensive variation, 
comparative genetic analysis (e.g., MLST) of this species resolves at least four 
distinct phylogroups (i.e., A, B1, B2, and D). Members of the B2 phylogroup—
and to a lesser extent the D phylogroup—are associated with extraintestinal 
disease 2-4. This is mostly attributed to the prevalence of extraintestinal 
pathogenic E. coli (ExPEC) strains. ExPEC cause diseases such as neonatal 
meningitis and sepsis and are the most common etiologic agent of community-
acquired urinary tract infections. These strains are of increasing importance to 
the global health community due to recent increases in the worldwide incidence 
of antibiotic resistant ExPEC isolates 5,6. 
A significant amount of work has been done characterizing ExPEC 
virulence. It is now appreciated that members of this lineage are capable of 
colonizing and infecting an overlapping set of host-associated extraintestinal 
niches but do so through different genetically encoded mechanisms 7. This 
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complicates the diagnostic identification and categorization of ExPEC strains. 
The increasing incidence of antibiotic resistant ExPEC strains will likely change 
treatment procedures for ExPEC associated infections, and having the capacity 
to reliably differentiate ExPEC from other lineages in a rapid, high-throughput 
fashion would allow physicians to make better informed treatment decisions. A 
singular genetic marker to identify ExPEC would, therefore, be of great use, but 
to the author’s knowledge, such a marker has not been described. 
 In previous work, we determined that the B2 phylogroup—and by 
extension, most ExPEC strains—could be differentiated from all other E. coli 
based solely on the composition of chromosomally encoded type-II toxin-antitoxin 
(TA) systems 8. In this way, the composition of an isolate’s TA systems could 
potentially be leveraged for identification much like a fingerprint. Here, we report 
the discovery of a phylogroup B2-specific truncation of the toxin-antitoxin system 
hicAB and term it hicE. We verified the conservation of the hicE truncation within 
phylogroup B2 E. coli using a combination of publically available sequenced E. 
coli strains and an array of clinical E. coli isolates. In all cases, we found hicE is 
100% indicative of phylogroup B2 E. coli. Furthermore, a different, distinct 
truncation of the hicAB locus—hicE.2—was observed in a subset of phylogroup 
D E. coli, suggesting an evolutionarily redundant truncation of this TA system in 
ExPEC lineages. 
 The conservation of hicE within phylogroup B2 E. coli—but not other 
lineages—led us to hypothesize that hicE may represent an evolutionary vestige 
that tracked with the emergence of ExPEC, possibly providing an immediate 
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benefit that relieved certain evolutionary constraints. We tested this by 
engineering the phylogroup B2-specific hicE truncation on the chromosome of 
the inferred ancestral strain MG1655 and monitoring the capacity of this strain to 
resist stresses and survive in ExPEC-associated environments. We found that 
MG1655 containing the hicE truncation showed a modest increase in resistance 
to various envelope stresses, including an increased resistance to ampicillin and 
polymyxin B exposure, and increased resistance to these stresses in is 
concomitant with heightened expression of the Cpx pathway. Forced expression 
of hicE in MG1655 allowed resistance to human serum similar to that observed in 
the serum resistant ExPEC strains CFT073 and UTI89. However, we find ExPEC 
strains are differentially reliant upon the hicE locus for resistance to similar 
envelope stresses. Most importantly, our data indicate the hicE truncation is 
specific to phylogroup B2 and can, therefore, be used as a singular genetic 
marker for identifying this subgroup of E. coli.  
 
Materials and methods 
Bacterial strains and plasmids 
All bacterial strains, plasmids, and primers used in this study are listed in 
Tables 4.1-4.4. Expression constructs were made using standard molecular 
biology techniques employing the plasmid pRR48 or pGEN-MCS. Expression of 
genes cloned into pRR48 is driven by the Ptac promoter which was induced by 
addition of 500 µM isopropyl-β-D-thiogalactopyranoside (IPTG) where indicated. 
Primers used to construct plasmids used in this study are indicated in Table 4.2  
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Table 4.1. Bacterial strains and plasmids 
Strain Description Source 
MG1655 K-12 lab strain 18 
MG1655∆hicAB::clmR 
MG1655 containing a chromosomal replacement of the 
hicAB locus with the chloramphenicol resistance cassette 
from pKD3 
This 
study 
MG1655
hicE
 
MG1655 with the B2 specific hicE truncation generated on 
the chromosome by replacing nucleotides  with a 
chloramphenicol resistance cassette from pKD3  
This 
study 
CFT073 UPEC strain (urosepsis isolate, O6:K2:H1) 19 
CFT073∆hicE::clmR 
CFT073 containing a chromosomal replacement of the hicE 
locus with the chloramphenicol resistance cassette from 
pKD3 
This 
study 
UTI89 UPEC cystitis isolate (O18:K1:H7) 20 
UTI89∆hicE::clmR 
UTI89 containing a chromosomal replacement of the hicE 
locus with the chloramphenicol resistance cassette from 
pKD3 
This 
study 
   
Plasmid Description Source 
pGEN-MCS AmpR high retention cloning plasmid for native expression 21 
pRR48 AmpR; contains MCS under the control of tac promoter 22 
phicE
Pnative
 
AmpR; native expression of hicE; contains hicE locus and 
100bp upstream cloned from UTI89 sequence into EcoRI, 
BamHI sites of pGEN-MCS 
This 
study 
phicAB Amp
R; hicAB sequence from MG1655 cloned into PstI, 
HindIII sites of pRR48 
This 
study 
pNLP10 Kan
R; low-copy-number cloning vector with promoterless 
luxCDABE operon 
23 
pNLP19 Kan
R; pNLP10 with rpoErseABC promoter driving 
luxCDABE 
23 
pJW1 KanR; pNLP10 with cpxP promoter driving luxCDABE 23 
pKM208 AmpR; IPTG inducible Red recombinase expression plasmid 24 
pKD3 Amp
R/ClmR; template plasmid containing clmR cassette for 
use in generating knockout strains 
25 
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Table 4.2. Primer sequences 
Primer Sequence 
hicAB KO  
 Forward 
GTTTACTTTGTTGATATACTCAGCGGCAGGGAGGCGATTGTGTAGGCTGG
AGCTGCTTCG 
 Reverse 
ATATCAGTTGTTAAAAATGACAACTTTTCGTTAACTGTAACATATGAATATC
CTCCTTAG 
hicAB KO confirmation 
 Forward TGCCATGAGTTGTCCTG 
 Reverse TGTTCTGCAAGCTGCTG 
hicE truncation 
 Forward 
TAGTGCTATTTTCGAGCAAATTACACACGGAGGTAAACTGTGTAGGCTGGA
GCTGCTTCG 
 Reverse 
AGGTACTTCAATAAAGTGATCGTGACTATTTAATGGCGAACATATGAATATC
CTCCTTAG 
hicE KO  
 Forward 
GTGCCTTTGAGCGTCGCCTCTAAGGTATTGCTGTTAAATGTGTAGGCTGGA
GCTGCTTCG 
 Reverse 
TCAAACCATCACCAGCGATAACTCTTTGCCAAGCGCATTACATATGAATAT
CCTCCTTAG 
hicE truncation/KO confirmation 
 Forward TGCCATGAGTTGTCCTG 
 Reverse TGTTCTGCAAGCTGCTG 
  
phicE
Pnative
 (pPN001) 
 Forward TCCTC GAATTC TGCATTGCATTCTGCCGTTGCGGCGATTTAG 
 Reverse CACT GGATCC CTGTAATCAAACCATCACCAGCGATAACTC 
phicAB (pPN008) 
 Forward AATCG CTGCAG GTGAAACAAAGCGAGTTCAG 
 Reverse GGGCG AAGCTT TTAAACCATCACCAGCGATAAC 
 
hicE diagnostic 
 Forward TGCCATGAGTTGTCCTG 
 Reverse TGTTCTGCAAGCTGCTG 
chuA diagnostic 
 chuA.1 GACGAACCAACGGTCAGGAT 
 chuA.2 TGCCGCCAGTACCAAAGACA 
yjaA diagnostic 
 yjaA.1 TGAAGTGTCAGGAGACGCTG 
 yjaA.2 ATGGAGAATGCGTTCCTCAAC 
TspE4.C2 diagnostic 
 TspE4C2.1 GAGTAATGTCGGGGCATTCA 
 TspE4C2.2 CGCGCCAACAAAGTATTACG 
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Table 4.3. In silico phylotyping and hicE analysis of reference E. coli strains  
Strain Origin chuA yjaA TSPE4.C2 Phylogroup hicE 
P12b Commensal − − − A − 
MG1655 Commensal (K-12) − + − A − 
UMNK88 Porcine ETEC − − − A − 
ETEC H10407 ETEC − + − A − 
ATCC 8739 Commensal − − − A − 
W3110 Commensal (K-12) − + − A − 
BL21(DE3) Commensal (K-12) − − − A − 
BW2952 Commensal − + − A − 
B str. REL606 Commensal − − − A − 
HS Commensal − − − A − 
IAI1 Commensal − − + B1 − 
55989 Diarrhea (EAEC) − − + B1 − 
W Nonpathogenic − − + B1 − 
SE11 Commensal − − + B1 − 
E24377A Diarrhea (ETEC) − − + B1 − 
O103:H2 str. 12009 EHEC − − + B1 − 
O26:H11 str. 11368 EHEC − − + B1 − 
O111:H- str. 11128 EHEC − − + B1 − 
KO11FL Nonpathogenic − − + B1 − 
UTI89 Cystitis (ExPEC) + + + B2 + 
APEC O1 Septitcemia (ExPEC) + + + B2 + 
S88 NMEC (ExPEC) + + + B2 + 
CFT073 Pyelonephritis (ExPEC) + + + B2 + 
ED1a Commensal + + + B2 + 
536 Pyelonephritis (ExPEC) + + + B2 + 
ABU 83972 Commensal + + + B2 + 
O127:H6 str E2348/69 Diarrhea (EPEC) + + + B2 + 
IHE3034 NMEC (ExPEC) + + + B2 + 
UM146 Crohn's Disease (AIEC) + + + B2 + 
O83:H1 NRG 857C Crohn's Disease (AIEC) + + + B2 + 
LF82 Crohn's Disease (AIEC) + + + B2 + 
SE15 Commensal + + + B2 + 
NA114 UPEC (ST131) + + + B2 + 
SMS-3-5 Environmental (SESEC) + − − D − 
UMN026 Cystitis (ExPEC) + − − D − 
042 Diarrhea (EAEC) + − − D − 
IAI39 Pyelonephritis (ExPEC) + − − D N/A 
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Table 4.3. Continued  
Strain Origin chuA yjaA TSPE4.C2 Phylogroup hicE 
O7:K1 str. CE10 NMEC (ExPEC) + − − D −* 
O55:H7 str. RM12579 EPEC + − − D − 
O55:H7 str. CB9615 
Infantile diarrhea 
(EPEC) + − − D − 
O157:H7 str. EDL933 Diarrhea (EHEC) + − − D − 
O157:H7 str. Sakai Diarrhea (EHEC) + − − D − 
O157:H7 XuZhou21 EHEC + − − D − 
O157:H7 str. TW14359 EHEC + − − D − 
O157:H7 str. EC4115 EHEC + − − D − 
−* hicE.2 allele       
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Table 4.4. Phylotyping and hicE analysis of clinical E. coli isolates     
Strain Origin chuA yjaA TSPE4.C2 Phylogroup hicE 
AB1 Septicemia + + + B2 + 
AB2 Septicemia + + + B2 + 
AB3 Septicemia + + + B2 + 
AB4 Septicemia + + + B2 + 
AB5 Septicemia + + − B2 + 
WB1 Septicemia + − − D −* 
WB2 Septicemia + + + B2 + 
WB3 Septicemia + + + B2 + 
WB8 Septicemia + + + B2 + 
WB11 Septicemia + − − D − 
AU1 Cystitis + + + B2 + 
AU2 Cystitis + + − B2 + 
AU3 Cystitis + + + B2 + 
AU4 Cystitis + + + B2 + 
AU5 Cystitis + + + B2 + 
AU6 Cystitis + + + B2 + 
AU7 Cystitis + + + B2 + 
AU8 Cystitis − − + B1 − 
ABF Body Fluid + − + D − 
A70 Stool + − + D − 
A71 Stool − + − A − 
A81 Stool + − − D − 
A84 Stool − + − A − 
A15 Asymptomatic bacteriuria − + − A − 
A18 Asymptomatic bacteriuria − − + B1 − 
A34 Asymptomatic bacteriuria − − − A − 
A37 Asymptomatic bacteriuria − + − A − 
A58 Asymptomatic bacteriuria − + − A − 
AS1 Stool + + + B2 + 
AS2 Stool + − − D −* 
AS3 Stool − − + B1 − 
AS4 Stool − + − A − 
AS5 Stool − + − A − 
AS6 Stool + − − D −* 
AS7 Stool − + − A − 
AS8 Stool + + + B2 + 
 −* hicE.2 allele      
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along with primers used to verify each clone by sequencing. Antibiotics (50 µg/ml 
kanamycin or 100 µg/ml ampicillin) were added to plates and growth medium to 
select for and maintain strains and plasmids when necessary. 
 
Phylotyping PCR 
 Each PCR sample contained crude genomic DNA extracted from isolates 
by heat lysis, 200 µM dNTPs, 500 nM specfic primers (found in Table 4.2), 2% 
dimethyl sulfoxide, Roche PCR buffer containing MgCl2 (10X buffer composition: 
100 mM Tris-HCl, 15 mM MgCl2, 500 mM KCl, pH 8.3), and 2.5 U Taq DNA 
polymerase (Roche). The PCR was run with a 55ºC annealing temperature for 32 
cycles on a Veriti Thermal Cycler (Applied Biosciences). Equal amounts of each 
PCR sample were resolved on a 1% agarose gel. 
 
Growth assays 
Cultures of UTI89, CFT073, MG1655, and their derivatives were grown 
shaking overnight at 37ºC in 5 ml of LB broth or modified M9 minimal medium 
containing casein amino acids (6 g/L NA2HPO4, 3 g/L KH2PO4, 1 g/L NH4Cl, 0.5 
g/L NaCl, 1 mM MgSO4, 0.1 mM CaCl2, 0.1% glucose, 0.0025% nicotinic acid, 
16.5 µg/ml thiamine, and 0.2% casein amino acids). Bacteria assayed for growth 
in 100 mM morpholineethanesulfonic acid (MES)-buffered LB (MES-LB) or 
methyl viologen (MV; aka paraquat) were first grown from frozen stocks overnight 
in LB. For growth in human serum, frozen aliquots of pooled human sera—taken 
from 7 healthy volunteers using standard protocols approved by the University of 
67 
 
Utah Institutional Review Board and provided by Dr. Andrew Weyrich—were   
thawed and diluted to the appropriate concentration using modified M9 medium. 
Heat inactivated serum (treated at 55ºC for 30 minutes) was diluted to 10% final 
concentration in modified M9 and used as a control. Overnight cultures were OD 
matched to OD600 = 0.6 and diluted 1:100 into appropriate growth media where 
growth of quadruplicate 200 µl samples in 100-well honeycomb plates was 
assessed at 37ºC using a Bioscreen C instrument (Growth Curves USA). MV 
was prepared fresh prior to addition to LB cultures. All reagents were obtained 
from Sigma-Aldrich unless specified otherwise. 
  
Reporter assays 
Bacteria carrying plasmids pNLP19 (rpoErseABC-lux) or pJW1 (cpxP-lux) 
were grown from frozen stocks at 37ºC with shaking overnight in 5 ml LB medium 
containing 50 µg/ml kanamycin. Overnight cultures were diluted 1:100 into 5 ml 
LB medium containing 50 µg/ml kanamycin and incubated with shaking at 37ºC 
for 2.5 h to reach exponential phase. Triplicate 200-µl aliquots of each sample 
were then transferred into a 96-well white, opaque-walled polystyrene microplate 
(Dynex Technologies), and luminescence was measured immediately with a 
Synergy HT multidetection microplate reader (BioTek Instruments, Inc.).  
 
Polymyxin B survival assays 
Bacterial cultures were grown from frozen stocks in 5 ml LB broth 
overnight (18 h) with shaking at 37ºC. Cultures were back-diluted 1:100 into fresh 
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LB medium and incubated with shaking at 37ºC for 2.5 h to reach exponential 
phase. Polymyxin B was added to each culture to a final concentration of 1 µg/ml 
and the cultures were incubated with shaking at 37ºC for 90 minutes. One 
milliliter of each culture was pelleted by centrifugation and rinsed twice with 
sterile PBS followed by serial dilution and plating on LB agar medium. Surviving 
bacteria were enumerated after incubation at 37ºC for 20 h. Data represent three 
independent experiments, and graphed values were calculated using the 
following equation:  
log10(percent survival normalized to WT) = log10{[(CFU/ml output)/(CFU/ml 
input)]/(average survival WT)}. 
 
Ampicillin persistence assays 
Bacterial cultures were grown from frozen stocks in 5 ml LB broth 
overnight (18 h) with shaking at 37ºC. Cultures were then back-diluted 1:10 into 5 
ml fresh LB broth containing 100 µg/ml ampicillin and incubated shaking at 37ºC 
for 6 h. Surviving bacteria were determined by enumerating CFUs of serial 
dilutions plated on LB agar plates incubated overnight at 37ºC. Data represent 
three independent experiments, and graphed values were calculated using the 
following equation:  
log10(percent survival normalized to WT) = log10{[(CFU/ml output)/(CFU/ml 
input)]/(average survival WT)}. 
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Statistics 
Unless otherwise stated, P-values were determined using a two-tailed 
unpaired t-test, calculated using GraphPad Prism 5 software.  
 
Results 
Phylogrouping of reference strains and clinical  
isolates of E. coli using the Clermont method 
Our findings are predicated upon the differentiation of E. coli strains into 
distinct phylogenetic groups or phylogroups. One PCR-based method for 
separating E. coli into four distinct phylogroups (i.e., A, B1, B2, or D) is the 
Clermont method. This approach relies on distinguishing these four phylgroups 
based on the presence or absence of the three genetic markers chuA, yjaA, and 
TspE4.C2 (Fig. 4.1A). The accuracy of the Clermont method has been shown to 
be comparable to multilocus sequence typing, especially in identifying 
phylogroup B2 E. coli 9. In this study, we utilize the Clermont method to 
phylogroup strains. Each of 45 different reference E. coli strains available in 
NCBI was parsed into its corresponding phylogroup based on the Clermont loci 
using the basic local alignment search tool (BLAST), and our results corroborate 
previous phylogenetic characterization of these strains (Table 4.3). Similarly, 36 
clinical E. coli isolates were categorized and typed through a PCR approach 
(Table 4.4). 
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Figure 4.1. Phylogroup analysis of publically available sequenced E. coli strains 
and clinical E. coli isolates reveals a conserved truncation of hicAB within 
phylogroup B2 strains. (A) Flowchart depicting the Clermont method of 
organizing E. coli into four phylogroups (A, B1, B2, and D) determined by the 
presence or absence of three DNA markers—chuA, yjaA, and TspE4.C2. (B) 
Diagram representing the hicAB genomic region of MG1655, CFT073, and 
O7:K1 str. CE10. Urosepsis isolate CFT073 is representative of phylogroup B2 
E. coli harboring the hicE truncation, and O7:K1 str. CE10 represents a 
phylogroup D strain containing the hicE.2 allele. (C) Pie chart showing the 
relative abundance of strains represented in the phylogroup analysis of 
sequenced and clinical E. coli isolates. The inner fractions correlate with the total 
number of strains containing the hicE locus within each phylogroup. 
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Phylogroup B2 E. coli harbor a conserved 
truncation of toxin-antitoxin system hicAB 
In previous work, we determined that phylogroup B2 E. coli could be 
differentiated from other sequenced E. coli based solely on the chromosomal 
composition of type-II TA systems 8.  Upon further investigation into the 
qualitative characteristics of TA systems harbored by the B2 phylogroup, we 
observed a consistent 445bp truncation of the hicAB locus. This truncation event 
begins 44 base pairs upstream of the hicA translational start site and ends 200 
bp into the 5’ portion of hicB, leaving behind a 238 bp fragment of hicB (Fig. 
4.1B). The resulting truncated hicB allele was termed hicE (named so because 
after truncation of the letter “B”, the letter “E” remains). We developed a PCR-
typing method to differentiate strains carrying full-length hicAB the hicE locus; 
hicAB-positive strains yield a 1,033 bp product compared to a 588 bp product 
yielded by hicE-positive strains. Using this strategy, we determined the presence 
or absence of the hicE truncation within the 81 reference and clinical E. coli 
strains. In 100% (31/31) of instances, the hicE locus correlated with phylogroup 
B2 E. coli (Fig. 4.1C and Tables 4.3 and 4.4). While surveying isolates for the 
hicE locus, we observed a 416 bp product in 21% (4/19) of phylogroup D strains 
(Tables 4.3 and 4.4). Sequencing the genomic region where the ancestral hicAB 
locus is expected to be located revealed a truncation of the hicAB locus, distinct 
from hicE, but consistent between the four phylogroup D isolates. This 
truncation—deemed hicE.2—begins 45 bp upstream of the hicAB operon and 
continues through hicA and hicB coding sequences, leaving only 66 bp of the 3’   
72 
 
end of hicB intact. We did not observe any correlation between the hicE.2 
containing strains and other phylogroup D strains containing the full-length hicAB 
locus. 
 
Introduction of the phylogroup B2-specific hicE locus into an ancestral  
hicAB-positive E. coli strain augments polymyxin B and  
ampicillin resistance 
To better understand the physiological effects of the hicE locus within E. 
coli, we engineered the hicE truncation within the chromosome of the inferred 
ancestral strain MG1655 (referred to herein as MG1655
hicE
) and compared the 
average survival of this recombinant strain to the wild type parent strain and a 
MG1655ΔhicAB mutant under different conditions. We found that relative to both 
wild type MG1655 and MG1655ΔhicAB, the MG1655
hicE mutant exhibited a 
significantly elevated resistance to killing by either polymyxin B (a membrane 
permeabilizing antibiotic) or ampicillin (a cell wall synthesis inhibiting antibiotic) 
(Fig. 4.2). Phylogroup B2 E. coli strains CFT073 and UTI89 showed marked 
differences in their reliance upon the hicE locus for survival under the same 
conditions. CFT073ΔhicE survived significantly better than wild type CFT073, 
whereas UTI89ΔhicE showed a significant decrease in survival compared to wild 
type UTI89 (Fig 4.2). 
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Figure 4.2. The hicE locus effects survival in polymyxin B and ampicillin. 
Each strain was subjected to (A) 100 µg/ml ampicillin for 6 h or (B) 1 µg/ml 
polymyxin B for 90 minutes. The survival of mutant strains was normalized to the 
survival of the accompanying wild type strain in each stress. Data represent the 
average of log10 transformed values from three independent experiments. 
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hicE influences the growth of the ancestral E. coli  
strain MG1655 in various stressing conditions 
The strain MG1655
hicE
 demonstrated a significant survival advantage 
when challenged with membrane stresses. Therefore, we wanted to determine 
the extent to which the hicE locus confers a survival advantage in other stressful 
environments. The bloodstream, which is encountered by ExPEC during 
bacteremic infections, contains several antibacterial factors such as complement. 
When activated, complement components in human serum attach to the outer 
membrane of serum sensitive bacteria and form a pore structure known as the 
membrane attack complex (MAC). MAC formation disrupts the integrity of the 
bacterial membrane leading to cell death. When challenged with active serum, 
we found that serum resistant strains CFT073 and UTI89 grew as expected, and 
MG1655
hicE
, although delayed, was able to grow while wild type MG1655 was 
not (Fig. 4.3B). The serum resistance observed in MG1655
hicE
 was not simply 
due to the loss of function in hicAB, as MG1655ΔhicAB was also unable to grow 
in the presence of active serum (Fig. 4.3B). To confirm if complement proteins 
were inhibiting the growth of wild type MG1655, we tested the ability of all strains 
to grow in serum that had been heat-treated, which renders complement proteins 
inactive. Indeed, all strains grew to similar densities in heat-killed serum (Fig. 
4.3A). Complementation of MG1655 with a plasmid encoding the hicE locus from 
UTI89 driven by its native promoter was sufficient for serum resistance, indicating 
that both cis and trans complementation of hicE within the ancestral strain   
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Figure 4.3. Expression of hicE has context dependent effects on growth of 
MG1655. Growth of ExPEC strains CFT073 and UTI89 together with inferred 
ancestral strain MG1655 and its associated mutants in (A) 10% heat killed 
serum, (B) 5% human serum, (C) LB buffered to pH 5.0 with MES (MES-LB), and 
(D) 1 mM methyl viologen (MV). Graphs are representative of at least two 
independent experiments performed in quadruplicate. 
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MG1655 promotes serum resistance (Fig. 4.3B). Although demonstrating the 
novel capacity to grow in human serum, we found that MG1655
hicE
 and 
MG1655/phicE
Pnative
 strains were more sensitive to growth in the low-pH media 
MES-LB and in media containing the superoxide generator methyl viologen (MV) 
compared to MG1655 and MG1655ΔhicAB (Fig. 4.3C-D). 
 
Presence of the hicE locus results in increased activity 
of the Cpx envelope stress response in MG1655 
 We hypothesized that increased resistance to membrane stresses within 
MG1655
hicE
 could be due to increased activity in the envelope stress response. 
To test this, we measured the activity of two major envelope stress response 
pathways—the rpoE and Cpx pathways. Activation of these pathways can be 
monitored by expression of the rpoE and cpxP genes, respectively. Plasmids 
carrying the luxCDABE operon driven by either the rpoE promoter or the cpxP 
promoter were transformed into MG1655, MG1655
hicE
, and MG1655∆hicAB, 
and luciferase expression was determined during exponential growth in LB 
media.  There was no significant difference in expression levels of rpoE (DNS), 
but MG1655
hicE showed a significant, three-fold increase in cpxP expression 
compared to both MG1655 and MG1655ΔhicAB (Fig. 4.4). 
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Figure 4.4. The hicE truncation increases cpxP activity in MG1655. The graph 
indicates expression levels of the luxCDABE operon driven by the cpxP promoter 
(pJW1) or a promoterless construct (pNLP10) following growth to exponential 
phase in LB broth. Data are shown as means ± standard errors of the means 
from three independent experiments performed in triplicate. 
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Discussion 
Our analysis of 81 E. coli strains shows a direct correlation between a 
truncation in the hicAB toxin-antitoxin system—named here hicE—and the B2 
phylogroup. This event may provide evidence of some selective pressures 
involved in the generation of the B2 lineage. When considering different genetic 
mechanisms of selection-driven fitness, the gross loss of genetic material has 
been shown to provide a better platform for adaptation to environmental 
challenge than a series of single nucleotide alterations 10,11. Once a foothold is 
obtained within a newly acquired niche, fine-tuning of fitness can continue, 
usually through gene gain or gene repurposing events 12,13. We can apply this 
rationale to what we observe with the hicE locus. Generation of the hicE locus 
involves the loss of genetic material (i.e., hicA and part of hicB), and when this 
truncation is engineered within MG1655, it confers resistance to various 
envelope stresses, including human serum (Fig. 4.1B, 4.2, 4.3A-B). However, 
this advantageous adaptation to a new environment comes with certain fitness 
trade-offs; MG1655
hicE
 showed a decreased capacity to grow in low pH and in 
the presence of reactive oxygen species (Fig. 4.3C-D). Coupling our 
phylogrouping data showing 100% of B2 E. coli contain the hicE locus together 
with the notion that the hicE locus offers a fitness advantage to an inferred 
ancestral strain within an ExPEC-associated niche, it is plausible that generation 
of the hicE locus was a defining event in the formation of the B2 lineage by 
allowing for niche expansion. It has been established that while modern-day 
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phylogroup B2 E. coli may be phenotypically similar (i.e., they cause similar 
pathologies within the human host), these bacteria   
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have arrived at this virulence potential through different evolutionary trajectories 
1,14,15. For example, our lab has previously characterized phylogroup B2 strains 
CFT073 and UTI89 to be differentially reliant upon the pore-forming toxin α-
hemolysin for virulence within a zebrafish infection model 15. In our current study, 
this trend continues, as these strains exhibit divergent reliance upon endogenous 
hicE for survival in polymyxin B and ampicillin (Fig. 2). Deletion of the hicE locus 
from CFT073 and UTI89 had no effect on survival in human serum (DNS). These 
data are not entirely surprising as both strains are known to express capsular 
polysaccharide, which itself contributes to serum resistance 16. Of note, both 
CFT073 and UTI89 have ameliorated the fitness cost of maintaining hicE, as 
each strain grew to higher densities in low pH media and in the presence of 
reactive oxygen species than MG1655
hicE
 (Fig. 4.3C-D). 
The Cpx pathway is a key envelope stress response pathway in E. coli, 
and activation of cpxP—the small periplasmic component of the Cpx system—is 
indicative of an active response to envelope stress 17. Using a luciferase reporter 
driven by the cpxP promoter, we were able to show that MG1655
hicE
 had 
heightened activation of the Cpx pathway (Fig. 4.4). This could potentially 
precondition bacterial cells to respond more quickly to envelope stresses, 
thereby promoting resistance and survival. The HicE protein encodes a putative 
DNA binding protein, and given the multifaceted phenotypes associated with this 
truncation, it could potentially act as a novel transcription factor to regulate 
expression of genes, including genes involved in the Cpx pathway. 
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Characterization of the putative molecular effects of hicE requires further 
investigation. This study’s primary focus was identifying a single genetic marker 
for differentiating phylogroup B2 E. coli, and we believe the hicE locus provides 
clinicians with a high fidelity diagnostic marker for identifying B2 pathogens.  
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CHAPTER 5 
 
 
 
DISCUSSION 
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 UPEC encode an array of genes required for the colonization and survival 
of host-associated niches such as the urinary tract. In the introduction to this 
dissertation, I outlined some previously characterized virulence factors that 
contribute to UPEC fitness and discussed various aspects of the host defense 
that would discourage these bacteria from effectively colonizing the urinary tract. 
From epidemiological data, we know that despite precautions taken by the host 
to maintain a sterile genitourinary system, invading bacteria can frequently cause 
infection therein. In addition to the discouraging frequency of UTI, UPEC are also 
competent to persist within the host and cause recurrent infections. A better 
understanding of persistence and subsequent recurrence is much needed. This 
dissertation was focused on gaining a better understanding of the genetic 
elements involved in UPEC stress resistance and persistence, focusing 
specifically on how the genetic makeup of these pathogens affects their 
physiology within the host. 
 Our findings in Chapters 2 and 3 highlight specific genes that are required 
by UPEC for efficient stress resistance and are, ultimately, necessary for robust 
colonization of the urinary tract. In particular, the pasTI TA system is an attractive 
chemotherapeutic target due to the seemingly pathogen-specific effects on 
bacterial stress resistance and kidney colonization that we observed. Current 
antibiotic therapies do not discriminate pathogen from nonpathogen, and when 
given a regimen of broad-spectrum antibiotics to treat an infection, patients’ 
endogenous microbiota are targeted nondiscriminately. Recent evidence 
suggests that antibiotic therapy can significantly alter the bacterial diversity, 
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affecting changes on the microbial diversity and associated metagenome 1. How 
these perturbations in the microbial community are related to complex illnesses 
such as Crohn’s disease and irritable bowel disease have not been definitively 
characterized, but there is mounting evidence that frequent antibiotic use can 
have long-term detrimental effects on the immune system and general 
physiology of the patient 2,3. For these reasons, among others, it is important that 
we find pathogen specific targets for common bacterial infections. We offer 
compelling evidence that TA systems—as opposed to global regulators of 
bacterial physiology such as the cAMP-CRP complex—may be good candidates 
for the generation of novel chemotherapeutic agents. 
 In order to find targets for pathogen-specific therapies, we felt it was best 
to understand the fundamental aspects of pathogenesis. That is, what 
differentiates a pathogen from a commensal bacterium? We know that the 
accumulation of virulence factors such as iron acquisition systems, secreted 
toxins, and adhesive organelles correlates with pathogenic variants of E. coli, but 
we have little understanding of how these strains evolved to their current states 4. 
In Chapter 4, we provide evidence that a degraded chromosomal TA system—
what we named the hicE locus—could have contributed to the evolution and 
pathogenicity of UPEC. While this locus seems clearly useful as a diagnostic 
marker for phylogroup B2 E. coli, it does not seem to be a realistic candidate for 
chemotherapeutic targeting. A chromosomal deletion of this locus within UPEC 
strains does not affect colonization of either the urinary tract or the 
gastrointestinal tract. These data highlight the redundancies of stress resistance 
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found in these pathogenic strains and provide us with a better understanding of 
possible evolutionary pathways that led to the formation of modern day UPEC. 
Future studies may unearth other evolutionarily conserved traits that affect 
pathogenesis and are, therefore, realistic candidates for pathogen-specific 
chemotherapeutic agents. Our hope is that the work of this dissertation will 
contribute to the knowledge necessary for discovering novel clinical therapies for 
the treatment of UTI and recurrent UTI. 
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In bacteria, laterally acquired genes are often concentrated within chromosomal regions known as genomic islands. Using a
recently developed zebrafish infection model, we set out to identify unique factors encoded within genomic islands that
contribute to the fitness and virulence of a reference urosepsis isolate—extraintestinal pathogenic Escherichia coli strain
CFT073. By screening a series of deletion mutants, we discovered a previously uncharacterized gene, neaT, that is
conditionally required by the pathogen during systemic infections. In vitro assays indicate that neaT can limit bacterial
interactions with host phagocytes and alter the aggregative properties of CFT073. The neaT gene is localized within an
integrated P2-like bacteriophage in CFT073, but was rarely found within other proteobacterial genomes. Sequence-based
analyses revealed that neaT homologues are present, but discordantly conserved, within a phyletically diverse set of
bacterial species. In CFT073, neaT appears to be unameliorated, having an exceptionally A+T-rich composition along with a
notably altered codon bias. These data suggest that neaT was recently brought into the proteobacterial pan-genome from
an extra-phyletic source. Interestingly, even in G+C-poor genomes, as found within the Firmicutes lineage, neaT-like genes
are often unameliorated. Sequence-level features of neaT homologues challenge the common supposition that the A+T-rich
nature of many recently acquired genes reflects the nucleotide composition of their genomes of origin. In total, these
findings highlight the complexity of the evolutionary forces that can affect the acquisition, utilization, and assimilation of
rare genes that promote the niche-dependent fitness and virulence of a bacterial pathogen.
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Introduction
As a species, Escherichia coli is best known for colonizing the
lower intestine of humans and other warm-blooded vertebrates
[1,2]. The contingent exit from the intestinal tract presents strains
of E. coli with a multitude of secondary habitats, including host-
associated and free-living niches [2,3,4,5,6]. A subset of E. coli
designated extraintestinal pathogenic E. coli (ExPEC) excels at
colonizing host-associated extraintestinal environments, resulting
in an array of human diseases including urinary tract infections,
bacteremia, and meningitis [7]. ExPEC strains also exhibit an
impressive zoonotic capacity, being able to persist and cause
disease in a variety of domesticated animals [8,9,10,11]. Collec-
tively, ExPEC-related diseases represent daunting medical, agri-
cultural, and economic burdens that threaten to worsen as
antibiotic-resistant strains become more prevalent [8,12,13]. The
evolutionary forces that underlie the emergence and niche
tropisms of ExPEC have yet to be completely defined. Considering
gene content, substantial intra-specific variation often exists
between bacterial isolates, particularly among strains of patho-
genic E. coli. Key questions regarding the origin of this
heterogeneity and its impact on the fitness of virulent strains
remain unanswered.
Bacteria are proficient at rapidly developing innovative,
selectable traits to maintain fitness within complex environ-
ments—a property known as ‘evolvability’ [14,15,16,17,18].
Despite being largely asexual organisms that multiply by binary
fission, bacteria engage in a genetically promiscuous behavior
known as ‘lateral gene transfer’ (LGT). Laterally acquired genes
can provide context-specific functions, such as the ability to
metabolize atypical substrates [19], adhere to a variety of surfaces
[7], neutralize antibiotics and other toxic compounds [5], or
participate in niche construction [20]. Bacteria have several means
of obtaining potentially beneficial elements through LGT: direct
acquisition from the environment (transformation), transfer
through cell-to-cell mating (conjugation), and acquisition from
bacterial viruses known as bacteriophages (transduction)
[14,21,22,23,24]. It has been estimated that ,81% of all genes
within a bacterial chromosome have been involved in LGT at
some point, suggesting that this behavior is not just an anomalous
event, but that over time it is a foundational component of
bacterial evolution [25].
PLOS Pathogens | www.plospathogens.org 1 February 2013 | Volume 9 | Issue 2 | e1003175
89 
 
The genomes of E. coli are laden with the signatures of past
LGT events. Since the first genome sequencing projects it has been
apparent that E. coli chromosomes are highly mosaic [26,27,28].
In part, this chromosomal architecture results from the presence of
‘genomic islands’ (GI) that intermittently disrupt synteny
[29,30,31,32,33,34]. Many GIs exhibit clear signs of having been
involved in past LGT events as they are often in proximity to
mobile elements, such as transposons, or are themselves integrated
phages or plasmids [35]. Accompanying this interchangeable
chromosomal arrangement is a vast superset of genes defined as
the pan-genome [32,36,37]. Whereas an average E. coli genome
contains about 4,700 genes, the pan-genome of this species is
estimated to be over 17,000 genes. Most E. coli strains share a
subset of the pan-genome, which encodes vertically inherited genes
that dictate the fundamental cellular properties of the lineage. This
core genome surprisingly accounts for only 40–50% of the genetic
makeup of any particular isolate. The rest of the chromosome
contains strain-specific combinations of genes that are infused
throughout the core genome and encode a variety of accessory
functions that can provide unique selective advantages [32,37,38].
With this information in mind, we systematically screened GIs
of a urosepsis ExPEC isolate for laterally acquired genes that affect
virulence in a surrogate zebrafish host model. We identified a
novel gene—designated neaT (nomadically evolved acyltransfer-
ase)—that is required during blood-borne, but not localized,
infections in both zebrafish and mice. The neaT locus was
unexpectedly rare in the genomes of closely related E. coli strains
and other Proteobacteria, suggesting that it was obtained from
outside the contemporary E. coli pan-genome. Proteobacterial neaT
homologues, in general, exhibit a high degree of allelic variance,
have reduced guanine and cytosine (G+C) content, and are often
localized within the integrated genomes of unrelated bacterio-
phages. These observations indicate that neaT-like alleles may have
been recently acquired on multiple occasions by the proteobacter-
ial supraspecies pan-genome. Together, our results provide
molecular and bioinformatic evidence that the acquisition of
unique genes like neaT during the evolution of particular ExPEC
isolates can significantly impact bacterial fitness and virulence
within specific host environments. Possible evolutionary forces that
generate the observed sequence-level features of neaT and the role
that bacterial individuality plays in pathogenesis are considered.
Results
The P2-like prophage b0847 promotes the fitness and
virulence of ExPEC strain CFT073 during systemic
infection of zebrafish embryos
The ExPEC strain CFT073 was isolated from the blood of a
human patient with acute pyelonephritis (kidney infection) [26,39].
This urosepsis isolate is versatile, with the apparent ability to
traverse several host microenvironments to reach the bloodstream,
and has a relatively large genome of 5,369 protein-coding genes
and several GIs. In previous work, we found that CFT073 is
exceptionally lethal in an infection model that uses zebrafish
embryos as surrogate hosts for the high-throughput analysis of
ExPEC virulence [40]. At 48 h post-fertilization (hpf), zebrafish
possess an innate immune system composed primarily of
phagocytic cells and antimicrobial peptides [41,42,43,44]. These
defenses mirror those employed by mammalian hosts to combat
ExPEC.
To identify GI-associated virulence factors carried by CFT073,
we screened 11 previously described deletion mutants that each
lack a specific GI (Table 1 and Figure 1A) [45]. In blinded assays,
48 hpf zebrafish embryos were infected with 1,000 to 2,000
colony-forming units (CFU) of either wild type CFT073 or one of
the 11 GI mutants. Bacteria were delivered into one of two
injection sites: the fluid-filled sac surrounding the heart referred to
as the pericardial cavity (PC), which mimics a localized tissue
infection, and the circulation valley (CV), which facilitates rapid
dispersal of bacteria into the bloodstream [40]. Each of these sites
likely challenges the pathogen with different nutrient limitations,
receptor availability, and host defenses.
In this infection model, increased growth of ExPEC is associated
with decreased survival of the host [40]. All 11 GI mutants, with
the exception of DGI-aspV, grew equally well in broth culture at
28.5uC and 37uC (data not shown). Following inoculation into the
PC, only deletion of the 123 kb GI PAI-pheV [I] resulted in a
significant decrease in virulence relative to wild type CFT073
(Figure 1B, top). This was not surprising as PAI-pheV [I] encodes
Author Summary
Bacterial pathogens, even those belonging to the same
species, can be incredibly diverse with regard to the genes
they carry. However, the design of vaccines and antibiotics
typically relies upon identification of general molecular
features shared by the targeted organisms. Thus, we have
traditionally focused on broadly conserved characteristics
of pathogenic bacteria, often ignoring the genes that
account for their individuality. In this article we report the
discovery of a unique gene, neaT, that promotes the
fitness of a pathogenic Escherichia coli isolate in zebrafish
and mouse models of systemic blood infections. Surpris-
ingly, neaT is rarely found in other related strains of E. coli
and appears to have been recently acquired from distant
lineages of bacteria via a process known as ‘lateral gene
transfer’ that is used by microbes to swap genetic material.
Expression of the neaT gene appears to help pathogens
avoid interactions with host immune cells, possibly by
altering bacterial surface structures. This work provides an
interesting example of how the lateral acquisition of a rare
gene can impact the niche-specific virulence properties of
a pathogen, shedding light on the mechanisms that drive
pathogen evolution and diversity.
Table 1. Summary of GI screen in zebrafish infection sites.
GI deletion variant Size (Kbp) PC Blood
n p value n p value
WpotB 44 9 0.2272 10 0.3581
GI-selC 68 9 0.6862 9 0.0307
GI-cobU 44 10 0.6689 10 0.0702
wb0847 33 9 0.2831 9 0.0056
GI-asnW 54 10 0.1338 10 0.9703
PAI-asnT [HPI] 32 10 0.7036 10 0.6317
PAI-pheV [I] 123 30 ,0.0001 30 ,0.0001
PAI-metV 32 10 0.7586 9 0.179
PAI-pheU [II] 52 10 0.2322 10 0.6321
PAI-aspV 100 10 0.2322 10 0.7972
PAI-serX 113 9 0.4113 10 0.6163
n denotes number of individual embryos used.
p values reflect the statistical significance of differences between wild type and
mutant killing kinetics.
doi:10.1371/journal.ppat.1003175.t001
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Figure 1. The wb0847 island is important for CFT073 pathogenicity during systemic infection in zebrafish embryos. (A) Diagram of GIs
and their location within the CFT073 chromosome that were screened in the zebrafish host. Magenta indicates island mutants that had no observable
defects, while green denotes island mutants that displayed significant attenuation. (B) The pericardial cavity (PC, top row) and blood (bottom row) of
48 hpf embryos were inoculated with 1,000–2,000 CFU. Fish were scored for death at 0, 24, 48, and 72 h post-inoculation (hpi). Data are presented as
Kaplan-Meier survival plots and p values were calculated using a log-rank (Mantel-Cox) test (sample sizes for each curve are listed in Table 1). (C) Equal
numbers (1,000–2,000 CFU total) of wild type and CFT073Dwb0847 were inoculated into the bloodstream of embryos. Fish were sacrificed and
bacterial loads enumerated at the indicated times by differential plating (n=10 to 20 embryos). Data are represented as competitive indices, where
negative values indicate a reduction in fitness of the mutant strain. (D) Bacteria were prepared as in (C) and inoculated into the PC or yolk. Fish were
sacrificed at 18 hpi and bacterial numbers determined (n= 9–10 embryos). Data from blood infections is the same as in (C), provided as a reference. P
values were determined using two-tailed Mann-Whitney t tests. Median values are indicated by bars in (C) and (D).
doi:10.1371/journal.ppat.1003175.g001
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the notable ExPEC-associated virulence factors a-hemolysin (pore-
forming toxin), SAT (vacuolating toxin), P pili (adhesive organ-
elles), aerobactin (iron acquisition system), and K2 capsule
(immune evasion). The ability of the DPAI-pheV mutant to still
kill approximately half of the embryos suggests that additional
factors with overlapping roles in virulence within the PC are
encoded outside of PAI-pheV and the 10 other GIs tested.
The DPAI-pheV mutant was also attenuated following inocula-
tion of the CV to initiate systemic infection, as were the GI
mutants DGI-selC, DGI-cobU, and Dwb0847 (Figure 1B, bottom).
In addition to several hypothetical genes, the selC and cobU islands
harbor genes that appear to be components of polyamine and iron
transport systems, respectively. Both polyamines and iron acqui-
sition systems are known to be important mediators of ExPEC
fitness in mouse models of infection [46,47,48]. Although the DGI-
cobU mutant exhibited only a modest reduction in virulence in
these assays using inoculation doses of 1,000–2,000 CFU/embryo,
with slightly higher doses between 2,000 to 3,000 CFU/embryo
this mutant displayed more dramatic and significant (p,0.05)
attenuation (Table S1). This observation supports previous
findings indicating that the inoculation dose can markedly
influence the discernibility of some mutant phenotypes in the
zebrafish host [40].
The remaining GI showing a phenotype in our screen is
composed of an intact integrated phage genome (prophage) named
‘wb0847’ (Figure 1B) [45]. This prophage is 33 kb in length and
contains 48 predicted open reading frames, most of which encode
recognizable phage proteins that share homology with genes of
tailed phages belonging to the order Caudovirales. More specifically,
wb0847 carries genes involved in regulation, replication, and
virion assembly that are related to and syntenic with the genes of
phage P2 and its relatives (Figure 2). From this analysis, it is clear
that the wb0847 prophage is a member of the P2-like phage group
and likely represents a fully functional phage genome complete
with all the essential genes associated with P2-like phages [49].
Aside from the DpheV mutant, with its fairly well characterized
assortment of virulence genes, Dwb0847 displayed the most
pronounced defect of the island mutants examined. Therefore,
the wb0847 GI became the primary focus of our investigation.
To further define the contribution of wb0847 to the virulence
and fitness of CFT073, we carried out competitive assays in which
a one-to-one mixture of wild type and mutant bacteria were
injected into the CV of zebrafish embryos (Figure 1C). At the
indicated time points, the infected embryos were homogenized
and bacteria present were enumerated by dilution plating on
selective agar. Dwb0847 carries a kanamycin resistance cassette
that was used to distinguish wild type and mutant strains. No
differences between wild type CFT073 and the Dwb0847 mutant
were observed until 6 h post-inoculation (hpi), when Dwb0847
titers began to decline (Figure 1C). These results indicate that the
wb0847 island is dispensable during initial stages of a systemic
infection, but enhances bacterial fitness at later time points,
coordinate with the upregulation of host inflammatory responses
engage. The Dwb0847 mutant displayed more modest, though still
significant, decreases in fitness during competitive assays against
wild type CFT073 within the PC and yolk sac at 18 hpi
(Figure 1D). Phagocytes are recruited into the PC en masse in
response to infection with ExPEC [40], possibly contributing to
the competitive disadvantage of the Dwb0847 mutant within this
niche. On the other hand, the yolk is a rich source of nutrients for
bacteria and is mostly free of phagocytes and other immunosur-
veillance mechanisms. However, the yolk does contain maternally
inherited antimicrobial compounds that could account for the
slight reduction in fitness of Dwb0847 within this host environment
Figure 2. Alignment of wb0847 genome to other P2-like bacteriophage. Related P2-like prophages are aligned relative to their respective
integration sites (att). Size is measured in kilobase pairs (Kbp). E. coli phages P2 and 186 and Salmonella phages Fels-2 and SopE5 were previously
characterized. HS2 is an uncharacterized prophage contained within the genome of the commensal E. coli strain HS. Our unpublished analysis
indicates that P2, 186, and Fels-2 represent three different ‘‘sequence types’’ based on virion proteins, which are typically .85% identical within each
of these three groups and 50–70% identical between the groups. Bracketed numbers below wb0847 indicate positions of the deletion mutants
generated to assess the functionality of genes within broad regions of wb0847. The neaT gene is distinguished by a red open reading frame in moron
position 2.
doi:10.1371/journal.ppat.1003175.g002
Rare Gene Promotes Bacterial Virulence
PLOS Pathogens | www.plospathogens.org 4 February 2013 | Volume 9 | Issue 2 | e1003175
92 
 
[50]. Competitive experiments in broth culture did not reveal
appreciable differences between the wild type and mutant strains
(data not shown).
wb0847 harbors a multigenic region that contributes to
fitness
To identify genes within wb0847 that, when deleted, recapit-
ulate the attenuated phenotypes of Dwb0847, we constructed
partial deletion mutants lacking one of three nearly equal-sized
regions of the prophage island (designated D1–2, D2–3, and D3–4,
as indicated along the wb0847 genome in Figure 2). In competitive
assays, the D1–2 and D2–3 mutants were significantly more fit
than the full Dwb0847 mutant at 12 hpi (Figure 3A). Analysis at
12 hpi allowed time for selection to take place, while limiting
artifacts due to bacterial replication at later time points in dead
and dying hosts where selective pressures are presumably weaker.
In these assays, only the D3–4 mutant phenocopied the complete
wb0847 island deletion mutant (Figure 3A). Lethality of this
mutant variant was also significantly reduced in comparison to
wild type CFT073 and the D1–2 and D2–3 mutants in
independent challenges (Figure 3B). These results indicate that
one or more genes within the terminal 3–4 region of the wb0847
prophage enhances both the fitness and virulence of CFT073
during systemic infections within the zebrafish host.
Temperate prophage genomes like wb0847 can carry ‘lysogenic
conversion’ genes that affect the bacterial host but are not essential
for lytic phage growth. To avoid disruption of critical phage
processes, the integration of this genetic material is generally
tolerated only in certain regions of the prophage genome. These
added sequences are known as ‘morons’, because bacteriophages
with such insertions have more DNA [51,52]. Moron genes
typically contain their own regulatory elements and vary among
individual phage genomes. They often alter the surface structure
or physiology of the bacterial host and can benefit the phage by
making its host refractory to competing parasites or otherwise
promoting bacterial survival and growth [52,53].
The P2-like phages appear to have at least two variable moron
positions (Figure 2). Using phage P2 as a reference, the location of
moron position 1 is between the DNA replication gene A and head
assembly gene Q, and moron position 2 is between the tail fiber
gene G and tail sheath gene FI (Figure 2) [49]. In wb0847 within
CFT073, the second moron site, which is absent from the D3–4
mutant, contains one open reading frame that is oriented in the
opposite transcriptional direction to the flanking tail genes. This
gene, which we named neaT for reasons described later, encodes a
putative acyltransferase (Pfam:PF01757). This gene is not
conserved among P2-like phages and is likely not critical for lytic
replication of wb0847.
In light of this information, neaT, the immediately proximal
gene yfdK (homologous to P2 phage tail gene G), and the collection
of distal tail genes (FI through D) were individually deleted from
the wb0847 prophage in CFT073. All three mutant derivatives—
DyfdK, DneaT, and DFI-D—were attenuated in their ability to kill
zebrafish embryos after injection into the blood via the CV
(Figure 3C). Despite the significantly reduced virulence of these
mutants, no defects in fitness were observed in competitive assays
with wild type CFT073 (data not shown). The lack of any
discernable fitness defects in competition assays may 1) reflect the
ability of wild type CFT073 to trans-complement the mutant
strains in vivo and/or 2) indicate that there is cooperative interplay
among the yfdK, neaT, and FI-D loci. Of note, disruption of loci
flanking neaT did not appreciably alter its expression in broth
culture (Figure S1). Furthermore, we found no evidence that the
neaT mutant could be complemented in vivo during competition
assays by acquiring wb0847 sequences from the wild type strain
(Figure S2). Interestingly, a yfdK homologue was recently shown to
aid the survival of a K-12 laboratory strain of E. coli in acidic
environments [54], but no mechanism for this effect is known, and
to the authors’ knowledge, yfdK homologues have not been
implicated in pathogenesis.
The neaT gene restores virulence to the wb0847 island
deletion mutant
The in vivo assays presented in Figure 3C and bioinformatic
analyses described below highlight neaT as a gene of potential
importance to the fitness and virulence of CFT073. To test this
possibility, the neaT locus, including an upstream promoter region
of 211 bp, was amplified from the CFT073 chromosome and
cloned into the high-retention plasmid pGEN-mcs, yielding
pGEN-neaTPnative. Semi-quantitative reverse transcription poly-
merase chain reaction (RT-PCR) indicated that neaT transcript
levels made from the pGEN-neaTPnative vector in broth culture
were about 1.7-fold higher than those observed in wild type
CFT073 (Figure S3). Complementation experiments were per-
formed comparing the lethality of wild type CFT073/pGEN-mcs,
Dwb0847/pGEN-mcs, and Dwb0847/pGEN-neaTPnative in zebra-
fish embryos after inoculation of the CV (Figure 3D). The
complete prophage deletion mutant Dwb0847 carrying the empty
vector pGEN-mcs exhibited a significant delay in killing relative to
either the wild type strain CFT073/pGEN-mcs or the comple-
mented mutant Dwb0847/pGEN-neaTPnative. In total, these
experiments identify neaT as a virulence determinant contained
within the wb0847 island of CFT073; therefore, the uncharacter-
ized neaT gene became the focal point for the remainder of our
investigation.
neaT is required for fitness during systemic, but not
localized infections in a mammalian host
To extend our observations made using zebrafish, we employed
a murine model to further define the requirement for neaT during
localized and systemic infections. For localized challenges, we took
advantage of a well-characterized mouse model of urinary tract
infection. Wild type CFT073 and the DneaT mutant were mixed at
a one-to-one ratio and inoculated via transurethral catheterization
into adult female CBA/J mice. After 3 days, animals were
sacrificed and bacterial titers within the bladders and kidneys were
enumerated, revealing no outright competitive advantage for wild
type CFT073 over the DneaT mutant in either organ (Figure 4A).
To appraise the requirement for neaT during systemic infections,
we utilized a recently described sub-lethal bacteremia model in
which CBA/J mice were injected with a one-to-one mixture of
wild type and mutant bacteria via the tail vein [55]. At 24 hpi the
DneaT mutant was recovered at significantly reduced levels from
the spleen and liver compared to wild type CFT073 (Figure 4B).
These results confirm and extend our findings in the zebrafish
host, demonstrating that neaT provides niche-specific advantages
to CFT073 during systemic infections.
Diversity and phage association of NeaT homologues
There are no closely related homologues of NeaT in E. coli.
Only four matches were found in the current NCBI collection of
170 RefSeq E. coli genomes (as of June 2012) that produce an
alignment E value,1026 with similarity over .50% of the NeaT
protein length. A PCR-based survey for the presence of neaT
within various clinical E. coli isolates corroborated our in silico
observation that neaT is rare among this taxon (Figure S4). Out of
21 randomly chosen isolates, none carried the CFT073 neaT allele.
Rare Gene Promotes Bacterial Virulence
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Homologues of neaT are also rarely detected in P2-like phage
genomes; among 45 randomly chosen P2-like phages and
prophages in E. coli, Salmonella, Shigella, and Enterobacter that we
examined, only wb0847 carries a neaT-like gene. The closest match
to NeaT in the NCBI database is encoded by locus Ent638_2581
of Enterobacter sp. 638, whose protein product is only about 33%
identical to NeaT. We note that several more distantly related neaT
homologues are present in the genomes of other temperate phages
and prophages of the bacterial family Enterobacteriaceae (Table 2).
They are found, for example, in the Shigella flexneri phage Sf6
genome and several uncharacterized prophages of S. flexneri, in E.
coli phage wV10 and a nearly identical prophage in the Shiga
toxin-producing E. coli isolate DEC4D, and in a putative prophage
within Citrobacter rodentium strain ICC168. The above Enterobacter
Figure 3. wb0847 harbors multiple loci that contribute to the fitness of CFT073 during systemic challenge. (A) Equal numbers (1,000–
2,000 CFU total) of wild type CFT073 and each mutant derivative indicated were inoculated into the bloodstream of embryos. Fish were sacrificed
and bacterial loads enumerated at 12 hours post inoculation (hpi) by differential plating (n.28). Data are presented as competitive indices with
negative values indicating a reduction in fitness of the mutant. P values were determined using two-tailed Mann-Whitney t tests; bars indicate
median values. (B), (C), and (D) 1,000–2,000 CFU of wild type CFT073, the indicated mutant, or recombinant derivative were each inoculated into the
blood of 48 hpf embryos. Fish were scored for death every 6 h starting at 18 hpi until 48 hpi (n=40 or more embryos for each curve). pGEN-mcs in
(D) serves as an empty vector control for pGEN-neaTPnative. Data in (B), (C), and (D) are presented as Kaplan-Meier survival plots. A log-rank (Mantel-
Cox) test was used to determine p values; ns = not significant.
doi:10.1371/journal.ppat.1003175.g003
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homologue Ent638_2581 is also carried within a putative
prophage that is similar to Shigella phage SfV. Each of these
phage-associated neaT homologues is un-ameliorated with
respect to its bacterial host genome (see below), and each lies
within a known moron position in its phage genome. Because
neaT homologues differ substantially in sequence conservation
and are found in a variety of tailed-phages, neaT-like genes may
have been laterally acquired by Enterobacteriaceae lineages on
several occasions, possibly via phage. Multiple neaT acquisition
events would indicate that this gene has an underlying
evolutionary importance to either the phages themselves or
their hosts. In considering its putative function (see Figures S5,
S6, and Text S1), its apparent lateral acquisition, and its allelic
variance within the proteobacterial lineage, this gene was
named ‘neaT’—nomadically evolved acyltransferase. In the
following sections we explore the evolutionary history of this
gene by analyzing the diversity and distribution of neaT-like
genes in more detail.
Figure 4. neaT enhances the fitness of CFT073 in a murine model of bacteremia. (A) Equal numbers (107 CFU total) of wild type CFT073 and
CFT073DneaT were transurethrally inoculated into the bladder of CBA/J female mice. Mice were sacrificed, organs harvested, and bacterial loads
enumerated at 3 d post inoculation. (B) Equal numbers (106 CFU total) of wild type and CFT073DneaT were inoculated into the bloodstream of CBA/J
female mice via tail vein injection and bacterial titers present in the spleen and liver were enumerated 24 h later. Data are shown as competitive
indices, where negative values indicate a reduction in the fitness of CFT073DneaT. Bars indicate median values for each group; n$9 mice. P values
determined using Wilcoxon-matched paired signed rank; ns = not significant.
doi:10.1371/journal.ppat.1003175.g004
Table 2. neaT homologues associated with bacteriophages.
%GC
Bacterial host strain Associated phage genome Gene ID neaT homologue bacterial genome
% identity to
neaTCFT073 (% query
coverage)
E. coli CFT073 P2-like wb0847 prophage 26107260 30 51 100 (100)
E. coli DEC4D e15-like prophage 377941589 31 50 22 (96)
E. coli O157:H7 e15-like phage wV10 89152472 31 49 22 (94)
Enterobacter sp. 638 unnamed lambdoid prophage 146312226 38 53 34 (98)
C. rodentium ICC168 unknown prophage fragment 283784796 37 55 32 (41)
S. flexneri serotype X Sf6 33334172 42 51 29 (35)
S. flexneri VA-6 Sf6-like defective prophage 333006890 42 51 29 (35)
S. flexneri K-218 unknown prophage 333006144 39 51 34 (86)
S. flexneri 4343-70 unknown prophage 332759112 39 51 34 (86)
doi:10.1371/journal.ppat.1003175.t002
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Phyletic distribution of neaT
To investigate the evolutionary source of E. coli neaT genes, we
assessed the phyletic distribution of its homologues. BLASTp
alignments were performed on the publically available NCBI
database using NeaT from CFT073 as a probe for the search sets
of Proteobacteria, Firmicutes, Bacteroidetes, Actinobacteria,
Spirochaetes, and Fusobacteria [56]. Sequences were declared to
be homologous if they had an alignment significance (E value) of
,1026 over .50% of their lengths [57]. These searches retrieved
a total of 317 non-paralogous NeaT-like sequences. The
distribution of phyla containing these sequences is depicted in
Figure 5A (left), revealing that the majority of neaT homologues are
from the Firmicutes and Bacteroidetes rather than Proteobacteria.
In an attempt to control for the inherent bias of NCBI databases,
we plotted the number of available gene sequences for each
phylum represented in Figure 5A (right). This plot demonstrates
that the high number of neaT homologues identified among non-
proteobacterial phyla is not due to a skew in sequence abundances.
To the contrary, total proteobacterial gene sequences overshadow
those from other phyla and therefore underscore the relative rarity
of neaT alleles in this taxon.
To quantify the phyletic distribution of NeaT homologues with
greater statistical confidence, we performed bi-directional align-
ments of NeaT using BLASTp with a manually assembled
database of open reading frames from a representative, yet broad,
assortment of 165 phylogenetically classified bacterial genomes
and associated plasmids obtained from NCBI (Table S3). This
analysis confirmed that, compared to random chance, neaT
homologues are significantly enriched among species belonging
to the phyla Firmicutes and Bacteroidetes (Figure 5B). Moreover,
many of the neaT homologues were detected in notable plant and
animal pathogens, including Erwinia spp., Bacillus spp., Staphylococcus
aureus, Streptococcus oralis, Clostridium botulinum, and Porphyromonas spp.
Results from similar alignments of neaT and all other wb0847-
encoded genes are presented graphically in Figure 5C. For each
prophage gene, the number of non-paralogous matches found in
the custom database are represented as bars (upper axis) and the
percent of those hits that are harbored within proteobacterial
genomes (lower axis) are plotted against the position of the gene
within wb0847 (x-axis). Given the host range of known P2-like
phages, it is not unexpected that the majority of genes within
wb0847 were exclusive to the proteobacterial phylum. Exceptions,
in addition to neaT, include homologues of wb0847 genes encoding
the phage integrase and a Dam methylase. However, neaT is
unique among the wb0847 prophage genes in that over 75% of its
matches (16 of 21) were from outside the Proteobacteria (Figure 5C
and Table S4). The discordant conservation of neaT highlights its
likely extra-phyletic origin.
neaT displays signatures of recent lateral transfer
If a gene has origins outside its immediate genome, it would
carry sequence-level vestiges of its previous host until it adopts the
characteristics of the current host—a process known as ‘amelio-
ration’ [27,58]. Commonly used parameters that distinguish
laterally transferred and unameliorated genes are atypical codon
usage and guanine-cytosine (G+C) content [57,59,60]. We
Figure 5. neaT is discordantly conserved. (A) Left: Phyletic distribution of neaT homologues among genomes retrieved from NCBI (n = 317).
Right: Number of gene sequences deposited in NCBI for each phylum as of November 2011. (B) Left: Pie graph showing distribution of neaT
homologues among each phylum represented in the custom database (n = 21 non-paralogous neaT genes). Right: Theoretical distribution of neaT
homologues within phyla present in the custom database based on random chance. P values for the observed versus theoretical phyletic abundance
of neaT homologues were calculated by .score analysis. (C) Upper y-axis: bar graph depicts total number of non-paralogous homologues retrieved
from the custom database (DB) for each gene encoded within wb0847 (plotted along the x-axis with respect to its position within the prophage
genome). The neaT open reading frame is indicated in red. Lower y-axis: bar graph showing the percent of proteobacterial homologuesfound in the
homologue set for each wb0847 gene. Sequences unique to CFT073 were assigned 100% proteobacterial conservation.
doi:10.1371/journal.ppat.1003175.g005
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analyzed these features of neaT in the context of the CFT073
genome and wb0847 prophage. Using all 5,369 protein-coding
genes of CFT073, the frequency with which specific codons are
used for each amino acid was calculated (Table S5). Each gene was
then assigned a ‘codon deviation score’ representing how often it
uses atypical codons (Methods and Table S6). Scoring correlates
with conformity; genes scoring low have a more typical codon
usage, whereas poorly conformed genes score high. This analysis
shows that neaT possesses a significantly abnormal codon usage
compared to the rest of the CFT073 genome (p=0.0260)
(Figure 6A, left panel). The neaT gene was also observed to be
G+C-poor (29.84%), making it a significant outlier from the
CFT073 genome-wide median of 51.5% (p=0.0001) (Figure 6A,
right panel). We also analyzed the codon deviation score
(Figure 6B, upper axis) and nucleotide composition (Figure 6B,
lower axis) of neaT with respect to the genome of wb0847. Most
genes withinwb0847 conform to the codon usage and G+C
content of CFT073. This is expected for a parasite that has been
co-evolving with proteobacterial hosts over an extensive period of
evolutionary time [59]. Thus, the aberrant codon usage and
nucleotide composition of neaT is not simply an inherited trait of
wb0847. Because of its relatively low G+C content and poorly
conformed codon usage, we conclude that neaT is a relatively
recent acquisition by both wb0847 and the genome of CFT073.
To determine if the apparently unameliorated state of neaT in
CFT073 is unique or if it is hinting at a more widespread
phenomenon, we plotted the G+C content of a representative
subset of neaT homologues identified in Figure 5 against the G+C
content of their respective genomes (Figure 6C). As a control, we
also plotted the G+C content of poxB, which encodes the metabolic
enzyme pyruvate oxidase and exists in an ameliorated state within
several phyla (Figure 6C, inset). Most proteobacterial neaT genes
Figure 6. neaT is maintained in an un-ameliorated state. (A) Left: distribution of codon deviation scores assigned to the 5,369 protein-coding
genes of CFT073. Right: distribution of %GC content of each protein-coding gene of CFT073. Bar and whiskers indicate median and interquartile
ranges. Red ‘X’ marks position of neaT within each distribution. (B) Upper y-axis: bar graph depicting codon deviation score for each wb0847 gene
plotted with respect to position within the prophage (x-axis cartoon, with the neaT gene highlighted in red.). Lower y-axis: line graph representing
fluctuations in %GC content across wb0847 (window=182 bp, step= 182 bp). (C) %GC content of neaT alleles found across phyla (color-coded)
plotted against the %GC content of each respective genome (x-axis). Inset shows the same sort of analysis for the poxB allele as a comparison. Points
falling on the dashed lines represent alleles that are completely ameliorated with respect to their host genomes. (D) Graph shows the ratio of %GC
content of neaT alleles and total genomic %GC content for individual isolates within the indicated phyla. Bars indicate medians, and p values were
determined using two-tailed Mann-Whitney t tests (n= 18 (Proteobacteria), 51 (Firmicutes), 22 (Bacteroidetes)).
doi:10.1371/journal.ppat.1003175.g006
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were significantly less ameliorated than those found in the
genomes of Bacteroidetes and many Firmicutes (Figure 6C and
D). Interestingly, even though Firmicutes genomes generally have
a low G+C content, neaT-like genes within this lineage are still
relatively G+C-poor, at least in a major fraction of Firmicute
species (Figure 6C). Cumulatively, these results indicate that, at
least among the three phyla compared here, neaT-like genes have
likely been associated with Bacteroidetes the longest, whereas
acquisition by the Proteobacteria was a more recent event.
Discussion
Summary and impact of findings
Presented here are the results from a screen conducted using the
ExPEC isolate CFT073 and a high-throughput zebrafish surrogate
host model of infection. We screened GIs for novel virulence
genes, which were expected to have a history of lateral gene
transfer. Three loci within the P2-like prophage wb0847 were
found to contribute to the virulence of CFT073 during systemic
infection. A previously uncharacterized gene—designated here as
neaT—was discovered to augment the virulence capacity of
CFT073, independent of other prophage components
(Figure 3D). We demonstrated that neaT is conditionally required
for maximal fitness during bacteremic infections of both zebrafish
and mice, suggesting that CFT073 has potentially co-opted this
phage-borne gene for specific virulence behaviors. By tracing the
evolutionary history of the neaT gene, we found that it is relatively
rare and has sequence-based features suggesting that it was
recently absorbed into the proteobacterial supraspecies pan-
genome. Signs of its novelty are typified by high allelic
variance—possibly a result of multiple entries into the Proteo-
bacteria lineage via phage—and its mostly unameliorated state
within proteobacterial genomes.
We also investigated the putative function(s) of NeaT in vitro.
The NeaT protein shares homology with several characterized
acyltransferases encoded within a variety of non-E. coli genomes.
These putative membrane-localized enzymes can modify compo-
nents of the bacterial cell wall, particularly peptidoglycan
[61,62,63,64]. Alteration of this macromolecule can often provide
bacterial pathogens with protection from host antimicrobial
peptides and enzymes such as lysozyme. However, deletion of
neaT had no effect on the sensitivity of CFT073 to lysozyme, the
antimicrobial cationic peptide polymyxin B, or antibacterial
factors present in human serum (see accompanying supplemental
Text S1). Interestingly, expression of neaT did alter the behavior of
CFT073 in swarming assays and induced bacterial aggregation on
swim plates (Figure S5A–C, Text S1)—phenotypes that may be
attributable to NeaT-mediated modification of components within
the bacterial envelope. We also found that expression of
recombinant NeaT can inhibit production of surface structures
like curli and cellulose in some strain backgrounds (Fig. S5D–E,
Text S1), supporting the notion that NeaT can affect salient
properties of the bacterial surface and thereby alter bacterial group
behavior.
The apparent capacity of NeaT to modulate bacterial
aggregation (Fig. S5C) is especially intriguing in light of a recent
work demonstrating that aggregate formation can promote
bacterial survival within the bloodstream of infected mice [65].
Building on these observations, we found that expression of the
neaT gene from a low copy number plasmid significantly decreased
the capacity of CFT073 to associate with murine macrophages,
suggesting that NeaT serves as an immune evasion factor (Fig. S6).
The specific mechanism(s) by which NeaT promotes bacterial
fitness during systemic infections, as well as the environmental cues
that control neaT expression, require further investigation. As it
stands, this work contributes to the idea that ExPEC isolates do
not all share the same set of virulence factors, which are likely
dictated by the distinct evolutionary trajectory and particular
niche tropism of each strain.
neaT-based models for evolution of laterally acquired
genes
Our analysis defines neaT as a recently acquired locus of the
Proteobacteria. Evidence for this is drawn from its discordant
conservation, abnormal codon usage, and low G+C content. In
large part, the unameliorated state of neaT-like genes in
Proteobacteria and Firmicutes genomes suggests that there is a
general phenomenon accounting for its relative A+T-rich compo-
sition beyond having originated in an A+T-rich genome, as
previously suggested [59]. We posit that the observed A+T-
richness of laterally transferred genes can be, to some extent,
accounted for by an ‘exploratory mechanism’ [16]. Upon
introgression of a foreign gene, its retention depends on its
adaption to the host’s genetic and cellular machinery, a process
that can take several millions of years [66]. During this time the
gene may fall under relaxed selection whereby mutations accrue
until a beneficial allele is ‘discovered’ and acted upon by selection.
Connecting relaxed selection to reduced G+C content is the
observation that there is a universal mutation bias for G/C to A/T
transitions in bacterial genomes [67,68,69]. It then follows that
immediately after a gene is acquired, it will initially accumulate
A+T-rich character until a selectable version is ameliorated. From
the findings presented here, we speculate that the neaT variant in
CFT073 is an example of a newfound allele that is being used to
promote bacterial fitness in pathogenic contexts.
Arguably, neaT may represent an ancient gene that has simply
failed to fix within the proteobacterial lineage. Therefore, an
alternative hypothesis is that the conditional requirement for neaT
by CFT073 within different environments may have driven its
current evolved state. We observed in two vertebrate model
systems that neaT contributes significantly to pathogen fitness
primarily during systemic infections. Considering the ecology of
many bacterial pathogens, a question often left unaddressed is:
what are the evolutionary forces that act on niche-specific genes in
the absence of selective pressure? Particularly for E. coli, which has
a complex multi-niche life cycle, the evolutionary consequences
resulting from time outside selective environments on genes like
neaT are not clear.
Work directly addressing this question is scarce. However,
insight into this issue is provided by findings that genes under
relaxed constraint have increased variance at the sequence level
[17,70,71,72,73]. In contrast to relaxed selection, which occurs
when purifying selection is alleviated, as discussed above, ‘relaxed
constraint’ refers to a limitation in the exposure of a particular
gene to selection. For example, eukaryotic genes with expression
patterns that are sex-restricted are effectively ‘hidden’ from
selection in half of the population. This is the case for the
Drosophila spp. maternal-effect gene bicoid, which is maternally-
restricted and critical for the embryonic development of fruit flies
[70]. The bicoid gene was found to have a 2-fold higher
heterozygosity compared to zygotically-expressed genes. Similarly,
genes with caste-biased expression (i.e., queen versus worker) in the
social insects Solenopsis invicta (fire ant) and Apis mellifera (honey bee)
were shown to be evolving more rapidly than genes expressed
among all castes [71]. For both of these situations, the higher
mutation rate observed for contextually expressed genes was
concluded to be due to relaxed constraint. Further investigation
into the exploratory mechanism and relaxed constraint hypotheses
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of neaT evolution is required and must be considered in parallel
with other processes and factors, including, for example, the
susceptibility of laterally transferred genes to endogenous restric-
tion enzymes [59].
ExPEC individuality and virulence
There exists an enormous amount of genetic heterogeneity
among Eubacteria lineages. Genome sequencing and bioinfor-
matic analyses have underscored this extensively. Perhaps the most
intriguing aspect of this diversity is that even closely related
members of the same species can differ greatly with respect to their
gene contents. Strikingly, any two E. coli genomes can differ by up
to 20–30% of their respective gene contents—in sharp contrast to
the relatively minor difference of 1% that exists between, for
example, the mouse and human species [32,74]. Decades worth of
epidemiological and experimental studies have focused on the
identification of genes that define the pathogenic behavior of
ExPEC [7,32]. However, it appears that a single, ubiquitous
genetic identifier of ExPEC, such as a gene encoding a particular
toxin or adhesin, does not exist and, rather, what actually binds
these pathogens is more qualitative and multigenic in nature
[32,75].
In support of this view, we recently demonstrated that the toxin
a-hemolysin, shared among many ExPEC isolates, is differentially
required for virulence depending on strain background [40].
Similarly, we found that the pathogenicity of particular ExPEC
isolates depends on another toxin, cytotoxic necrotizing factor,
while other equally virulent strains naturally lack this gene.
Coupled with the work presented here, these observations suggest
that there exists a spectrum of only partially overlapping virulence
gene requirements among ExPEC, reflecting the idea that these
pathogens have emerged from distinct evolutionary trajectories
driven by LGT [76,77]. Accordingly, we found that the expression
of NeaT from plasmid pGEN-neaTPnative in other E. coli strains,
including Nissle 1917 (gut isolate), F11 (cystitis isolate), and S88
(meningitis isolate), did not augment virulence in the zebrafish
infection model (data not shown). These findings suggest that the
ability of a rare gene like neaT to affect fitness and virulence is
dependent upon the genetic background of individual bacterial
strains. The beneficial effects of neaT, and its potential to sweep
through bacterial populations, is therefore likely linked to the
presence, or coordinate acquisition, of other as-yet undefined
bacterial factor(s). The identification, characterization, and con-
tinued monitoring of rare genes like neaT will be important to our
understanding of ExPEC evolution. As a case in point, we note
that the sasX gene, originally defined as rare among strains of
methicillin resistant Staphylococcus aureus (MRSA), increased in
prevalence among MRSA isolates between 2003 and 2011 and is
now considered an emerging virulence determinant [78]. Inter-
estingly, like neaT, sasX is also maintained within a prophage and
can affect bacterial interactions with phagocytes. At this point, it is
difficult to predict if neaT will sweep ExPEC populations in the
future, but work presented here along with recent findings
concerning sasX underscore how laterally acquired genes can
alter the virulence potential of bacterial pathogens, continually
challenging the development of broad spectrum therapeutics.
Going forward, as we continue to characterize the composition
of pan-genomic elements of ExPEC and other pathogens, it will be
important to consider the evolutionary context of their virulence
genes. Identifying the spatial and temporal parameters that govern
the lateral acquisition of virulence genes from distant lineages will
need to be reconciled. Genome compatibility (codon and tRNA
usage) and ecology are thought to be influential in the success of
LGT events between bacteria [79,80,81]. In light of this, several
interesting questions arise. How did neaT come to be in the
proteobacterial gene pool? How does residence of neaT within a
prophage impact its evolution? What conditions fostered the
assimilation of neaT into the virulence regulon of its host? Using
neaT as a stepping-stone, it will be informative to resolve the
amount of strain-specific innovation that goes into producing and
fine-tuning pathogen genomes. By understanding the mechanisms
of chromosome assembly and the sources of individual genetic
components, unrealized patterns may emerge that could prove
useful for future diagnostics and disease mitigation.
Methods
Ethics statement
Animals used in this study were handled in accordance with
IACUC protocols approved at either the University of Utah or the
University of Michigan Medical School following standard
guidelines as described at www.zfin.org and in the Guide for the
Care and Use of Laboratory Animals, 8th Edition [55,82].
Bacterial strains and plasmids
All bacterial strains and plasmids used in this study are listed in
Table 3. Unless specified otherwise, bacteria were cultured
statically at 37uC for 24 h in 20 ml of a defined M9 minimal
medium (6 g/l Na2HPO4, 3 g/l KH2PO4, 1 g/l NH4Cl, 0.5 g/l
NaCl, 1 mM MgSO4, 0.1 mM CaCl2, 0.1% glucose, 0.0025%
nicotinic acid, 0.2% casein amino acids, and 16.5 mg/ml thiamine
in H2O). Antibiotics (kanamycin or ampicillin) were added to the
growth medium when necessary to maintain recombinant
plasmids or select for mutants.
Targeted gene knockouts were generated in the ExPEC isolate
CFT073 using the lambda Red-mediated linear transformation
system [83,84]. Briefly, a kanamycin resistance cassette was
amplified using polymerase chain reaction (PCR) from pKD4
with 40-base pair overhangs specific to the 59 and 39 ends of each
targeted locus. PCR products were introduced via electroporation
into CFT073 carrying pKM208, which encodes an IPTG
(isopropyl-b-D-thiogalactopyranoside)-inducible lambda red re-
combinase. Knockouts were confirmed by PCR. Primer sets used
are listed in Table S8.
Cloning and construction of neaT expression constructs were
done using standard molecular techniques employing the high-
retention plasmid pGEN-mcs [85]. For native regulation, neaT
(locus tag: c0970), plus 211 bp of upstream sequences, were
amplified from the chromosome of CFT073 and TA-cloned into
pCR2.1-TOPO vector per manufacture’s protocol (Invitrogen).
Subsequently, the cloned fragment was isolated using BamHI and
NotI restriction enzymes (New England Biosciences) and ligated
into pGEN-mcs using the same sites, yielding pGEN-neaTPnative.
For construction of pGEN-neaTPlac, a synthetic ribosome binding
sequence was introduced upstream of neaT within the 59 PCR
primer, and the resulting PCR product was ligated via an
engineered NdeI restriction site with the lac promoter amplified
from pGFPmut3.1 (Clonetech). The ligated Plac-neaT product was
amplified and TA-cloned into the pCR2.1-TOPO vector. Using
BamHI and NcoI restrictions sites, the Plac controlled neaT variant
was then sub-cloned into pGEN-mcs. All experiments involving
pGEN-neaTPlac were performed without IPTG induction. Primer
sequences used to generate these plasmids are listed in Table S8.
Zebrafish embryos
*AB wild-type zebrafish embryos were collected from a
laboratory-breeding colony that was maintained on a 14-h/10-h
light/dark cycle. Embryos were grown at 28.5uC in E3 medium
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(5 mM NaCl, 0.17 mM KCl, 0.4 mM CaCl2, 0.16 mM MgSO4)
containing 0.000016% methylene blue as an anti-fungal agent.
Infection of zebrafish embryos
One ml from each 24 h bacterial culture was pelleted, washed
once with 1 ml sterile PBS (Hyclone) and re-suspended in 1 ml
PBS to obtain appropriate bacterial densities for microinjection.
Prior to injection, 48 hpf embryos were manually dechorionated,
briefly anesthetized using 0.77 mM ethyl 3- aminobenzoate
methanesulfonate salt (tricaine) (Sigma-Aldrich), and embedded
in 0.8% low-melt agarose (MO BIO Laboratories) without
tricaine. Approximately 1 nl of bacteria was injected directly into
the pericardial cavity or the blood via the circulation valley located
ventral to the yolk sac using a YOU-1 micromanipulator
(Narishige), a Narishige IM-200 microinjector, and a JUN-AIR
model 3-compressor setup. For each experiment, average CFU
introduced per injection were determined by adding 10 drops of
each inoculum into 1 ml 0.7% NaCl, which was then serially
diluted and plated on Luria-Bertani (LB) agar plates. For co-
challenge experiments, input doses were plated on LB agar+/
2kanamycin (50 mg/ml) to determine relative numbers of the wild
type and mutant strains present. After injection, embryos were
carefully extracted from the agar and placed individually into wells
of a 96-well microtiter plate (Nunc) containing E3 medium lacking
both tricaine and methylene blue. For lethality assays, fish were
examined at indicated times over the course of a 48 or 72 h period
and scored for ‘‘death’’, defined here as the complete absence of
heart rhythm and blood flow. Survival graphs depict total pooled
results from two or more independent experiments in which
groups of 10 to 20 embryos were injected. To quantify bacterial
numbers during the course of co-challenge experiments, embryos
were homogenized at the indicated time points in 500 mL PBS
containing 0.5% Triton X-100 using a mechanical PRO 250
homogenizer (PRO Scientific). Homogenates were then serially
diluted and plated on LB agar+/2kanamycin (50 mg/ml) to
determine relative numbers of wild type and mutant bacteria.
Table 3. Bacterial strains and plasmids.
Strain or Plasmid Description Reference
E. coli
CFT073 ExPEC (urosepsis isolate, O6:K2:H1) [26]
Nissle 1917 Probiotic (gut isolate, O6:K5:H1) [86]
HS Commensal (gut isolate, O9) [87]
Plasmids
pKM208 Encodes IPTG-inducible lambda Red recombinase; Ampr [88]
pKD4 Template source for kanamycin resistance cassette;Kanr [84]
pGEN-mcs High retention vector with an empty multiple cloning site; Ampr [85]
pGEN-neaTPnative pGEN-mcs containing a natively controled neaT variant; Ampr This study
pGEN-neaTPlac pGEN-mcs containing a neaT variant constitutively expressed
from a leaky lac promoter; Ampr
This study
Recombinant strains
CFT073/pKM208 CFT073 with pKM208; Ampr This study
CFT073Dwb0847 CFT073 wb0847::kan [45], this study
CFT073D1–2 CFT073 1–2::kan (locus tags c0932 through c0945) This study
CFT073D2–3 CFT073 2–3::kan (locus tags c0946 through c0962) This study
CFT073D3–4 CFT073 3–4::kan (locus tags c0963 through c0978) This study
CFT073DneaT CFT073 neaT::kan (locus tag c0970) This study
CFT073DyfdK CFT073 yfdK::kan (locus tag c0969) This study
CFT073DFI-D CFT073 FI-D::kan (locus tags c0971 through c0978) This study
CFT073/pGEN-mcs CFT073 with pGEN-mcs (empty vector); Ampr This study
CFT073/pGEN-neaTPlac CFT073 with pGEN-neaTPlac; Ampr This study
CFT073DneaT/pGEN-mcs CFT073DneaT with pGEN-mcs (empty vector); Ampr, Kanr This study
CFT073DneaT/pGEN-neaTPnative CFT073DneaT with pGEN-neaTPnative; Ampr, Kanr This study
CFT073DneaT/pGEN-neaTPlac CFT073DneaT with pGEN-neaTPlac; Ampr, Kanr This study
CFT073Dwb0847/pGEN-mcs CFT073Dwb0847 with pGEN-mcs (empty vector); Ampr, Kanr This study
CFT073Dwb0847/pGEN-neaTPnative CFT073Dwb0847 with pGEN-neaTPnative; Ampr, Kanr This study
Nissle 1917/pGEN-mcs Nissle 1917 with pGEN-mcs (empty vector); Ampr This study
Nissle 1917/pGEN-neaTPnative Nissle 1917 with pGEN-neaTPnative; Ampr This study
Nissle 1917/pGEN-neaTPlac Nissle 1917 with pGEN-neaTPlac; Ampr This study
HS/pGEN-mcs HS with pGEN-mcs (empty vector); Ampr This study
HS/pGEN-neaTPnative HS with pGEN-neaTPnative; Ampr This study
HS/pGEN-neaTPlac HS with pGEN-neaTPlac; Ampr This study
doi:10.1371/journal.ppat.1003175.t003
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Mouse infections
For co-challenge during urinary tract infection, seven- to nine-
week old female CBA/J mice (Jackson Labs) mice were
anesthetized using isoflurane inhalation and inoculated via
transurethral catheterization with 50 ml of a 1:1 wild type to
mutant bacterial suspension containing a total of 107 bacteria
suspended in PBS. Bladders and kidneys were recovered 3 days
later and each was weighed and homogenized in 1 ml containing
0.025% Triton X-100. Homogenates were serially diluted and
plated on LB agar+/2kanamycin (50 mg/ml) to determine
number of both wild type and mutant bacteria. Mouse experi-
ments were repeated at least twice.
For systemic infections, female CBA/J mice (Jackson Labs) aged
6 to 8 weeks were restrained using a Universal Restrainer
(Braintree Scientific, Braintree, MA) and inoculated via the tail
vein over a 30 s period with a 100 ml bacterial suspension,
delivering 106 CFU/mouse. The inoculum was prepared by re-
suspending overnight cultures in PBS and diluting them to
16107 CFU/ml. For co-challenges, wild type and mutant
suspensions were mixed 1:1 before inoculation. Perfusion was
performed on euthanized animals by cutting a small hole in the
right cardiac ventricle and infusing the left ventricle slowly with
40 ml 0.9% sterile saline before organ removal. Blanching of the
organs occurred with the first 20 ml of sterile saline. Excised
spleens and livers were homogenized in 3 ml PBS using a
mechanical homogenizer (Omni International, Marietta, GA), and
homogenates were plated using an Autoplate 4000 (Spiral Biotech,
Norwood, MA) onto LB agar+/2kanamycin (50 mg/ml) to
differentiate wild type and mutant strains.
Statistical analysis of zebrafish and mouse infections
Kaplan-Meier survival and scatter plots were generated using
GraphPad Prism 5. For Kaplan-Meier survival plots (independent
challenges), the log-rank (Mantel-Cox) test was used to determine
statistical differences between datasets. For competitive assays (co-
challenges), numbers of wild type and mutant bacteria present in
the inoculum and recovered from host tissues were determined as
described above and a competitive index was calculated using the
following equation where wt represents numbers wild type
bacteria:
competitive index~
log10 mutant
input
!
wtinput
" #!
mutantoutput
!
wtoutput
" #$ %
Negative values obtained using the competitive index equation
indicate a reduction in mutant fitness. To determine statistical
significance, the Wilcoxon signed-rank test (with a hypothetical
value of 0) on log-transformed competitive index values was used
for co-challenges and the two-tailed Mann-Whitney statistical
analysis was performed to determine significant differences
between samples in non-competitive assays.
Bioinformatic analyses
Homology searches and phyletic enrichment of
homologue sets. A custom database of 165 genomes and
associated plasmids was assembled using the compilation of
protein coding genes (.faa files downloaded from ftp://ftp.ncbi.
nih.gov/genomes/Bacteria/) of each isolate listed in Table S3.
BLASTp (v. 2.2.20, [56]) was used to run bidirectional protein
alignments between the wb0847 genome and the database to
identify homologues. Two sequences were considered homologous
if they aligned along .50% of their lengths with an E value of
,1026. To identify phyletic enrichment, sets of non-paralogous
homologues for each wb0847 gene were analyzed for relative
contributions made by each phylum. Then, based on the number
genes in each homologue set, the same number of genomes was
randomly sampled from the genome list in Table S3. In this way,
we could determine the significance of the phyletic contributions
to each homologue set that was observed compared to a
theoretical random sampling. With custom software written in
Python using SciPy, p values were generated from a Z score.
Standard scores were calculated using the equation below, where x
is the observed proportion contributed by a single phylum, m is the
theoretical average contribution by the same phylum (n = 1000
random samplings), and s is the standard deviation: z = (x2m)/s
Sequences used for comparisons between the GC content of
neaT from CFT073 and homologues in other bacteria (see
Figure 6C) were retrieved manually from NCBI for downstream
analysis. Genome GC compositions were obtained from NCBI
Genomes (http://www.ncbi.nlm.nih.gov/genomes/MICROBES/
microbial_taxtree.html)
Nucleotide composition analysis. For nucleotide composi-
tion analysis, the nucleotide sequences of protein coding genes of
CFT073 (.ffn files downloaded from ftp://ftp.ncbi.nih.gov/
genomes/Bacteria/Escherichia_coli_CFT073_uid57915/) were
used to calculate codon deviation scores and GC content using
custom software written in Python with SciPy or NumPy. For
codon deviation scores, genome-wide protein coding nucleotide
sequences were analyzed for codon usage frequencies on a per
amino acid basis. The resulting table (Table S5) was then used to
determine differences between specific codon frequencies con-
tained within a particular gene and the genome-wide frequency.
The absolute values of differences in frequency were summed over
a single gene to obtain the final codon deviation score. Statistical
significance was determined by Z-score analysis using the genome-
wide mean codon deviation score and standard deviation. Table
S6 lists all deviation scores and p values for the CFT073 genome.
GC content of genes was determined by counting the proportion
of guanines and cytosines over the length of a given locus, and Z-
score analysis was again implemented to determine the position of
each gene within the genome-wide distribution (Table S7).
Supporting Information
Figure S1 Expression of the neaT gene in various
mutant backgrounds. RNA was extracted from the indicated
strains after overnight growth in M9 medium and used to generate
cDNA libraries by reverse transcription (+RT). To control for
genomic DNA contamination, a set of samples was prepared in
parallel without reverse transcriptase (2RT). Wild type CFT073,
CFT073DneaT, CFT073DyfdK, and CFT073DFI-D were used to
determine the relative expression levels of neaT in each genetic
background. Three mg of each cDNA library was used as a
template for PCR amplification (30 cycles) of an internal 218 bp
fragment of neaT. Equal amounts of each PCR reaction were
resolved using 1% agarose gels.
(TIF)
Figure S2 Determination of in vivo lateral transfer of
the neaT gene. Zebrafish were inoculated with a one-to-one
mixture of wt CFT073 and CFT073DneaT. Infections progressed
for ,12 h post-inoculation prior to homogenization and recovery
of bacteria by plating on LB agar+/2kanamycin. Bacterial
colonies recovered from 5 separate fish were used for colony
PCR to detect presence of either the kanamycin resistance gene
(lane 1 control, ,1,500 bp) or neaT (lane 2 control, 218 bp
internal fragment). No double positive colonies were detected.
Primers used to amplify the kanamycin gene are specific to the
Rare Gene Promotes Bacterial Virulence
PLOS Pathogens | www.plospathogens.org 13 February 2013 | Volume 9 | Issue 2 | e1003175
101 
 
priming regions of the pKD4 template plasmid. neaT was
amplified using neaT RT forward/reverse (Table S8).
(TIF)
Figure S3 Plasmid-based neaT expression analysis.
RNA was extracted from the indicated strains after overnight
growth in LB broth and used to generate cDNA libraries by
reverse transcription (+RT). To control for genomic DNA
contamination, a set of samples was prepared in parallel without
reverse transcriptase (2RT). Wild type (WT) CFT073 or HS were
used to reference basal neaT message levels. CFT073DneaT or
HS carrying pGEN-mcs (empty vector, EV), pGEN-neaTPnative
(native promoter, NP), or pGEN-neaTPlac (over-expressing, OE)
were used to determine the relative expression levels of pGEN-
neaT variants in each genetic background. Three mg of each
cDNA library was used as a template for PCR amplification (28
cycles) of an internal 218 bp fragment of neaT. Equal amounts of
each PCR reaction were resolved using 1% agarose gels. Graph
shows average levels of neaT transcripts 6 SD normalized to 16S
rRNA (not shown). Data are presented relative to WT CFT073,
n = 3.
(TIF)
Figure S4 Survey of clinical isolates for presence of the
neaT gene. Various clinical E. coli isolates were surveyed for
presence of the neaT gene using polymerase chain reaction.
Primers used in (A) amplified a 218 bp region internal to neaT
(Table S8). (B) Shows amplification of the 16s ribosomal RNA
gene as a control. Isolates are described as: strain (clinical disease
presentation).
(TIF)
Figure S5 neaT contributes to multicellular behaviors.
(A) Swarm motility of wild type (wt) CFT073 and its mutant
derivatives on 0.25% Eiken agar plates following overnight
incubation at 37uC. (B) Complementation of swarm defect of
CFT073DneaT by introduction of pGEN-neaTPlac. The empty
vector pGEN-mcs and pGEN-neaTPnative did not complement the
DneaT mutant. (C) Swim motility of indicated CFT073 derivatives
following incubations at 37uC for times indicated. Red arrows
indicate advancing swim fronts and insets show magnified bright
field images of the center region of each plate. (D) Images of single
Nissle 1917 colonies carrying pGEN-mcs or pGEN-neaTPlac grown
for 48 h at 37uC on agar plates containing 0.001% Congo red dye
to stain curli fibers. (E) Streaks of Nissle 1917 carrying pGEN-mcs,
pGEN-neaTPnative, or pGEN-neaTPlac grown overnight at 37uC on
1.2% LB agar containing 50 mg/ml Fluorescent Brightener 28 to
visulalize cellulose production. Image was captured under
ultraviolet light.
(TIF)
Figure S6 NeaT limits bacterial interactions with
murine macrophages. (Left) The indicated bacterial strains
were added to bone marrow derived macrophage (BMDM)
monolayers at a multiplicity of infection of 10. After a 1-h
incubation at 37C, total viable bacteria remaining in the wells
were enumerated. (Right) Alternatively, monolayers were washed
at the 1-h time point with PBS, prior to lysis, in order to determine
numbers of macrophage-associated bacteria. Bars represent the
means 6 SD of three independent experiments performed in
triplicate. *p,0.05, **p,0.01; as determined by Student’s t test.
(TIF)
Table S1 Summary of results obtained from initial GI
screen using different dose ranges.
(XLSX)
Table S2 Summary of inconclusive in vitro experi-
ments.
(XLSX)
Table S3 List of strains contained within the custom
165 genome database.
(XLSX)
Table S4 List of strains/genomes from the 165 genome
database that contain at least one neaT homologue.
(XLSX)
Table S5 Codon usage frequency for each amino acid
based on the 5,369 protein-coding genes of CFT073.
(XLSX)
Table S6 Codon deviation score for each gene in
CFT073.
(XLSX)
Table S7 GC content for each gene in CFT073.
(XLSX)
Table S8 Primers used in this study to generate
recombinant strains and plasmids.
(XLSX)
Text S1 Expression of NeaT may alter bacterial group
behavior.
(DOCX)
Text S2 Supporting methods used in Text S1, Figure S5
and S6.
(DOCX)
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Figure A.S1. Expression of the neaT gene in various mutant backgrounds. 
RNA was extracted from the indicated strains after overnight growth in M9 
medium and used to generate cDNA libraries by reverse transcription (+RT). To 
control for genomic DNA contamination, a set of samples was prepared in 
parallel without reverse transcriptase (−RT). Wild type CFT073, CFT073ΔneaT, 
CFT073ΔyfdK, and CFT073ΔFI-D were used to determine the relative 
expression levels of neaT in each genetic background. Three µg of each cDNA 
library was used as a template for PCR amplification (30 cycles) of an internal 
218 bp fragment of neaT. Equal amounts of each PCR reaction were resolved 
using 1% agarose gels. 
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Figure A.S2. Determination of in vivo lateral transfer of the neaT gene. Zebrafish 
were inoculated with a one-to-one mixture of wt CFT073 and CFT073ΔneaT. 
Infections progressed for ~12 h postinoculation prior to homogenization and 
recovery of bacteria by plating on LB agar+/−kanamycin. Bacterial colonies 
recovered from five separate fish were used for colony PCR to detect presence 
of either the kanamycin resistance gene (lane 1 control, ~1,500 bp) or neaT (lane 
2 control, 218 bp internal fragment). No double positive colonies were detected. 
Primers used to amplify the kanamycin gene are specific to the priming regions 
of the pKD4 template plasmid. neaT was amplified using neaT RT 
forward/reverse. 
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Figure A.S3. Plasmid-based neaT expression analysis. RNA was extracted from 
the indicated strains after overnight growth in LB broth and used to generate 
cDNA libraries by reverse transcription (+RT). To control for genomic DNA 
contamination, a set of samples was prepared in parallel without reverse 
transcriptase (−RT). Wild type (WT) CFT073 or HS were used to reference basal 
neaT message levels. CFT073ΔneaT or HS carrying pGEN-mcs (empty vector, 
EV), pGEN-neaTPnative (native promoter, NP), or pGEN-neaTPlac (over-
expressing, OE) were used to determine the relative expression levels of pGEN-
neaT variants in each genetic background. Three µg of each cDNA library was 
used as a template for PCR amplification (28 cycles) of an internal 218 bp 
fragment of neaT. Equal amounts of each PCR reaction were resolved using 1% 
agarose gels. Graph shows average levels of neaT transcripts ± SD normalized 
to 16S rRNA (not shown). Data are presented relative to WT CFT073, n = 3. 
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Figure A.S4. Survey of clinical isolates for presence of the neaT gene. 
Various clinical E. coli isolates were surveyed for presence of the neaT gene 
using polymerase chain reaction. Primers used in (A) amplified a 218 bp region 
internal to neaT. (B) Shows amplification of the 16s ribosomal RNA gene as a 
control. Isolates are described as: strain (clinical disease presentation). 
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Figure A.S5. neaT contributes to multicellular behaviors. (A) Swarm motility of 
wild type (wt) CFT073 and its mutant derivatives on 0.25% Eiken agar plates 
following overnight incubation at 37°C. (B) Complementation of 
CFT073ΔneaT by introduction of pGEN-neaTPlac. The empty vector pGEN-mcs 
and pGEN-neaTPnative did not complement the ΔneaT mutant. (C) Swim motility 
of indicated CFT073 derivatives following incubations at 37°C for times indicated. 
Red arrows indicate advancing swim fronts and insets show magnified bright field 
images of the center region of each plate. (D) Images of single Nissle 1917 
colonies carrying pGEN-mcs or pGEN-neaTPlac grown for 48 h at 37°C on agar 
plates containing 0.001% Congo red dye to stain curli fibers. (E) Streaks of 
Nissle 1917 carrying pGEN-mcs, pGEN-neaTPnative, or pGEN-neaTPlac grown 
overnight at 37°C on 1.2% LB agar containing 50 µg/ml Fluorescent Brightener 
28 to visulalize cellulose production. Image was captured under ultraviolet light. 
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Figure A.S6. NeaT limits bacterial interactions with murine macrophages. 
(Left) The indicated bacterial strains were added to bone marrow derived 
macrophage (BMDM) monolayers at a multiplicity of infection of 10. After a 1-h 
incubation at 37°C, total viable bacteria remaining in the wells were enumerated. 
(Right) Alternatively, monolayers were washed at the 1-h time point with PBS, 
prior to lysis, in order to determine numbers of macrophage-associated bacteria. 
Bars represent the means ± SD of three independent experiments performed in 
triplicate. *p<0.05, **p<0.01; as determined by Student's t test. 
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The Cpx Stress Response System Potentiates the Fitness and Virulence
of Uropathogenic Escherichia coli
Irina Debnath, J. Paul Norton, Amelia E. Barber, Elizabeth M. Ott, Bijaya K. Dhakal, Richard R. Kulesus, Matthew A. Mulvey
Division of Microbiology and Immunology, Pathology Department, University of Utah, Salt Lake City, Utah, USA
Strains of uropathogenic Escherichia coli (UPEC) are the primary cause of urinary tract infections, representing one of the most
widespread and successful groups of pathogens on the planet. To colonize and persist within the urinary tract, UPECmust be
able to sense and respond appropriately to environmental stresses, many of which can compromise the bacterial envelope. The
Cpx two-component envelope stress response system is comprised of the inner membrane histidine kinase CpxA, the cytosolic
response regulator CpxR, and the periplasmic auxiliary factor CpxP. Here, by using deletion mutants along with mouse and ze-
brafish infectionmodels, we show that the Cpx system is critical to the fitness and virulence of two reference UPEC strains, the
cystitis isolate UTI89 and the urosepsis isolate CFT073. Specifically, deletion of the cpxRA operon impaired the ability of UTI89
to colonize the murine bladder and greatly reduced the virulence of CFT073 during both systemic and localized infections within
zebrafish embryos. These defects coincided with diminished host cell invasion by UTI89 and increased sensitivity of both strains
to complement-mediated killing and the aminoglycoside antibiotic amikacin. Results obtained with the cpxP deletion mutants
were more complicated, indicating variable strain-dependent and niche-specific requirements for this well-conserved auxiliary
factor.
Urinary tract infections (UTIs) afflict a large proportion of thehuman population, representing an enormous health and fi-
nancial burden worldwide (1). Most UTIs are caused by a geneti-
cally diverse group of bacteria known as uropathogenic Esche-
richia coli (UPEC). These pathogens can survive and grow within
urine and the lumen of the bladder, but many can also bind and
invade uroepithelial cells (2–4). Within the bladder, entry into
uroepithelial cells can promote UPEC survival and persistence,
rendering the pathogens protected from a variety of stresses and
commonly used antibiotics (3, 5, 6). Prior to introduction into the
urinary tract, UPEC likely first colonizes the host nasopharynx
and gastrointestinal tract, where it does not appear to elicit any
overt pathology (7–9). Within these varied host environments,
and while in transit between hosts, UPEC will encounter an as-
sorted array of stresses, including reactive nitrogen and oxygen
species, nutrient limitation, shearing forces, professional phago-
cytes, complement and other antimicrobial compounds, compe-
tition with other microbes and, potentially, antibiotics (10–15).
The ability to deal with these stresses is of paramount importance
to the success of UPEC as a pathogen.
The envelope of Gram-negative bacteria interfaces with the
extracellular environment, functioning as both a sensor of exter-
nal conditions and as a selectively permeable physical barrier. En-
velope stress response pathways are likely critical to the ability of
UPEC to detect and respond to potentially fatal environmental
insults during the course of infection.UPEC, aswell as otherE. coli
strains, encode a number of envelope stress response systems, in-
cluding sigma E (!E), Rcs, Psp, and the BaeSR and CpxRA two-
component systems (16–19). The Cpx system is comprised of the
inner membrane histidine kinase CpxA and the cytoplasmic re-
sponse regulator CpxR (20–22). Autophosphorylation of CpxA in
response to envelope stress results in the phosphorylation of
CpxR, which then functions as a transcriptional regulator. CpxR
controls the expression of protein folding and degrading factors
involved in relieving envelope stress and can also regulate biofilm
formation (23–26), bacterial adherence (23, 27, 28), motility and
chemotaxis (29, 30), type III and type IV secretion systems (31–
35) and, possibly, the synthesis of bacterial toxins (27, 36, 37).
Studies using E. coli K-12 strains like MG1655 and MC4100 have
indicated that CpxR may regulate the expression of well over 100
genes (38, 39).
In E. coli and other microbes, the Cpx system is subject to
negative feedback through CpxP, a small CpxR-regulated
periplasmic protein that can bind the sensor kinase CpxA, keeping
it in an inactive state (40, 41). CpxR binding sites are situated
upstream of the cpxP gene within a conserved 146-bp region that
separates cpxP from the cpxRA operon. CpxP is the most highly
inducible member of the Cpx regulon so far identified, and it has
elevated expression in response to both envelope stress and entry
into stationary-phase growth (40, 42). In addition to its role as a
negative regulator of CpxA, CpxP also functions as an adaptor
protein, interacting with subsets of misfolded periplasmic pro-
teins and delivering them to the protease DegP for degradation
(43, 44). In this process, CpxP is degraded alongwith itsmisfolded
substrate, suggesting a mechanism by which bacteria can post-
translationally modulate CpxP levels. By varying the amounts of
CpxP within the periplasm, bacteria may be able to fine-tune the
Cpx stress response, limiting inappropriate activation of CpxA in
the absence of envelope stress and permitting rapid shutoff of the
system once the stress is under control (20, 45).
The Cpx system appears to have a key role in regulating the
virulence potential of a number of pathogens (17), including Sal-
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monella spp. (46, 47), Legionella pneumophila (31, 48), Shigella
spp. (33–35), enteropathogenic E. coli (32, 49, 50), Actinobacillus
suis (51),Haemophilus ducreyi (52, 53), Xenorhabdus nematophila
(37, 54), and Yersinia pseudotuberculosis (55–57). However, direct
evidence that the Cpx system can affect pathogen fitness and vir-
ulence in vivowithin an animal host is limited to only a few studies
(47, 50, 53, 54). In UPEC, the Cpx system has been examined
primarily with respect to its ability tomodulate the expression of P
pili, filamentous adhesive organelles that can promote bacterial
interactions with host kidney cells (27, 28, 58). Here, by using
isogenic deletion mutants, we assessed how components of the
Cpx stress response system affect the fitness and virulence of two
referenceUPEC isolates. Employing in vitro assays coupledwith in
vivo mouse and zebrafish infection models, we demonstrate that
cpxP and cpxRA can have profound and sometimes divergent ef-
fects on the pathogenic potential of UPEC.
MATERIALS AND METHODS
Bacterial strains andplasmids.The bacterial strains and plasmids used in
this study are listed in Table 1. Targeted gene knockouts were created in
the human cystitis isolate UTI89 and the urosepsis isolate CFT073 by
using lambda Red-based homologous recombination as previously de-
scribed (59, 60). Briefly, the chloramphenicol resistance cassette (clmr)
was amplified from the template plasmid pKD3with flanking 40-bp over-
hangs specific for the target cpxP or cpxRA loci. PCR products were elec-
troporated into UTI89 and CFT073 carrying the plasmid pKM208, which
encodes an isopropyl-!-D-thiogalactopyranoside (IPTG)-inducible
lambda Red recombinase. The yiiP (fieF) gene was knocked out by using a
similar approach. Knockout strains were selected on Luria-Bertani (LB)
agar plates containing chloramphenicol (20 "g/ml) and verified by PCR
using the primers listed in Table 2.
Expression constructs were made using the low-copy-number plas-
mid pGEN-MCS and standard molecular biology techniques (61). The
cpxP gene and the cpxRA operon were cloned by PCR from the UTI89
chromosome. The primers used (Table 2) to amplify each locus were
designed to include 250 bp of upstream and 100 bp of downstream se-
quences, along with terminal PstI and SalI restriction sites. PCR products
were cut using PstI and SalI and ligated into pGEN-MCS to create the
CpxP andCpxRA expression constructs pJLJ41p and pJLJ42, respectively.
TABLE 1 Bacterial strains and plasmids
Strain or plasmid Description
Source or
reference(s)
Wild-type strains
UTI89 UPEC, cystitis isolate (O18:K1:H7) 6, 95
CFT073 Urosepsis isolate (O6:K2:H1) 96
Recombinant strains
UTI89#cpxP UTI89 #cpxP::clmr This study
UTI89#cpxRA UTI89 #cpxRA::clmr This study
UTI89#fieF UTI89 #fieF::clmr This study
CFT073#cpxP CFT073 #cpxP::clmr This study
CFT073#cpxRA CFT073 #cpxRA::clmr This study
CFT073#fieF CFT073 #fieF::clmr This study
Plasmids
pKM208 IPTG-inducible Red recombinase expression plasmid, Ampr 60
pGEN-MCS High-retention plasmid containing empty multiple-cloning site, Ampr 61
pJLJ41p cpxP sequence with native promoter from UTI89 cloned into pGEN-MCS; Ampr This study
pJLJ42 cpxRA sequence with native promoter from UTI89 cloned into pGEN-MCS; Ampr This study
pNLP10-lux Low-copy-number cloning vector with promoterless luxCDABE operon; Kanr 39
pJW1-cpxP-lux pNLP10 with PcpxP::luxCDABE, Kanr 39
TABLE 2 Primers used in this studya
Primer Sequence (5=–3=)
cpxP KO
Forward ATGCGCATAGTTACCGCTGCCGTCATGGCCT
CAACGCTGGGTGTAGGCTGGAGCTGCTTC
Reverse CTACTGGGAACGTGAGTTGCTACTACTCAATA
GCTTCAACCATATGAATATCCTCCTTAG
cpxP confirmation
Forward CTATCGTTGAATCGCGACAG
Reverse GGATGGTGTCTATGGCAAGG
cpxRA KO
Forward ATGAATAAAATCCTGTTAGTTGATGATGACC
GAGAGCTGGTGTAGGCTGGAGCTGCTTC
Reverse TTAACTCCGCTTATACAGCGGCAACCAAATC
ACCAGCCGTCATATGAATATCCTCCTTAG
cpxRA confirmation
Forward ACTGCCAGCGTTGAGGCCATGA
Reverse GAGTGTAGGCCTGATAAGACGCTATCAGC
fieF KO
Forward ATGAATCAATCTTATGGACGGCTGGTCAGTC
GGGCGGCTGTGTAGGCTGGAGCTGCTTCG
Reverse TTATGAAAGCATAGACCGTTTACCCTCCCTG
GGTACGACGCATATGAATATCCTCCTTAG
fieF confirmation
Forward CCTTGCCATAGACACCATC
Reverse TCAGGTCAGGCCAAATGG
pJLJ41p
Forward (PstI) AATCCTGCAGATTGTTTAAATACCTCCGAGGC
Reverse (SalI) TAGAGTCGACTACCAGCGCGGCGAGAATAC
pJLJ42
Forward (PstI) TGCTCTGCAGTCATTTGCTCCCAAAATCTTTCT
Reverse (SalI) GCTAGTCGACAGCGGCAAGATCGAAGATTTTT
a Added restriction sites underlined. KO, knockout.
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Growth curves. Bacteria were grown from frozen stocks at 37°C with
shaking overnight in 5 ml of LB broth or modified M9 minimal medium
(6 g/liter Na2HPO4, 3 g/liter KH2PO4, 1 g/liter NH4Cl, 0.5 g/liter NaCl, 1
mM MgSO4, 0.1 mM CaCl2, 0.1% glucose, 0.0025% nicotinic acid, 16.5
!g/ml thiamine, and 0.2% casein amino acids). Cultures were then di-
luted 1:100 into the indicated medium, and the growth of quadruplicate
200-!l samples in shaking 100-well honeycomb plates at 37°C was as-
sessed using a Bioscreen C instrument (Growth Curves USA). For com-
petition assays, wild-type and mutant strains diluted 1:200 were mixed at
a 1-to-1 ratio in 5 ml modified M9 medium and grown with shaking at
37°C. After 2, 4, and 6 h of growth, titers of the mutant and wild-type
strains were determined by plating serial dilutions on LB agar with or
without chloramphenicol (to distinguish wild-type and mutant strains).
Competitive indices were calculated as follows: log10[(mutantoutput/wild-
typeoutput)/(mutantinput/wild-typeinput)]. Media and other reagents used
in these assays were purchased from Sigma-Aldrich.
Amikacin susceptibility assays. Bacteria were grown from frozen
stocks with shaking at 37°C in 5mlmodifiedM9mediumwith or without
100 !g/ml ampicillin (used to maintain plasmids). Overnight cultures
were diluted 1:100 into 1mlmodifiedM9mediumcontaining amikacin at
concentrations ranging from 1 to 40 !g/ml. Each culture was then grown
with shaking at 37°C for 24 h. The MIC of each strain was determined as
the lowest concentration of amikacin needed to prevent growth.
cpxP promoter activity assays. Bacteria carrying pNLP10-lux or
pJW1-cpxP-luxwere grown from frozen stocks at 37°Cwith shaking over-
night in 5mlmodifiedM9medium containing 50!g/ml kanamycin (39).
Overnight cultures were diluted 1:100 into 5 ml modified M9 medium
containing 50!g/ml kanamycin and incubated with shaking at 37°C for 4
h to reach stationary phase (optical density at 600 nm, "1.0). Triplicate
100-!l aliquots of each sample were then transferred into a 96-well white,
opaque-walled polystyrene microplate (Dynex Technologies), and lumi-
nescence was measured immediately with a Synergy HT multidetection
microplate reader (BioTek Instruments, Inc.).
Hemagglutination assays. Hemagglutination titers were determined
using guinea pig red blood cells (Colorado SerumCompany) as described
previously (62). Bacteria used in these assays were grown statically from
frozen stocks in 20mlmodifiedM9medium or LB broth for 48 h at 37°C.
MouseUTImodel. Seven- to 8-week-old female CBA/Jmice (Jackson
Laboratory) were used, following IACUC-approved protocols as previ-
ously described (5, 63, 64). Wild-type and mutant bacterial strains were
grown from frozen stocks in 20ml static modifiedM9medium for 24 h at
37°C. Prior to inoculation, bacteria were pelleted by centrifugation for 10
min at 8,000 # g and then resuspended in phosphate-buffered saline
(PBS). Mice were anesthetized by using isoflurane inhalation and care-
fully inoculated by transurethral catheterization with 50 !l of a bacterial
suspension containing 1 # 107 CFU. For competitive assays, wild-type
UTI89 was mixed 1:1 with either the $cpxP or $cpxRA mutant prior to
inoculation. For noncompetitive assays, each strain was inoculated sepa-
rately. Bladders were harvested aseptically at 3 days postinoculation,
weighed, and homogenized in sterile PBS containing 0.02%TritonX-100.
Bacterial titers present in the input pools and in the bladder homogenates
were determined by plating serial dilutions on LB agar plates. For com-
petitive assays, LB agar plates with or without chloramphenicol (20 !g/
ml) were used to distinguish the wild-type and mutant strains. Competi-
tive indices were calculated as follows: log10[(mutant CFU inoculated/
wild-type CFU inoculated)/(mutant CFU recovered/wild-type CFU
recovered)]; based on this equation, values of less than 0 indicated that the
wild-type strain outcompeted the mutant. Experiments were repeated
two to three times, and combined data are shown.
Zebrafish infections. Zebrafish used in this study were handled in
accordancewith IACUC-approved protocols and following standard pro-
cedures (www.zfin.org), as previously described (65). *AB zebrafish em-
bryos were collected from mixed egg clutches in a breeding colony that
was maintained on a 14-h light/10-h dark cycle. Embryos were grown at
28.5°C in E3 medium (5 mM NaCl, 0.27 mM KCl, 0.4 mM CaCl2, 0.16
mM MgSO4) containing 0.000016% methylene blue as an antifungal
agent. At 48 h postfertilization (hpf), embryos were manually dechori-
anated, briefly anesthetized with 0.77 mM ethyl 3-aminobenzoate
methanesulfonate salt (Tricaine; Sigma-Aldrich), and embedded in low-
melting-point agarose (Mo Bio Laboratories) without Tricaine. Agarose-
embedded embryos were then transferred to E3 medium lacking methyl-
ene blue and infected individually with wild-type CFT073 or the cpx
mutants. Bacteria were grown from frozen stocks, held static in 12 ml
modified M9 medium at 37°C for 24 h. One milliliter from each culture
was pelleted, washed once with 1ml PBS, and resuspended in PBS prior to
inoculation into either the pericardial cavity or circulation valley by using
an Olympus SZ61 or SZX10 stereomicroscope together with a YOU-1
micromanipulator (Narishige), a Narishige IM-200 microinjector, and a
JUN-AIR model 3 compressor setup. For each bacterial strain, 500 to
1,000 CFU suspended in 1 nl PBS was injected per fish. Inoculation titers
were determined by adding 10 drops (1 nl each) to 1ml 0.7%NaCl, which
was then serially diluted and plated on LB agar plates. Following injection,
embryos were carefully removed from the agar, placed individually into
wells of a 48-well plate (Nunc) containing E3 medium, and incubated at
28.5°C. Fish viability was assessed at regular intervals for 72 h following
injection by monitoring heart beats and blood flow.
Bacterial host cell association and invasion assays.Host cell associ-
ation and gentamicin protection-based invasion assays were performed as
previously described (66, 67). Strains used in these assays were grown at
37°C for 48 h in static LB broth to induce expression of type 1 pili. Human
bladder epithelial cells, designated 5637 (HTB-9; ATCC), were grown at
37°C in 5% CO2 using RPMI 1640 medium (Invitrogen) supplemented
with 10% heat-inactivated fetal bovine serum (HyClone). Bladder cells
were infected with amultiplicity of infection of%15 bacteria per host cell.
Serum resistance assays. Frozen aliquots of pooled human sera, taken
from 7 healthy volunteers by using standard protocols approved by the
University of Utah Institutional Review Board, were provided by Andrew
Weyrich. Care was taken to not freeze and thaw samples multiple times.
Bacteria from overnight cultures grown with shaking at 37°C in modified
M9 medium were pelleted by spinning at 8,000 # g for 5 min, washed
twice, and resuspended in PBS to obtain %1 # 106 CFU/ml. About 5 #
104 CFUof each bacterial strain wasmixed individually withmodifiedM9
medium containing 20% serum, and 200-!l aliquots of each suspension
were immediately placed in a 96-well microtiter plate and incubated with
gentle shaking for 2.5 h at 37°C. Plates were then placed on ice, and sur-
viving bacteria were enumerated by plating serial dilutions on LB agar.
Results were normalized to input titers. Heat-inactivated serum (treated
at 55°C for 30 min) was used as a negative control.
Statistical analysis. The Mann-Whitney U test, Wilcoxon matched
pair test, log-rank (Mantel-Cox) test, and Student’s t test were performed
using Prism 5.01 software (GraphPad Software). P values of less than 0.05
were defined as significant.
RESULTS
TheCpx systemmodulates UPEC resistance to amikacin.By us-
ing lambda Red-mediated linear recombination, the cpxRA
operon and the cpxP gene were individually deleted from two
reference UPEC strains, the cystitis isolate UTI89 and the urosep-
sis isolate CFT073. As the first step in our efforts to phenotypically
characterize these mutants, we assessed their sensitivities to the
aminoglycoside antibiotic amikacin. Previous studies showed that
laboratory K-12 E. coli strains lacking cpxA or cpxRA have in-
creased sensitivity to amikacin, whereas induction of the Cpx
pathway or the expression of constitutively active cpxA mutants
(cpxA*) provides strains with improved resistance to amikacin
(68–70). Resistance has been attributed to the ability of the Cpx
system to activate transcription of drug exporters as well as factors
that help alleviate the stress of mistranslated proteins that may
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accumulate within the bacterial envelope due to amikacin effects
on ribosome activity (25, 70, 71).
In agreement with results obtained using K-12 strains (68, 69),
we observed that both UTI89!cpxRA and CFT073!cpxRA were
highly sensitive to amikacin relative to their wild-type counter-
parts, as determined by MIC assays (Table 3). Plasmid pJLJ42,
which carries the cpxRA operon under the control of its native
promoter, complemented both !cpxRA mutants, whereas the
empty vector pGEN-MCS had no effect (Table 3 and unpublished
observations). Deletion of cpxP, which leaves CpxA less repressed
(40, 45), rendered UTI89 and CFT073 notably more resistant to
amikacin (Table 3). Expression of recombinant cpxP using plas-
mid pJLJ41 restored the resistance of the !cpxPmutants to wild-
type levels. Of note, deletion of the gene yiiP (fieF) located imme-
diately downstream of cpxP did not affect the sensitivity of either
UTI89 or CFT073 to amikacin (unpublished observations).
These results indicate that the Cpx response in the UPEC iso-
lates operates, not unexpectedly, similarly to the Cpx response in
K-12 strains. To further address this point, we utilized a low-copy-
number reporter construct containing the cpxP promoter fused to
a promoterless luxCDABE operon (39). In both CFT073 and
UTI89, the deletion of cpxRA ablated expression of the cpxP re-
porter in early-stationary-phase cultures, whereas deletion of cpxP
greatly enhanced expression (Fig. 1). These data parallel those
reported for similar assays carried out with K-12 strains, support-
ingmodels in whichCpxP functions in part as a negative regulator
of Cpx activation (40, 45).
The Cpx system provides UPEC with a fitness advantage
within the bladder.To address whether or not theCpx system can
affect the fitness of UPEC within the urinary tract, we utilized a
well-established UTI model system, focusing on bladder coloni-
zation by the cystitis isolate UTI89. Adult female CBA/Jmice were
inoculated via transurethral catheterization with wild-type
UTI89, UTI89!cpxRA or UTI89!cpxP, and 3 days later bacterial
titers within the bladder were determined. In noncompetitive as-
says, in which equal numbers of the wild-type and mutant strains
were inoculated separately into different mice, the !cpxRA mu-
tant was recovered in significantly lower numbers than wild-type
UTI89 (Fig. 2A). In contrast, no significant difference was ob-
served between wild-type UTI89 and the !cpxP mutant. Similar
results were obtained in competitive assays, inwhich thewild-type
strain was mixed 1:1 with each mutant strain prior to inoculation
(Fig. 2B and C). These results indicated that cpxRA, but not cpxP,
is required by UTI89 to effectively colonize the bladder.
During the course of a UTI, UPEC comes across a variety of
environmental stresses that can potentially limit its survival and
growth within the host (10–15). These stresses include reactive
nitrogen and oxygen radicals and numerous membrane-damag-
ing substances. In LB broth andmodifiedM9medium, the cpxRA
and cpxP deletion mutants grew normally, whether on their own
inmonoculture or in direct competitionwith thewild-type strains
(Fig. 3). Likewise, no defects were observed with the !cpxRA or
!cpxPmutants when challenged in vitro with nitrosative stress (1
mM acidified sodium nitrite), oxidative stress (0.5 or 1 Mmethyl
viologen), or envelope stress generated by addition of 0.1% so-
dium dodecyl sulfate (unpublished observations). These findings
indicate that deletion of cpxRA or cpxP does not alter the ability of
UPEC to handle generalized stresses.
Divergent effects of the Cpx system on host cell invasion by
UPEC. Effective colonization of the bladder by UPEC generally
requires the expression of functional type 1 pili (63, 72–75). These
filamentous adhesive organelles mediate bacterial attachment to
and invasion of bladder epithelial cells, promoting the establish-
FIG 1 Deletion of cpxP enhances Cpx activation in both CFT073 and UTI89.
Graphs indicate expression levels (" standard deviations) of the luxCDABE
operon driven by the cpxP promoter in wild-type UTI89 (A) and wild-type
CFT073 (B) and their mutant derivatives, following growth to early stationary
phase inmodifiedM9medium.The pNLP1-luxplasmid carries a promoterless
luxCDABE operon. Each graph shows the means " standard errors of the
means of three independent experiments performed in triplicate.
TABLE 3 Amikacin MIC assay resultsa
Strain MIC (#g/ml)
UTI89 18
UTI89!cpxRA 6
UTI89!cpxP 28
UTI89(pGEN-MCS) 16
UTI89!cpxRA(pJLJ42) 30
UTI89!cpxP(pJLJ41p) 18
CFT073 20
CFT073!cpxRA 6
CFT073!cpxP 30
CFT073(pGEN-MCS) 20
CFT073!cpxRA(pJLJ42) 16
CFT073!cpxP(pJLJ41p) 20
a The assay was repeated three times and the same results were obtained.
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ment and persistence of UPEC within the urinary tract (5, 6, 63,
76). In yeast agglutination assays, as well as hemagglutination as-
says performed using guinea pig red blood cells, we observed no
overt differences in the expression of type 1 pili by the !cpxRA or
!cpxP mutants relative to the wild-type UPEC isolates (unpub-
lished observations). However, UTI89!cpxRA did show a slight,
but significant ("20%), decrease in its ability to adhere to human
bladder epithelial cells in culture (Fig. 4A). This reduction in ad-
herence corresponded with a similar ("30%) decrease in host cell
invasion by UTI89!cpxRA, as determined in gentamicin protec-
tion assays (Fig. 4B). These modest defects in host cell adherence
and invasion could be rescued by complementation of the!cpxRA
mutant with pJLJ42. In contrast to UTI89!cpxRA, the!cpxPmu-
tant had no defect in its ability to bind bladder epithelial cells (Fig.
4A), but it was able to invade the host cells at a much higher
frequency than either wild-type UTI89 or the !cpxRA mutant
(Fig. 4B). Complementation of UTI89!cpxPwith pJLJ42 reduced
the invasion frequencies of thismutant towild-type levels. Impor-
tantly, wild-type UTI89 and the!cpxRA and!cpxPmutants grew
similarly in the cell culture medium, and all three strains were
equally susceptible to killing by gentamicin at the concentration
(100 #g/ml) used in these invasion assays.
Cpx components promote UPEC virulence in zebrafish. To
assess effects of theCpx systemonUPECvirulence, and not fitness
per se, we next focused on CFT073 in a zebrafish infection model
that was recently developed in our laboratory (65). In this model
system, bacteria are microinjected into 48-hpf zebrafish embryos
via either a fluid-filled sac surrounding the heart, known as the
pericardial cavity (PC), or directly into the bloodstream through
the circulation valley. UPEC does not usually spread from the PC,
whereas the pathogens rapidly disseminate systemically following
inoculation of the bloodstream.At 48 hpf, zebrafish are dependent
upon innate host defenses that include phagocytes, antimicrobial
peptides, and complement—the same sort of defenses that mam-
malian hosts employ against UPEC (77–81). The use of zebrafish
has proven to be an effective way to identify and functionally
define virulence factors of relevance to UPEC and related patho-
gens that can colonize an assorted array of hosts and host tissues
(unpublished observations and references 65 and 82).
Relative to UTI89 and many other UPEC isolates, CFT073 is
especially lethal to zebrafish embryos (65). Here, we compared
the lethality of wild-type CFT073 to CFT073!cpxRA and
CFT073!cpxP following inoculation of 500 to 1,000 CFU of
each strain individually into the PC or blood. In this infection
model, increased bacterial growth correlates with decreased
host survival (65). Wild-type CFT073 killed most of the ze-
brafish embryos within 24 h, irrespective of the site of inocu-
lation (Fig. 5). In comparison to the wild-type strain, the viru-
lence of both the !cpxRA and !cpxP mutants was significantly
decreased. Virulence defects associated with CFT073!cpxRA
and CFT073!cpxP were particularly evident following inocu-
lation of the blood (Fig. 5B), which in general appears to be a
more challenging and stressful environment than the PC (65).
Wild-type CFT073 and the !cpxRA and !cpxP mutants grew
similarly in modified M9 minimal medium at 28.5°C, the tem-
perature at which the zebrafish embryos are maintained. Plas-
mid pJLJ42 (cpxRA) and pJLJ41 (cpxP) rescued the virulence
defects associated with CFT073!cpxRA and CFT073!cpxP, re-
spectively, but the wild-type strain carrying empty vector was
attenuated, complicating interpretation of our in vivo comple-
mentation assays (unpublished observations).
Strain-dependent effects ofCpx components on serumresis-
tance.Urine, like serum, contains numerous antibacterial factors,
including heat-labile components of the complement system that
can mediate bacterial opsonization and the formation of mem-
brane attack complexes (14, 83–85). By modulating the composi-
tion and resilience of the bacterial envelope, we hypothesized that
FIG 2 The Cpx system promotes UPEC fitness within the bladder. Adult
female CBA/J mice were infected via catheterization with wild-type UTI89,
UTI89!cpxP, orUTI89!cpxRA in noncompetitive (A) and competitive (B and
C) assays. Graphs show bacterial titers present in the bladder at 3 days postin-
oculation. Bars denote median values for each group (n! 12 mice). The data
in panel B are graphed in panel C as competitive indices. P values were deter-
mined using the Mann-Whitney U test (A) or Wilcoxon-matched paired
signed rank test (B). ns, no significant difference.
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the Cpx system can alter the sensitivity of UPEC to serum com-
ponents. To examine this possibility, serum resistance assays were
performed using wild-type UTI89 and CFT073 along with the
!cpxRA and !cpxPmutants. In these assays, both UTI89!cpxRA
and CFT073!cpxRA were significantly more sensitive to pooled
human sera than their wild-type counterparts (Fig. 6A).
UTI89!cpxP was likewise sensitive, whereas CFT073!cpxP
showed no decrease in serum resistance relative to wild-type
CFT073. Serum resistance defects associated with UTI89!cpxRA,
CFT073!cpxRA, and UTI89!cpxP were rescued by plasmids car-
rying CpxRA (pJLJ42) or CpxP (pJLJ41), as appropriate (Fig. 6B).
In assays that used heat-inactivated serum, which lacks functional
complement, no differences were observed between the wild-type
and mutant strains (Fig. 6C). Together, these data indicate that
CpxRA, with strain-dependent input from CpxP, can enhance
UPEC resistance to serum and, specifically, complement.
DISCUSSION
This study was aimed at delineating the impact of the Cpx enve-
lope stress response system on the fitness and virulence of UPEC.
Our results demonstrated that CpxRA and the auxiliary factor
CpxP can affect the ability of UPEC to colonize distinct host en-
vironments. Employing a well-established mouse UTI model, we
found that deletion of cpxRA limited the ability of the reference
cystitis isolate UTI89 to effectively colonize the bladder, whereas
deletion of cpxP had onlymodest effects. In laboratory K-12 E. coli
strains, CpxP is not an essential regulator of the Cpx system, and
instead it appears tomodulate how quickly CpxA can be activated
or inactivated in response to changing levels of envelope stress (20,
40, 43, 45). Within the bladder, the regulatory effects of CpxP are
apparently dispensable to UTI89, at least at the 3-day time point
that was analyzed. In contrast, deletion of either cpxRA or cpxP
markedly attenuated the virulence of the urosepsis isolate CFT073
during both localized and systemic infections in zebrafish em-
bryos. These data suggest that CpxP is differentially required by
UPEC, depending upon strain background and the host environ-
ment. This idea was further supported by in vitro assays that
showed that the resistance of UTI89 to complement-mediated
killingwas dependent uponbothCpxRAandCpxP,while CFT073
required only CpxRA.
The Cpx system is intercalated within a complex web of signal-
ing cascades and linked up with multiple biosynthetic and meta-
bolic pathways (25, 38, 39, 41, 45, 86–88), making it difficult to
FIG 3 CFT073 andUTI89mutants lacking either cpxP or cpxRA grow normally in LB broth andmodifiedM9medim. (A and B)Growth of wild-typeUTI89 and
associated!cpxP and!cpxRAmutants grown in LB broth (A) andmodifiedM9medium (B). Graphs are representative of at least three independent experiments
performed in quadruplicate. (C to F) Results of competitive growth assays carried out inmodifiedM9mediumwithwild-typeCFT073 andUTI89 versus isogenic
!cpxRA or !cpxP mutants, as indicated. Data are presented as box-and-whiskers plots, with means " the minimum and maximum values from three
independent experiments.
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discern with clarity the specific mechanisms by which Cpx com-
ponents moderate UPEC stress resistance and virulence pheno-
types. It is clear, however, that basic regulation of the Cpx system
in UPEC functions similarly to the Cpx system in nonpathogenic
K-12 E. coli strains. In K-12 strains, CpxP regulates Cpx activation
via a negative feedback loop (40), and this also appears to be the
case in UPEC (Fig. 1). Furthermore, deletion of cpxRA rendered
both UTI89 and CFT073 highly sensitive to the aminoglycoside
amikacin (at 3!g/ml), whereas deletion of cpxP increased amika-
cin resistance. These data are in agreement with work carried out
in K-12 strains (68–70) and support the notion that activation of
the Cpx system safeguards against aminoglycoside antibiotics.
Protection is likely afforded by Cpx-mediated upregulation of
proteases and other factors that alleviate envelope stress initiated
by the mistranslation of inner membrane proteins in the presence
of amikacin (70). Cpx activation may also heighten bacterial re-
sistance to antibiotics via effects on the expression of drug trans-
porters (25, 71).
The protective effects of Cpx activation are limited andwill not
shield against all concentrations and types of antibiotics, includ-
ing the aminoglycoside gentamicin, used in our host cell invasion
assays (70). This means that the slight but significant decrease in
host cell invasion by UTI89"cpxRA and the elevated invasion fre-
quencies seenwithUTI89"cpxP are likely not attributable to Cpx-
regulated effects on the susceptibility of UTI89 to gentamicin.
Instead, the Cpx system may affect bacterial survival during or
immediately after internalization or, alternatively, modulate the
efficacy of the invasion process directly by affecting the surface
characteristics of UPEC. The latter possibility is buoyed indirectly
by observations showing that disruption of the Cpx system can
alter bacterial interactionswith hydrophobic abiotic surfaces (89).
Of note, UPEC mutants lacking either cpxRA or cpxP were not
obviously different from the wild-type strains with respect to mo-
tility, biofilm formation in microtiter plate assays, or the expres-
sion of curli or type 1 pili (unpublished observations). This indi-
cates that many of the phenotypes commonly associated with
UPEC virulence are unaffected by disruption of the Cpx system.
The reduced capacity of UTI89"cpxRA to bind and invade
bladder epithelial cells may contribute to the inability of this mu-
tant to effectively colonize the bladder. However, it is probable
that additional CpxRA-regulated activities also play a role. These
activities may include Cpx-mediated alterations of the bacterial
envelope and peptidoglycan layer that enable bacteria to better
deal with antimicrobial peptides and proteins like complement
(90). The complement system can mediate bacterial opsonization
and the formation of membrane attack complexes, thereby facili-
tating the clearance of bacteria during both localized and systemic
infections (83). The strain-dependent requirement for CpxP in
UPEC resistance to complement-mediated killing, as reported
here (Fig. 6), highlights the individuality of UPEC isolates, which
are often genetically diverse, while also raising questions regarding
the functionality of highly conserved proteins like CpxP.
In addition tomodulating the activity of CpxA,CpxP can func-
FIG 4 Cpx effects on bladder cell invasion by UTI89. Human bladder epithe-
lial cells were infected with the indicated strains for 2 h, followed by an addi-
tional 2-h incubation in medium containing gentamicin (100 !g/ml). Graphs
show the total cell-associated bacterial titers prior to addition of gentamicin
(A) and for gentamicin-protected, intracellular bacteria (B). Data are ex-
pressed relative to wild-type UTI89 (black bars) or UTI89 carrying the control
plasmid pGEN-MCS (gray bars) as the means# standard errors of the means
of at least three independent experiments performed in triplicate. The indi-
cated P values were calculated using Student’s t test.
FIG 5 The Cpx system is required for full virulence of CFT073 in zebrafish
embryos. The PC (A) or blood (B) of 48-hpf zebrafish embryos was inoc-
ulated with 500 to 1,000 CFU of wild-type CFT073, CFT073"cpxP, or
CFT073"cpxRA, as indicated. Fish were scored for death at 0, 24, 48, and 72
h postinoculation. Data are expressed as the percent survival over time
(n ! 17 embryos). P " 0.0008 for the "cpxP and "cpxRA mutants versus
control wild-type CFT073, as determined using Mantel-Cox log rank tests.
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tion as a periplasmic chaperone and may act as a sensor for metal
ions, like zinc and copper (43, 44, 91, 92). UTI89 is apparently
more dependent upon one or more of these activities when chal-
lenged with complement, whereas CFT073 can make do without
CpxP. It is feasible that structural homologues of CpxP, such as
Spy and ZraP (92–94), can substitute for CpxP under specific con-
ditions in strains like CFT073. The Cpx system is best known for
its effects on the expression of periplasmic chaperones and pro-
teases in response to envelope stress, and the misregulation of
these and other factors likely contribute to the myriad defects
observed with the !cpxP and !cpxRAmutants in our assays.
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Acute cystitis is one of the most commonly encountered bacterial infections and is responsible for substantial
morbidity and high medical costs in the United States and across the globe. Though generally considered to be
self-limiting and easily treated with antibiotics, urinary tract infections (UTIs) are often incompletely resolved
by antibiotic therapy and frequently recur. This is in part due to the ability of uropathogenic bacteria to
invade, replicate, and persist within host epithelial cells. The biological complexity of these infections combined
with a dramatic rise in antibiotic-resistant pathogens highlight the need for alternative therapies. In this review
we examine current management strategies for UTIs, as well as emerging treatments, including novel com-
pounds that block bacterial interactions with the urothelium and vaccines focused on preventing both acute
and recurrent infections.
Keywords. UPEC; antibiotic resistance; vaccine; cystitis; recurrent UTI.
A urinary tract infection (UTI) is deﬁned as microbial
inﬁltration of the otherwise sterile urinary tract and is
one of the most common bacterial infections world-
wide. UTIs encompass infections of the urethra (ure-
thritis), bladder (cystitis), ureters (ureteritis), and
kidney (pyelonephritis). There is an estimated annual
occurrence of well over 8 million UTIs in the United
States, many of which result in a visit to a physician [1].
Nearly all patients with UTI are prescribed a regimen
of antibiotics, with roughly 1% of patients requiring
hospitalization. The annual cost of UTI treatment in
the United States is estimated at $2.14 billion [2], a
value compounded by the frequency of recurrent infec-
tions. In this review we discuss the epidemiology of
acute and recurrent UTIs, detail current management
strategies, and explore emerging therapeutics.
EPIDEMIOLOGYOF UTIs
UTIs are the most frequent bacterial infection seen in
the outpatient setting: 1 in 3 women will develop a UTI
requiring antibiotic treatment by age 24, and 50% expe-
rience at least 1 UTI during their lifetime [1]. The inci-
dence of cystitis is signiﬁcantly higher in women than
men, likely the result of anatomic differences. Speciﬁ-
cally, the shorter female urethra can facilitate bacterial
transit from the urethral opening to the bladder. Colo-
nization of the vaginal introitus by gastrointestinal
pathogens can also increase the likelihood of urinary
tract inﬁltration [3, 4]. Other factors, including urinary
tract obstruction, incomplete voiding, and aberrant
structural anatomy also predispose individuals to UTIs.
Additional risk factors include prior history of UTIs,
vaginal intercourse within the past 2 weeks, use of con-
traception with spermicide, low vaginal estrogen lev-
els [1, 5], and individual genetic background (extensively
reviewed in [6]). While a number of comorbidities in-
crease susceptibility to UTI, the majority of UTIs occur
in otherwise healthy women.
The most common bacterial cause of uncomplicated
community-acquired UTI is uropathogenic Escherichia
coli (UPEC), representing >80% of infections [1]. These
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bacteria inhabit the lower intestinal tract of warm-blooded ver-
tebrates where they lead a seemingly innocuous existence until
they gain access to a niche, such as the urinary tract, where they
can cause disease. Other pathogens commonly associated with
uncomplicated UTI include Staphylococcus saprophyticus, Kleb-
siella species, Proteus mirabilis, and Enterococcus faecalis [7].
One of the more ominous issues on the horizon for bacterial
infections, with UTIs being no exception, is the rise of antibiot-
ic-resistant organisms. One especially troubling example is the
heightened incidence of sequence type 131 (ST131) strains of
UPEC around the world. These strains often exhibit high levels
of resistance to multiple antibiotics and have undergone rap-
id intercontinental dispersal over the last decade [8]. ST131
strains are an increasingly common cause of community-acquired
UTIs, spurring efforts to better identify and treat these resilient
pathogens [8, 9]. Factors driving the global spread of ST131
strains are incompletely understood, but likely include the ac-
quisition of antibiotic resistance genes, such as those encoding
extended-spectrum β-lactamases (ESBLs), and the capacity to
effectively utilize a broad range of metabolites [8, 10]. These
characteristics may give ST131 strains a competitive advantage
within host environments, increasing the likelihood of their
dissemination within and between individuals.
RECURRENT UTIs AND INTRACELLULAR
BACTERIAL RESERVOIRS
The burden of UTIs is compounded by their high rate of recur-
rence. Recurrent UTI (rUTI)—deﬁned as 2 uncomplicated
infections in a 6-month time period or 3 infections within a
year—cause a tremendous amount of morbidity and are frustrat-
ing to patients and physicians alike [1]. Despite administration
of antibiotics that seemingly clear the infection (determined by
negative urine cultures), the probability that a patient will
develop a second UTI within 6 months is 25%, with the chance
of recurrence over a 12-month period increasing to 46%. The
historical view of rUTI pathogenesis is that each recurrence
represents an independent inoculation of the urinary tract.
However, this model does not satisfactorily explain many
(>50%, by some estimates) rUTI episodes in which the bacterial
strains responsible for both the initial infection and the recur-
rence are genetically identical [11]. An alternative mechanism
for recurrence involves the establishment of protected, intracel-
lular bacterial reservoirs within the bladder mucosa (Figure 1).
UPEC can invade host epithelial cells, including the termi-
nally differentiated superﬁcial umbrella cells that line the
lumen of the bladder, as well as the underlying, immature
Figure 1. Events that promote the establishment and recurrence of urinary tract infection (UTI). (1) During a UTI, uropathogenic Escherichia coli (UPEC;
green) can replicate within the lumen of the bladder or (2) attach to and invade bladder epithelial cells. (3) Following invasion, UPEC is either shuttled back
out to the lumen or trafﬁcked into late endosome-like compartments. (4) Disruption of these compartments and subsequent entry of UPEC into the host
cytosol allows for rapid intracellular bacterial growth and the development of intracellular bacterial community. During these events, UPEC can acquire al-
ternate morphologies, including the formation of long, ﬁlamentous cells that are resistant to host defenses such as neutrophils. (5) Infection can trigger the
exfoliation of bladder cells, a process that aids in the elimination of adherent and internalized bacteria. The efﬂux of UPEC from host bladder cells, includ-
ing those undergoing exfoliation, facilitates pathogen dissemination within and between hosts. (6) UPEC that remains bound within late endosome-like
compartments in the urothelium can establish long-lived intracellular quiescent reservoirs that are often enmeshed within actin ﬁlaments (red) and ex-
tremely difﬁcult to eradicate with antibiotic treatments. The resurgence of UPEC from these reservoirs can initiate recrudescent infections. Abbreviation:
IBC, intracellular bacterial community.
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intermediate and basal cells [12]. Within superﬁcial bladder
cells, UPEC can enter the host cytosol and rapidly multiply,
forming a bioﬁlm-like assembly known as an intracellular bac-
terial community (IBC) [12, 13]. The development of IBCs can
enhance the ability of UPEC to establish itself within the
urinary tract, building up large numbers of bacteria while se-
questered away from the ﬂow of urine and the inﬂux of inﬂam-
matory cells and antibacterial molecules. IBCs, however, are
not long-lived and will eventually disperse or be shed along
with the infected host cells [14]. Indeed, the remnants of IBC-
containing host cells can be detected in urine samples isolated
from women seeking treatment for UTIs [3]. The efﬂux of
UPEC from within IBCs, as well as the eventual exfoliation of
the infected superﬁcial cells, may potentiate the dissemination
of UPEC both within the urinary tract and between hosts.
Rather than forming an IBC, UPEC can enter a dormant
state within host epithelial cells after trafﬁcking into mem-
brane–bound compartments that become enmeshed within
host actin ﬁlaments [12]. The quiescent nature and intracellular
localization of these bacteria renders them resistant to most an-
tibiotics and inaccessible to inﬁltrating neutrophils and other
host defenses [13, 14]. Experimental models indicate that these
quiescent intracellular UPEC reservoirs can persist for long
periods in the absence of any overt clinical symptoms, even
with the use of antibiotic treatments that effectively sterilize the
urine [14]. Environmental signals, such as the reorganization of
actin ﬁlaments that occurs as bladder cells undergo terminal
differentiation, can trigger the resurgent growth of UPEC,
prompting the development and dispersal of IBCs and the rein-
itiation of clinical symptoms. According to this model, rUTIs
may in many instances be more accurately deﬁned as recrudes-
cent infections. These issues highlight the need for therapeutic
strategies that effectively target both active and dormant stages
of UTI.
CURRENTMANAGEMENTOF UTIs
Initial diagnosis of acute uncomplicated cystitis is typically
based on patient medical history, taking into account past indi-
vidual and family health issues, sexual activity, and current
symptoms. Common indicators of acute cystitis include urinary
urgency and frequency, pain when voiding (dysuria), lower ab-
dominal discomfort, and cloudy or dark urine. The diagnosis
of patients presenting with these classic symptoms may be con-
ﬁrmed by urinalysis showing the presence of red blood cells,
high nitrite levels, and leukocyte esterase in the urine.
Although medical history and urinalysis are sufﬁcient for the
diagnosis of most uncomplicated UTIs, the gold standard for
diagnosis of acute cystitis includes a bacteriological urine
culture with identiﬁcation of the causative agent and antimicro-
bial susceptibility testing. Using fresh, midstream urine, clinical
conﬁrmation of an uncomplicated UTI is classically deﬁned as
≥105 colony-forming units (CFU)/mL of urine. However, this
deﬁnition has recently been modiﬁed based on observations
that many uropathogens are capable of eliciting clinical pathol-
ogy in the urinary tract even with low levels of bacteriuria [1].
Consequently, as little as 103 CFU/mL urine, in the presence of
overt UTI symptoms, is now considered sufﬁcient for diagnosis
of acute cystitis [15]. Current recommended treatments for
acute uncomplicated cystitis are described in Table 1 [1, 16].
Treatment of rUTI
For women who suffer from rUTI, low-dose antibiotic prophy-
laxis such as nitrofurantoin (100 mg per day), cephalexin (250
mg daily) or trimethoprim-sulfamethoxazole (40 mg/200 mg
daily) can provide symptomatic relief and protection against
subsequent infections [17]. For women whose UTIs are coinci-
dent with sexual activity, a single, postcoital prophylactic antibi-
otic can be effective in preventing infections [18]. Self-initiated
antibiotics are also useful for women with frequent recurrent
infections. After diagnosing themselves based on symptoms
and/or a urine dipstick, they can initiate a 3-day regimen
without needing to visit a physician [18].
The increasing prevalence of antibiotic-resistant uropatho-
gens is likely to limit the effectiveness of our current antibiotic
arsenal. For example, individuals who suffer from serious re-
current or chronic UTIs due to ESBL-producing ST131 strains
may beneﬁt greatly from carbapenems such as ertapenem [9],
but these antibiotics are considered one of our last lines of
defense and so should be used cautiously. The ongoing emer-
gence of antibiotic-resistant strains, in conjunction with the
high frequency of rUTIs, highlights the need for a better under-
standing of these infections and the development of new thera-
peutic strategies.
EMERGING THERAPIES
As noted above, many rUTIs are thought to arise from the
ability of bacteria to attach to and invade the bladder mucosa,
where they can form intracellular reservoirs protected from an-
tibiotics and host defenses. As such, many emerging treatments
for UTIs are aimed at blocking adhesion of bacteria to the
urothelium and thereby preventing the establishment of trou-
blesome reservoirs. Type 1 pili (or ﬁmbriae), which are multi-
protein ﬁlamentous adhesive structures encoded by virtually all
UPEC isolates, are generally indispensible for colonization of
the urinary tract [11]. The adhesin protein FimH, which is lo-
calized at the distal tip of each type 1 pilus, binds mannose resi-
dues on host glycoprotein receptors and allows UPEC to
adhere to and invade host bladder cells [19]. Type 1 pili also
promote bioﬁlm formation and the development of IBCs [20].
Because type 1 pili are important colonization factors, the
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therapeutic potential of inhibiting the assembly or function of
these adhesive organelles has received considerable attention.
Pilicides and Mannosides
The assembly of type 1 pili occurs through the chaperone-
usher pathway, relying on the periplasmic chaperone FimC for
the stabilization, folding, transport, and assembly of pilus sub-
units [21]. Small synthetic molecules known as pilicides, which
are designed to target periplasmic chaperones and consequent-
ly interfere with pilus assembly, provide an attractive approach
for blocking bacterial adhesion and subsequent reservoir for-
mation. In vitro, pilicides effectively inhibit pilus biogenesis, re-
ducing UPEC adherence to bladder epithelial cells as well as
type 1 pili–dependent bioﬁlm formation [22, 23]. The efﬁcacy
of pilicides in animal infection models has not been reported.
Researchers have also speciﬁcally targeted the FimH adhesin
by use of soluble receptor analogues, or mannosides, that act as
antiadhesives. These molecules bind FimH and prevent it from
interacting with host receptors [24]. Recently, orally available
mannoside derivatives have been developed that show great
promise as therapeutics [25, 26]. In a murine UTI model, these
agents work prophylactically, preventing bacterial invasion into
bladder tissue [26]. They can also be used to treat established
and catheter-associated infections, acting synergistically with
standard antibiotic treatments to reduce UPEC titers within the
urinary tract of infected mice [27].
Both mannosides and pilicides have exciting potential as
future therapies for the treatment of uncomplicated cystitis and
rUTI, and both types of reagents may help circumvent the
rising tide of antibiotic-resistant organisms. However, one po-
tential concern with the systemic administration of either man-
nosides or pilicides is potential adverse effects on commensal
E. coli strains and other members of the intestinal microbiota,
many of which also express type 1 pili [28]. Current thinking
by many in the ﬁeld is that use of pilicides and mannosides will
likely be less disruptive than current antibiotic treatment proto-
cols, but this supposition requires additional investigation.
Vaccinology
An alternate strategy for the prevention of recurrent and
chronic UTIs is the development of systemic or mucosal vac-
cines. Over the past 20 years, several vaccination approaches
have been explored, including the use of heat-killed whole bac-
teria, bacterial cell extracts, and puriﬁed UPEC-associated viru-
lence factors as antigens. Vaccination of women using a vaginal
suppository containing 10 heat-killed strains of uropathogenic
bacteria showed much promise in recent years [29, 30]. This
multivalent vaccine formulation, known as Solco Urovac, in-
cluded 6 E. coli strains plus 1 strain each of P. mirabilis,
Morganella morganii, Klebsiella pneumoniae, and E. faecalis.
Urovac passed phase 2 clinical trials and was shown to reduce
the incidence of UTI caused by E. coli in sexually active women
Table 1. Common Treatment Options for Uncomplicated Cystitis
Antibiotic Mechanism Dosage Notes
Nitrofurantoin
monohydrate/macrocrystals
Inhibits protein, DNA,
RNA, and cell wall
synthesis
100 mg orally, twice daily
for 5 d
Low resistance rates and risk
of adverse side effects.
Similar efficacy compared to
a 3-d regimen of
trimethoprim-
sulfamethoxazole
Trimethoprim-
sulfamethoxazole
Inhibits nucleic acid
synthesis by folate
synthesis inhibition
160 mg/800 mg (1 double-
strength tablet), twice
daily for 3 d
Only for use when local
resistance rates do not
exceed 20% and in patients
who do not have sulfa drug
allergies
Fosfomycin trometamol Blocks cell wall
synthesis by
inactivating
enolpyruvyl
transferase
3 g in a single dose Minimal resistance and risk of
collateral damage. Inferior
efficacy compared to other
regimens
Pivmecillinam Disrupts synthesis of
cell wall by
inhibiting formation
of peptidoglycan
cross-links
400 mg, once daily for 3–7 d Low resistance rates and risk
of adverse side effects. Not
available in North America
The choice of antibiotics should be made after considering patient allergy and compliance history, local resistance rates, drug availability, and cost.
Fluoroquinolones such as ciprofloxacin are highly effective and can be given if none of the recommended antimicrobials can be used. However, resistance rates to
these drugs are on the rise and it is recommended that they be reserved for conditions other than acute cystitis. β-lactam antibiotics, such as amoxicillin, cefdinir,
cefaclor, or cefpodoximine, in 3- to 7-day treatment regimens can be given when other recommended agents cannot be used. However, β-lactam antibiotics have
inferior efficacy and a higher rate of resistance, particularly in ST131 strains. Ampicillin should not be used because it displays relatively poor efficacy in the
treatment of urinary tract infections and resistance rates to ampicillin are typically high.
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between 20 and 50 years of age with histories of rUTI [29].
Although some individual patients in the study showed increas-
es in anti–E. coli antibody levels, no statistically signiﬁcant dif-
ferences between vaccinated and placebo control groups were
detected, possibly accounting for the lack of any follow-up
phase 3 trials.
Speciﬁc bacterial factors that have been targeted as vaccine
candidates for UTI include the type 1 pilus–associated adhesin
FimH and UPEC-associated iron acquisition systems. Like pili-
cides and mannosides, antibodies directed against FimH can
interfere with the functionality of type 1 pili, disrupting the
ability of UPEC to colonize the urinary tract. Vaccination with
puriﬁed FimH coupled to its periplasmic chaperone FimC
offered protection against UPEC when administered systemi-
cally in both murine and primate models of cystitis [31–33]. A
similar vaccine containing a truncated version of FimH protect-
ed mice from experimentally induced cystitis when given by
either intramuscular or intranasal (mucosal) inoculation, using
CpG oligonucleotides as adjuvant [34].
Most bacteria require iron for survival, and while there is
ample iron in the human body, it is sequestered and generally
inaccessible to bacteria. Consequently, UPEC and many other
pathogenic bacteria rely upon iron-chelating molecules and re-
ceptors that enable them to scavenge essential iron from the
host [35]. Use of puriﬁed bacterial iron receptor proteins for
vaccination against UPEC has had mixed results. Of 7 UPEC-
associated iron receptors tested as vaccines in mice, 2 (IreA and
LutA) provided signiﬁcant protection against experimentally
induced cystitis [36]. Vaccination with another iron receptor,
Hma, protected against kidney infection, but not cystitis. For
this analysis, the puriﬁed iron receptors were delivered intrana-
sally after being conjugated to cholera toxin to increase antige-
nicity.
In total, these studies highlight both FimH and iron recep-
tors as potentially valuable vaccine candidates that merit
further investigation. However, as with mannosides and pili-
cides, the use of puriﬁed iron receptors, FimH, or other UPEC-
associated factors as vaccines may have inadvertent effects on
members of the endogenous microbiota that should be consid-
ered. In addition, the route of vaccine delivery and the types of
adjuvants utilized need to be optimized for maximal efﬁcacy
in humans. While individuals prone to recurrent or chronic
UTIs may beneﬁt greatly from the development of anti-UPEC
vaccines, the costs and risks of this strategy require further
evaluation.
Despite these hurdles, initial success in the development of
anti-UPEC vaccines has spurred the search for additional
vaccine antigens. Candidate approaches, in which known viru-
lence factors such as ﬂagellin are targeted, continue to generate
promising results [37], but less biased methods that are not nec-
essarily reliant on our limited understanding of UTI
pathogenesis may prove more fruitful. Along these lines, re-
searchers have developed in silico approaches, known collec-
tively as reverse vaccinology, to probe the increasingly large
number of sequenced bacterial genomes for pathogen-speciﬁc,
surface-localized antigens [38, 39]. These traits in a vaccine
antigen should increase the efﬁcacy of antibody responses
while limiting cross-reactivity with nonpathogenic bacteria.
This approach to vaccine design is encapsulated in a publicly
available, Web-based system known as Vaxign (http://www.
violinet.org/vaxign/). By screening for outer membrane pro-
teins with amino acid sequences that are conserved among
UPEC isolates, but absent from nonpathogenic E. coli strains as
well as humans and mice, Vaxign identiﬁed 22 putative UPEC-
speciﬁc vaccine targets [40]. Several of these are functionally
undeﬁned, and a few are known to be expressed by UPEC
during UTI, but to date none have been shown to protect
against cystitis. The reﬁnement of reverse vaccinology, coupled
with gene expression proﬁling, proteomic analyses, and emerg-
ing high-throughput genetic screens, promises to greatly
enhance our ability to identify useful vaccine targets.
CONCLUSIONS
Although UTIs are often considered to be easily managed in-
fections, they remain a huge burden for millions of individuals
and our healthcare system. The increasing prevalence of antibi-
otic resistance among uropathogens presents a major challenge
to the clinical management of UTIs. Recurrent infections, in-
cluding those caused by antibiotic-sensitive pathogens, are ex-
ceptionally common and are likely attributable in part to the
establishment of recalcitrant intracellular bacterial reservoirs
within the bladder mucosa. Eradication of these clinically rele-
vant reservoirs will require a better understanding of the under-
lying molecular mechanisms that allow for their persistence.
The ongoing development of new antimicrobial approaches,
such as the use of pilicides and mannosides in conjunction
with antibiotics, will provide new treatment options, while the
identiﬁcation of new vaccine candidates and optimized vacci-
nation protocols promises relief to individuals who suffer from
recurrent or chronic UTI.
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